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Summary
S
An oral fat tolerance test was administered to groups of normal male and female volunteers, 
and to a group of patients undergoing coronary angiography. The changes in plasma 
lipoprotein fractions were monitored during the post prandial phase. Vitamin A (retinyl 
palmitate) was added to the fat load to mark lipoproteins of intestinal derivation.
In healthy male subjects the post prandial rise in plasma triglyceride was associated with 
an increase in the size of lipoproteins of density less than 1.006kg/l, and with characteristic 
changes in the composition of the other lipoprotein classes. Triglyceride rose in LDL and 
HDL in parallel with the rise in p<1.006 triglyceride. Phospholipid in LDL and HDL continued 
to rise beyond the peak of triglyceridaemia. HDL cholesteryl esters fell at the peak, and the 
free cholesterol content of LDL and HDL rose in the late phase of lipaemia. Retinyl palmitate 
was present in significant amounts 24 hours after the initial fat meal.
The pattern of changes was interpreted in terms of lipoprotein surface and core lipid 
compositions. There was a decline in the ratio of free cholesterol to phospholipid in the 
surface regions of LDL, and a fall in the ratio of cholesteryl ester to triglyceride in the core of 
both LDL and HDL.
Post prandial triglyceridaemia correlated positively with fasting levels of the apo B 
containing lipoproteins, and negatively with HDL. There was an inverse correlation with post 
heparin lipoprotein and hepatic lipase activities. Triglyceridaemia was positively related to the 
actual free cholesterol content of LDL, but negatively to the post prandial changes in LDL free 
cholesterol. The fall in HDL cholesteryl ester and cholesteryl ester/triglyceride ratio were 
negatively related to triglyceridaemia.
Females had lower fasting VLDL and higher HDL than males. Post prandial triglycerides 
were less and post heparin lipoprotein lipase activity was greater. There was a greater 
increase in plasma free cholesterol during lipaemia and a fall as opposed to a rise in plasma 
cholesteryl ester. Retinyl palmitate levels were less at all times, but most significantly at 24 
hours after the fat meal.
In subjects undergoing coronary angiography fasting LDL cholesterol was positively 
related and HDL cholesterol negatively related to angiogram score. Post prandial 
triglyceridaemia was positively related to angiogram score, but fasting triglycerides were not. 
The best single predictor of angiogram score was retinyl palmitate levels 24 hours after the fat 
load. Retinyl ester levels were also strongly related to LDL cholesterol.
Increasing the cholesterol content of the fat load had no effect on post prandial lipids.
Decreasing the fatty acid saturation of the test meal decreased triglyceridaemia only 
slightly. Chylomicrons obtained after saturated or unsaturated fat loads differed in the 
composition of their triglyceride content, but not in the composition of phospholipid fatty 
acids. These chylomicrons were catabolised at similar rates during in vitro lipolysis.
x
Three weeks treatment with fenofibrate reduced fasting VLDL and LDL, and increased 
HDL3 . Post prandial triglycerides were decreased, and the post prandial fall in HDL 
cholesteryl esters was eliminated. Retinyl palmitate was apparently increased during lipaemia 
but levels were unchanged at 24 hours.
Three weeks treatment with nicotinic acid reduced fasting VLDL and LDL and increased 
HDL2. Post prandial triglycerides were reduced but retinyl esters were unchanged. There 
were no significant changes in other aspects of post prandial lipid flux.
Possible mechanisms explaining these findings are discussed.
Chapter 1
Introduction
jess than an hour after consuming a meal containing fat the blood serum takes on a white, 
cloudy appearance, sometimes with white streaks floating on the surface. The subject 
matter of this paper concerns the nature of this post-prandial or alimentary lipaemia in terms 
of the alterations in plasma fat transport which it represents.
1.1 Of the White Serum 
S
Among the earliest accounts of this phenomenon, Robert Boyle in 1665 reported an incident 
which had come to his attention in which "they had, in the house o f a physician, newly 
opened a man's vein, wherein they fo u n d  m ilk instead o f blood".1 In his book 'De Corde' 
published in 1669 Dr Richard Lower, a colleague of Boyle's extends these observations, 
stating that "vessels appeared fu ller o f m ilk than o f blood, i f  a vein was incised after a good 
breakfast or luncheon".2 He goes on to describe a series of experiments in which he 
illustrates the route whereby food is digested and assimilated into the blood. It is clear from 
these writings that he was well aware of the nature of the white serum. "Although this 
phenom enon bad been observed by the doctors o f earlier days", he grants, "they were quite 
unaware o f its cause".
Over one hundred years later, in 1772 William Hewson described several cases of people 
with white serum, perhaps the first documented cases of hyperlipidaemia.3
"Mary Rider, about twenty five  years o f age, o f a fresh complexion, and lusty, has not had her 
menses fo r  these seven m onths. She discharges blood som etim es by vom iting a n d  
sometimes by stool; complains o f a pa in  in her left side and  in her stomach; she has an  
inclination to eat, but when she tries, she soon loathes her food. She complains o f great 
lassitude and sleepiness; her pulse is ninety-five in a minute. She has been bled twelve times 
w ithin these six months, and every time the serum was as white as milk".
l
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Hewson examined the serum from these cases of whiteness under a microscope and found it 
to contain a number of small globules. These globules he observed were spherical and agreed 
more with the globules of milk than the red particles of blood, which were smaller and were 
flat. Hewson considered the particles to be oily in nature. "Recollecting that butter had been 
got from  such hum an serum I  tried, by agitating some o f it, a little diluted, to separate its oil or 
chum  it w ithout success". He eventually allowed the serum to dry on a piece of paper and 
found the residue to be greasy.
In a footnote to these studies in the collected works of Hewson,4 George Gulliver 
confirms his estimate of the size of these particles "to be scarcely a>of an inch and
agreeing in all respects with the molecular base o f the chyle", a term adopted by Gulliver to 
signify the particulate nature of the chyle whilst discussing the subject at length in his 
appendix to Gerber's Anatomy of 1842.5
The advent of the dark field microscope provided a basis for future quantitative studies 
of lipaemia, and inspired those researchers of a lyrical disposition. In the first description of 
the appearance of these particles in the dark field Edmunds6 noted that blood "... seems like 
a wholly new substance, with m ultitudes o f glancing particles which look like motes in a 
sunbeam". Simon Gage7 imagined the blood to be "literally alive with these dancing particles" 
which, he continued, "were shown as clearly as the stars in the m ilky way on a clear dark 
night". Other authors have variously described these bright particles as 'fat dust', and 
'haemokonia' -blood dust.8 The term chylomicron was proposed by Gage in 1920,7 to 
designate their origin (in the chyle) and their dimensions (diameter 1.0 ^m).
In 1924 the same author, in collaboration with Pierre Fish published a review of their 
w ork8 in which they laid a foundation for the quantitative assessment of post prandial 
chylomicronaemia, and investigated some of its physiological and environmental 
determinants. Using the techniques of dark field microscopy they established that it was the 
fat component alone of newly absorbed food that gave rise to chylomicrons, and that it took 
from j  to I 5 hours after eating fatty food for them to appear in serum. They examined the
effects of different kinds of fat, inter-individual differences in man and animals, the effects of 
age and gender, and the influence of mental conditions on alimentary lipaemia.
Quantitation of lipaemia by dark field microscopy9-10 involved visualisation of a capillary 
blood sample (obtained by thumb prick) at set times after eating, followed by a direct count
of the number of chylomicrons in a specified grid area of the fie ld  a technical exercise
likened by some authors to counting snowflakes in a storm.8 The rapid Brownian motion of 
the particles necessitated several counts of each area by different individuals in order to 
improve the accuracy of the mean count. This number was then plotted against time to 
produce a 'chylomicrograph', the area of which was determined by planimetry and used as a 
measure of the magnitude of lipaemia. This technique was used by several groups of workers 
at this time,*11 and continued in use as late as 1950.12,13
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Alternative techniques for the quantitation of lipaemia included measurement of the 
thickness of the 'cream line' after spinning serum in a centrifuge at 15000 revolutions per 
minute (rpm) for a set time, 14 or the use of the Tyndall Light Box which measured the 
scattering of incident light by lipaemic sera, the electrical signal generated being proportional 
to the size as well as the number of particles.14
Other groups used chemical methods based on the estimation of neutral fats to examine 
the effects of a fatty meal on blood lipids,15 and it was established that the chylomicrograph 
and blood fat curves rose and fell in parallel.11 Evidence for the composition of chylomicrons 
remained largely circumstantial however, till the advent of the ultracentrifuge allowed their 
preparation in purified form.
Early workers were hindered by the inconvenience of having to halt spins every fifteen 
minutes to allow the equipment to cool down.16 Nevertheless they were able to confirm that 
the main component of the largest particles at least was triglyceride, and it was soon 
confirmed that they also carried cholesterol.14 Although investigations into the nature of 
chylomicrons continued, the arrival of the ultracentrifuge signaled a decline in the use of the 
chylomicrograph as attention was diverted to the newly discovered lipoproteins, and only 
recently has its use been revived.17
Much of the early interest in chylomicronaemia was stimulated by the recognition that 
blood lipids were somehow involved in the development of atherosclerosis. Similarly the 
discovery that plasma lipids were transported as lipoproteins led to an explosion of interest, 
which continues today, in the study of lipoproteins and atherosclerosis.
1.2 The lipoproteins 
S
In several laboratories the ultracentrifuge soon became an essential tool in the study of serum 
lipids, and techniques quickly achieved a high degree of sophistication.1* 19 Lipoproteins were 
identified as large molecular structures in which polar and non-polar lipids are complexed 
with specific amphiphilic proteins (the apolipoproteins or apoproteins) for purposes of 
trans-portation through the plasma.
The general structure of these macro-molecules places neutral lipids (cholesteryl esters 
and triglycerides) in the core of a spherical particle, separated from the external aqueous 
environment by a surface monolayer consisting of apoproteins and the more polar lipids, 
mostly phospholipids, but including free cholesterol.20 The mutual solubilities of these lipids 
may allow appreciable quantities of cholesterol to be distributed into the core, and small but 
significant amounts of cholesteryl ester and triglyceride to enter the surface monolayer.21 In 
this model relative amounts of the more dense surface components increase with the square 
of the lipoprotein radius, and amounts of the less dense core components increase with the 
cube of the particle radius.
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Figure 1.1 The lipoproteins occupy a continuum of size 
and density determined by the relative contributions of 
lipid and protein to their total mass. This continuum can be 
divided by empirical means into several classes with 
apparent physiological significance, and within which the 
majority of plasma lipoproteins lie. Nonetheless such 
operational definitions are to some extent arbitrary, and 
obscure the existence of particles with similar physical 
properties but different physiological background.
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In the ultracentrifuge five major lipoprotein classes and several subclasses have been 
identified, and have gained widespread recognition and use in clinical as well as research 
laboratories (Figure 1.1). They are defined either in terms of their hydrated density (g/ml), or 
their rate of flotation through a salt solution of specific gravity 1.063 g/ml. The latter is 
expressed in terms of Svedberg units of flotation (S/)*22. The following section provides only 
a brief description of the main characteristics of these lipoprotein classes.
Chylomicrons
These are the largest and least dense of the plasma lipoproteins. They are synthesized by the 
intestine and transport newly absorbed dietary fat through the bloodstream. Under normal 
physiological conditions they are not present in fasting blood.
Very low density lipoproteins (VLDL)
These particles share similarities with chylomicrons in that their main component is 
triglyceride. They differ however in that they are synthesized from endogenous materials in 
the liver, and are present in fasting as well as post prandial blood.
The triglyceride component of both chylomicrons and VLDL are hydrolysed in the 
plasma by the enzyme lipoprotein lipase (LpL) present on the endothelial surfaces of blood
vessels. Both chylomicrons and VLDL may give rise to 'remnants'   catabolic products
which seem less susceptible to further lipolysis. These remnants are relatively enriched in 
cholesterol and are efficiendy cleared from the plasma by hepatocytes.
Interm ediate density lipoproteins (LDL)
Present only in low concentration in normal plasma these lipoproteins represent an 
intermediate stage in the formation of LDL from VLDL. They contain relatively less 
triglyceride and more cholesteryl ester than VLDL.
Low density lipoproteins (LDL)
These are the major carriers of cholesterol in plasma. They are formed in the circulation by 
catabolism of hepatic VLDL and IDL, and are removed by hepatic and extra-hepatic tissues in 
a specific receptor mediated process which allows regulation of cellular cholesterol uptake.
High density lipoproteins (HDL)
These are the smallest and most dense lipoproteins. They are formed in the plasma either 
from precursors synthesised in the gut and liver, or from catabolic products generated at the 
surface of triglyceride rich lipoproteins during lipolysis.
*One Sf  unit is equal to 10"^ cnvVdyne/g at 26°C.
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HDL exhibit considerable structural and metabolic heterogeneity. The two major 
subfractions of physiological significance are termed HDL2 and HDL3 , and are separated on 
the basis of size or density. Other species of HDL, notably those with and without apo E, can 
be separated by affinity techniques and also appear to be physiologically important
_________________ Table 1.1 Key proteins involved in  lipid metabolism
Protein Function
a). A poproteins
AI Structural protein in HDL; LCAT activator; Receptor ligand
All Structural protein in HDL
B43 Structural protein in chylomicrons
B100 VLDL-LDL structural protein; Receptor ligand
Q  ?LCAT activator
CII LpL cofactor
Cin LpL modulator
E Receptor ligand
b). Receptors
apo B/E Cellular uptake and degradation of VLDL an LDL
apo E Hepatic uptake of chylomicron remnants; ? uptake of apo E rich HDL
c). Enzymes
LCAT* Cholesterol sequestration and esterification in lipoproteins
LpL*1 Hydrolysis of triglycerides in chylomicrons and VLDL
HLP Hydrolysis of triglycerides and phospholipids in IDL, LDL, and HDL.
LIP* Several species facilitate the movements of phospholipid, cholesteryl esters,
and triglycerides between lipoprotein classes in plasma.
’Lecithin: cholesterol acyl transferase, ^Lipoprotein lipase, ^Hepatic lipase, "Lipid transfer protein. 
Adapted from reference 23-
The metabolism of these lipoprotein classes is directed by a num ber of protein
components;   receptors on cell membranes, enzymes in plasma, and apoproteins
distributed on the lipoprotein surface (Table l.l).As well as a structural role apoproteins 
regulate the metabolism of lipoproteins by modulating the activity of the plasma enzymes or 
by mediating their uptake by specific lipoprotein receptors. Their distribution in the various 
lipoprotein classes is given in Table 1.2.
Apo AI is a cofactor for the enzyme lecithin: cholesterol acyl transferase (LCAT) which 
transfers fatty acids from phospholipids to cholesterol forming cholesteryl esters. The 
activity of LCAT is mostly associated with HDL, the major repository of apo AI in plasma, and
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leads to esterification of free cholesterol present in the surface monolayer of these 
lipoproteins.
Apo CII is an essential activator of LpL whereas the presence of apo CIII on triglyceride 
rich lipoproteins may suppress LpL activity and also modify the ability of receptors to bind 
with apoE.
Apo Bioo is present on VLDL, IDL, and LDL of hepatic origin, and is the ligand for the 
LDL receptor. This receptor is responsible for the uptake of LDL by cells and plays an 
important role in the regulation of cellular and plasma cholesterol levels. Apo B48 is present 
only on triglyceride rich lipoproteins of intestinal origin and is not thought to be important 
in receptor mediated processes.
Apo E is also a ligand for the LDL receptor. It exists on chylomicrons and VLDL, and on a 
subgroup of HDL. The presence of apo Bioo or E on a lipoprotein does not guarantee uptake 
by a particular receptor however, and it seems likely that the lipid content and physical 
properties of a lipoprotein particle may modify receptor interactions.
The presence of apo E on chylomicrons seems to be important in the clearance of 
remnant particles by the liver. The receptor responsible for uptake of these remnants 
appears to be distinct from that responsible for uptake of LDL, and has apo E alone as its 
ligand. A number of other receptors have been proposed to mediate the uptake of abnormal 
lipoproteins from the circulation.
Table 1.2 Concentration o f apoproteins in serum lipoproteins
Chylomicrons VLDL LDL h d l 2 HDL3
AI 33 trace trace 65 62
All trace trace trace 10 23
AIV 14 - - p trace
B 5 25 95 3 -
C 32 55 2 13 5
D p p p 2 4
E 10 15 3 3 1
Figures are grains per lOOg of protein. Adapted from reference 24.
1.3 Lipoproteins and atherosclerosis 
S
"Atherosclerosis is generally considered to be the major disease o f this era. Its consequences 
in the coronary, cerebral, and  peripheral arteries, in the form  o f occlusive phenomena, are 
responsible fo r  more death and disability than any other disease"}9
Thus wrote John Gofman in 1950, in the introduction to an article in which he and his 
collaborators at the Donner Laboratory in Berkely presented new evidence on the role of the 
serum lipoproteins in atherosclerosis. In 1988 Nobel laureates Michael Brown and Joseph
Goldstein, introducing a symposium on the same subject stated that "In recent years the
case against plasm a lipoproteins as inciting agents in atherosclerosis has been established 
beyond reasonable doubt".2*
The intervening years have witnessed a massive investment by the scientific and medical 
communities in their investigations into the nature of this major disease, and the involvement 
of the lipoprotein system in its initiation and progression.
1.3.1 Pathological and epidem iological aspects o f  atherosclerosis
Atherosclerosis consists anatomically of a combination of changes in the intima of arteries 
involving an accumulation of lipids and complex carbohydrates with blood and its 
constituents, accompanied by a hardening and thickening of the arterial wall. Hie initiating 
factors are not precisely known but the condition seems to develop slowly over a period of 
decades. So called 'fatty streaks', visible in the walls of arteries from puberty, contain cells 
filled with many lipid droplets giving them a characteristic appearance which has prompted 
the descriptive term 'foam cell'. However it is not known what causes these streaks, or even 
whether they progress to become bona fid e  atherosclerotic plaque.
Progression of the disease involves the accumulation of cell debris, cholesterol crystals & 
esters, and calcium in a necrotic centre, overlying which is a fibrous cap of proliferated 
smooth muscle cells, extra- and intra-cellular lipid, and collagen. As it develops this plaque 
occupies progressively more space within the vascular lumen, eventually interfering with 
normal blood flow. When the lumen is reduced to about a third of its normal diameter 
ischaemia of the tissues distal to the narrowing ensues, leading to clinical conditions such as 
coronary heart disease (CHD), cerebrovascular insufficiency, and peripheral arterial occlusive 
disease. In a further stage of development the plaque may rupture or fissure, leading to 
haemorrhage, ulceration and thrombosis.
Coronary heart disease (eg. angina pectoris, myocardial infarction, sudden cardiac death) 
is a widespread manifestation of atherosclerotic disease, and is the major cause of premature 
death and disability in many industrialised countries. For these nations it represents a major 
financial drain in terms of lost working hours and medical resources. The United Kingdom 
(UK) is prominent in the world ranking of CHD mortality rates, and within the UK Scotland
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fares worse than England or Wales. ^  Even within Scotland there are large regional variations 
in mortality, with the Greater Glasgow area demonstrating the highest rate.27
Lacking precise knowledge of the causative factors in atherosclerosis, and noting these 
large population differences, epidemiologists have been prompted to introduce the concept
of risk factors factors within populations which have been found to be associated with an
increased likelihood of developing the disease. Many such risk factors have been identified28 
and new ones are frequently suggested. Some of these are genetic in origin, and some relate to 
dietary or social habits. Very often however, risk is associated with a combination of genetic 
disposition and unhealthy lifestyle, thus the origins of the disease are generally referred to as 
m ultifactorial, with several possible factors, perhaps individually but more probably 
interacting in unhappy concert, to produce the symptoms.
Foremost and most consistent among established risk factors have been cigarette 
smoking, hypertension, and raised blood lipids.28-29 Of these the most relevant to this study is 
the role of lipids in atherosclerosis.
1.3.2 C holesterol and atherosclerosis
The ubiquity of cholesterol deposition in the atherosclerotic lesion,30 the strong positive 
correlations between serum cholesterol and the incidence of the disease,31-32 and the recent 
finding that therapy aimed at reducing serum cholesterol levels in hypercholesterolacmic 
subjects is accompanied by a reduction in the incidence of the disease,33'33 leaves little doubt 
that cholesterol metabolism is somehow involved in atherosclerosis. It has even been 
suggested that some minimum serum cholesterol may be necessary for the development of 
atherosclerosis.36
The relationship of cholesterol levels to CHD extends in a continuum down through the 
normal cholesterol levels found in Western society,37 and has led to the advocation of 
nationwide cholesterol lowering, with the introduction of action limits encompassing a 
substantial proportion of the population.38
1.3.3 Triglycerides and atherosclerosis
Despite the fact that populations at risk from CHD consume large amounts of triglyceride 
daily, and that the quantity and quality of this fat is intimately related to the development of 
the disease,31 the concentration of triglyceride in plasma has never received the unanimous 
recognition as a risk factor that cholesterol has. There are probably several reasons for this.
Firstly, triglyceride is not directly associated with the atherosclerotic lesion in the 
incriminating fashion that cholesterol is.30 Secondly, people suffering from conditions such as 
Type I hyperlipidacmia, in which serum triglyceride can reach levels in excess of 10 mmol/1, 
are not particularly susceptible to developing atherosclerosis.39 Lastly, the results of 
epidemiological studies have not demonstrated a consistent independent relationship
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between plasma triglycerides and CHD, and so have failed to convince the medical profession 
of their importance.40
Nevertheless concerns over the possible role of triglycerides in heart disease remain.41 
Serum triglycerides are frequently either moderately or markedly elevated in individuals 
suffering coronary infarction. In a widely quoted review of the subject Hulley et al noted 26 
out of 27 studies examined in which there was a positive association between CHD and serum 
triglyceride.40 It was discovered however, that this univariate relationship disappeared when 
other risk factors, with which serum triglycerides are correlated, were included in multiple 
logistic regression analyses. They concluded that there is little reason to believe that 
triglycerides are causally related to the disease, since the associations observed derive from a 
mutual association with other risk factors, namely serum and HDL cholesterol, and body 
mass.
However, by introducing an interaction term  into their multiple regression analyses a 
recent report suggests that triglycerides may be an 'independent' predictor of CHD in 
subjects with relatively low serum cholesterol (<5.7mmol/l)42 and in the ongoing Framingham 
study43 there is a suggestion that high triglycerides are a risk factor in those who have a ratio of 
serum to HDL cholesterol which is greater than 3.5.
These examples illustrate the fundamental problem presented by the multifactorial 
nature of the disease. Static measurement of serum cholesterol provides useful information 
regarding the likelihood of developing CHD. Similarly, measurement of HDL cholesterol, 
blood pressure, body mass, smoking habits, the unsaturated fat content of the diet, or plasma 
triglyceride bring additional information. Taken together these factors may be integrated to 
provide an overall picture of an at risk person, or population.
However these factors are frequently physiologically related, statistically correlated, and 
quite possibly interactive rather than merely additive in their effects44 It may be futile 
therefore to attempt to extract the relative risk attached to any one factor in searching for the 
causes of the disease.
Morphologically, triglyceride and cholesterol are united in the lipoproteins for transport 
through the plasma. Physiologically, the metabolism of triglycerides is intimately related to 
that of all the lipoprotein classes,45-46 and in hypertriglyceridaemic subjects there are 
distinctive abnormalities in lipoprotein structure and metabolism, which can be corrected by 
correction of the hypertriglyceridaemia 47
It was not a conclusion of Hulley et al that triglycerides were uninvolved in 
atherosclerosis, only that there was no evidence to support screening for, or treatment of,
isolated hypertriglyceridaemia.40 In their paper these authors complained th a t "Triglyceride
is often lum ped together with cholesterol in  this fashion, which tends to discourage 
physicians from  making separate judgem ents fo r  the two hyperlipidcemias".
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They concede however that it is difficult to test separate intervention in triglyceride or 
cholesterol levels by dietary or pharmacologic means due to their close relationship in a 
common transport system. It may be therefore that serum cholesterol and triglyceride 
cannot be considered separately, and that elevations in one or the other reflect alterations in 
specific lipoprotein fractions which, although perhaps showing a disproportionate effect on 
the levels of one lipid, ultimately affect both.
In the recently conducted Helsinki Heart Study35 the drug Gemfibrozil was found to 
reduce the incidence of CHD in dyslipidacmic men. This drug lowered serum cholesterol by 
10%. It also lowered triglyceride by 43%, non HDL cholesterol by 14%, and raised HDL 
cholesterol levels by 10%. In other words it corrected the overall pattern  of lipoprotein 
transport in a manner favourable to the reduction of heart disease.
1.3.4 Chylomicronaem ia and atherosclerosis
Post prandial chylomicronaemia was among the first of the lipid disorders suspected in the 
genesis of atherosclerosis. It was a consistent finding of early studies that lipaemia was more 
severe in people suffering from ischaemic heart disease. 13,48' 51 As an hypothesis it was 
attractive since its transient nature could explain the common occurrence of the disease in 
otherwise normo-cholesterolaemic subjects.
The atherogenicity of lipaemia was initially considered to reside in the large size and 
particulate nature of the chylomicrons, and that post prandial triglyceridaemia was merely an 
indication of the number of chylomicrons present. Moreton49 for example, considered 
intimal deposition "to be directly related to the physical state o f the lipids", and deemed it 
therefore "meaningless and  unnecessary to measure triglycerides during alimentary lipcemia".
He theorised that intimal macrophages of the reticulo-endothelial system identified these 
large particles as foreign bodies and engulfed them, and that while the triglyceride could be 
easily catabolised and absorbed by the cells of the intima, the residual cholesterol could not, 
and gradually accumulated in the cytosol leading to the formation of cholesterol laden foam 
cells.
Denborough51 considered the relationship to CHD to be derived from an association of 
lipaemia with fasting triglycerides, with exogenous and endogenous triglyceride rich particles 
competing for a common removal mechanism. Lipxmia in itself was not thought to be 
causally related to the disease.
In more recent times the theory has been revived in slightly different form by 
Zilversmit,52 who suggested that the interaction with the endothelium during lipolysis may 
provide an environment conducive to cholesterol deposition. The finger of blame had now 
shifted however from the chylomicron itself to the chylomicron remnant, a cholesteryl ester 
enriched particle, resistant to further lipolysis and removed directly from the circulation by 
receptor uptake.
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The appeal of this theory was again that it might constitute a 'latent dyslipidaemia' which 
could explain the development of the disease in normolipidaemic individuals.53 It was lent 
further support by the finding that cholesteryl ester enriched chylomicron remnants closely 
resembled 6 -VLDL, an abnormal lipoprotein found in circumstances of high risk for the 
development of atherosclerosis.54
More recently still the growing appreciation of the inter-related and dynamic nature of 
lipoprotein metabolism55 (see later) suggests another possibility, not exclusive of the above, 
that lipaemia may influence atherosclerosis indirectly by altering lipid flux through the 
lipoproteins, shifting cholesterol into less well regulated and potentially atherogenic 
pathways. Such a concept is founded in the belief that certain lipoprotein classes possess 
particularly atherogenic characteristics.
1.3.5 Atherogenic lipoproteins
Cholesterol in foam cells is generally thought to be derived from circulating lipoproteins. 
When there is a positive cholesterol balance in which uptake of lipoprotein cholesterol 
exceeds catabolism or efflux, cholesterol accumulation ensues .56 The nature of the 
lipoprotein particle that gives rise to this situation and induces foam cell formation has been 
the focus of much research activity. Candidates include native LDL,57 large LDL,58 chemically 
or physically modified LDL,59 oxidised LDL,36 6 -VLDL,60 and the remnants of triglyceride rich 
lipoproteins.61 Central to the arguments regarding foam cell formation by these lipoproteins 
is the regulation of cellular cholesterol content by specific cell surface receptors.
The LDL receptor, because of its ability to recognize specific domains on apo B and E, 
binds lipoproteins carrying these peptides and leads to internalization of the whole 
lipoprotein by endocytosis. Hydrolysis of internalized lipoproteins releases cholesterol into 
the cytoplasm where it initiates a process of auto-regulation, suppressing further receptor 
synthesis and reducing cholesterol production by inhibiting the enzym e 
hydroxymethylglutaryl coenzyme A reductase (HMG CoA reductase). Cholesterol itself may 
be put to use by the cell, exported as bile acids or in lipoproteins, or esterified by ACAT and 
stored as cholesteryl esters.
Since the LDL receptor also recognises apo E on certain lipoproteins it is thought that a 
species of HDL carrying apo E may return cholesterol from the periphery to the liver,54 
although the quantitative significance of this pathway in man remains to be established.
Whereas cholesterol balance in most cells is controlled by the LDL receptor, 
macrophages and certain other cells of reticulo-endothelial origin seem to possess only a few 
of these.59 They are furnished however with other distinct receptors thought to play a role in 
the uptake of certain abnormal lipoproteins. These receptors differ from the LDL receptor 
in that their expression is only poorly regulated by the cholesterol load of the cell. Therefore 
even in the presence of large amounts of intra-cellular cholesterol they continue to be
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expressed and to remove their ligands from the plasma, resulting in a critical accumulation of 
cholesteryl ester, and leading eventually to foam cell formation.
Among these the acetyl LDL receptor seems to specifically identify LDL which has been 
chemically modified in certain ways, for example by acetylation, aceto-acetylation, or 
treatment with malondialdehyde.59 The native ligand for this receptor remains unknown.
8 -VLDL is a peculiar lipoprotein which has the flotation properties of VLDL, and the 
electrophoretic mobility of LDL. These particles are present in Type III hyper­
lipoproteinemia, and can be induced by feeding diets high in cholesterol and f a t  both
conditions associated with a greatly increased risk of developing CHD. They are thought to 
represent exaggerated forms of the remnants of triglyceride rich lipoproteins which have 
become particularly enriched in cholesteryl esters, and they are capable of provoking 
massive cholesterol accumulation in macrophages, and foam cell formation.54-62
A 8 -VLDL receptor, like the acetyl LDL receptor is found only on cells of reticulo­
endothelial origin, and in keeping with the general function of these cells has been suggested 
to play a backup or cleanup role in conditions where normal routes are overloaded .59 
Chylomicrons, hypertriglyceridacmic (but not normal) VLDL, and 8 -VLDL are all sequestered 
by this receptor.63
Chylomicron remnants enriched in cholesteryl ester are among the most potent 
naturally occurring initiators of foam cell formation.62 and a specific chylomicron remnant 
receptor thought to exist on hepatocytes has been postulated to be present on macrophages 
also. It has never been isolated however, and its identity has recently been questioned.64 By 
virtue of their size, cholesteryl ester and apo E content, chylomicron remnants bear some 
resemblance to the 8 -VLDL mentioned above, and there has been evidence to suggest that 
they may enter macrophages by the same route 63 The activity of this receptor seems to be 
constitutive and not suppressed by cholesterol feeding, or drug therapy. It is therefore 
probably not functional in regulating cellular cholesterol levels.
If plasma cholesterol were to remain within lipoproteins which are taken into cells by 
the LDL receptor then cellular cholesterol uptake would be afforded some degree of 
regulation. (As long as LDL receptor capacity does not become overloaded) However factors 
which tend to divert cholesterol transport from this path into abnormal lipoprotein species 
may lead to increased amounts being removed from the circulation by less well regulated 
pathways, and may favour the deposition and accumulation of cholesterol in cells. Such 
factors may arise in a variety of situations, including, as will be discussed later, periods of high 
triglyceride flux.
1.4 Exogenous fat transport 
S
"The relative rate at which the fa t is being poured into the blood is indicated by the steepness 
o f the upward limb o f the (cbylomicrograph) curve between any two intervals.
The relative rate a t which the fa t is being removed from  the blood between any two 
intervals is indicated by the steepness o f the downward limb o f the curve.
The ascending and descending limbs o f the curve are a composite o f the opposing 
factors, viz, i f  there is an excess o f addition o f fa t over the subtraction at any given time, the 
curve will go up, and  its steepness will indicate the relative excess addition. On the other 
band, i f  the elim ination o f the fa t is greater than the addition at any given time, then there will 
be a descent o f the curve, and its steepness will indicate the relative excess o f the reduction ”
SH Gage and PA Fish. (1924) American Journal of Anatomy, 34 pl7.
The magnitude of alimentary lipaemia is determined by the composite effects of 
environmental and physiological factors affecting rates of chylomicron entry into the 
bloodstream, and factors affecting their clearance. The mechanisms involved comprise a 
system of 'exogenous fat transport' whereby dietary fats are assimilated by the body. These 
processes may conveniently be set into three stages:-
a) the digestion and absorption of fat in the gut,
b) the formation of chylomicrons from newly absorbed or synthesized materials in the 
endothelial cells of the intestine,
c) the transport and catabolism of chylomicrons in the plasma.
During any of these phases events may influence the development of lipaemia in the plasma. 
Details of the digestion and absorption of fats have largely been established over the past fifty 
years, and have been reviewed extensively in the literature.65"67 Only a brief summary of 
present understanding is included here, followed by a description of the principal stages in 
chylomicron formation and catabolism including their interactions with other lipoprotein 
classes during lipaemia
1.4.1 The fa t com ponent o f  the diet
The term 'fat' properly refers to triglycerides which, along with phospholipids and 
cholesterol, are the major classes of lipid in the diet. The fat soluble vitamins are biologically 
important but are quantitatively a minor component It has been estimated66 that the average 
Western adult consumes approximately lOOg of fat per day, providing some 40% of total 
calories. Dietary intake of phospholipid, mainly lecithin, is approximately 2.2g69 and 
cholesterol l.Og per day,70 to which a further 12g of phospholipid and l.Og of cholesterol 
derived from bile and gut endothelial cell debris are added in the g u t69.
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The structure and physico-chemical properties of triglycerides, phospholipids and 
cholesterol are to be found in many chemistry and biochemistry texts. In addition to the 
conventional chemical definitions biologically active lipids have been classified by Patton71 on 
the basis of their occurrence in foods, and by Small72 on the basis of their behaviour in 
aqueous systems.
T ^^130assi^ationo^biol^ ic^^^cttveJ^i^
a). C om position o f dietary lipid
Physiol fam -£g- Chemical Composition
Surface lipids
Fat droplets
Membranes
external seed 
coat
adipose tissue
internal cell 
membranes
Hydrocarbons, wax esters, 
ketones, triglycerides, fatty 
acids, alcohols, aldehydes, 
sterols, alkane diols, terpenoids
Triglycerides (terrestrial plants 
and animals)
Wax esters and triglycerides 
(marine animals).
Phospholipids, sterols, 
sphingolipids, galactolipids, 
carotenoids.
b). Lipids in  aqueous system s
Non polar
Insoluble in water and do not interact with water eg. cholesterol esters, carotene. 
Polar
Insoluble non-swelling amphiphiles:-
Low solubility in water, form an immiscible liquid or solid phase eg. long chain 
fa tty  acids, diglycerides, triglycerides, sterols.
Insoluble swelling amphiphiles:-
Insoluble in water, but interact to form a liquid crystalline phase in which water is 
sandwiched between polar groups (known as swelling), eg. phospholipids, mono­
glycerides, ionised fa tty  acids.
Soluble amphiphiles:-
Soluble in water at low concentration. Form micelles in which polar group faces out 
and non-polar group faces inward, eg. bile acids, ionic detergents, soaps.
The scheme of Patton (Table 1.3a) recognises that the digestive system has evolved to deal 
with foodstuffs in their natural environment - their 'molecular ecology* as he calls it - where 
they occur not only in molecular mixture with other lipids, but also with carbohydrates, 
proteins, minerals, and indigestible fibres. Quantitatively lipid digestion is virtually 
synonymous with the digestion of triglyceride stored in fat droplets, although minor 
components of the diet, the surface and membrane lipids of this classification, are 
nonetheless essential to the physiological processes of digestion, absorption, and transport 
of fat
The bio-availability of lipids is heavily dependent on their ability to interact with water, 
and the rationale underlying the evolution of physiological fat transport systems has been to 
increase this ability. In this respect the classification of Small (Table 1.3b) is of interest.
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Although this scheme is based on the physical behaviour of purified lipids when mixed with 
water, it has been useful in predicting their behaviour in physiological systems where polar 
and non-polar lipids occur in the various combinations already mentioned. Thus the 
amphipathic nature of certain lipids is employed to solubilize those which are more 
hydrophobic.
1.4.2 The digestion o f fat
The basic reaction of digestion is the conversion of triglyceride, a non-swelling insoluble 
lipid, into a form which can better interact with water. This function is performed by a series
of lipases enzymes which catalyse the hydrolysis of fatty acid ester bonds. The intermediate
product is a diglyceride which is also insoluble, and the end products are monoglycerides, 
fatty acids, and glycerol. In order to facilitate this reaction fats are first emulsified.
Mechanical disruption of bulk fat takes place in the mouth, by the action of chewing, and 
in the stomach by its peristaltic activity, progressively forming a more finely divided 
emulsion. In the acid (pH 1.0) environment of the stomach peptic digests of protein, 
complex polysaccharides, and phospholipids derived from the membranous materials of 
ingested food provide a potential source of the amphiphiles necessary for the formation of 
em ulsions .73 By orientation at the surfaces of lipid droplets these amphiphiles reduce 
lipid/water interfacial tension, stabilize the emulsion and significantly increase the surface area 
of fatty substrate available for hydrolysis by surface active lipases.74
Triglyceride remains in the stomach for 2 to 4 hours75 during which time 10-30% may be 
hydrolysed .68 Lingual lipase, secreted by glands on the dorsal surface of the tongue, is 
particularly suited to the gastric environment and is probably responsible for this initial 
hydrolytic activity.76 It has an add  pH optimum, is resistant to peptic digestion, and does not 
require bile salts for its action. It also shows much higher activity with short or medium chain 
than with long chain fatty adds, and is specific for primary esters of triglycerides, attacking 
the sn-3 position twice as fast as the sn-1 position.76 The main products of hydrolysis by this 
enzyme are long chain sn-1,2 diglycerides and fatty adds.
Shorter chain fatty adds liberated at this stage are soluble in water and are absorbed 
directly through the stomach wall and transported bound to albumin to the liver via the 
portal vein, while longer chain fatty adds tend to partition within the hydrophobic core of 
emulsion particles.73 The acidic emulsion (at this stage referred to as chyme), is dispensed 
intermittently into the upper small intestine (duodenum) through the pyloric sphincter. The 
squirting of chyme through this valve produces shear forces which further assist in fine 
emulsification. Lipid droplets entering the duodenum are less than 0.5 pm in diameter and 
highly stable 65
The low pH of the chyme and the presence of fatty adds causes the release of the 
hormone cholecystokinin pancreozymin (CCK-PZ) from duodenal mucosal cells into the
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bloodstream, and induces gall bladder contraction and pancreatic enzyme secretion. The 
combined action of bile and pancreatic juice, which enter the duodenum close to the pyloric 
sphincter, bring about a marked change in the chemical and physical form of the ingested 
lipid emulsion.
Although in themselves poor emulsifying agents, bile salts aid emulsification when in 
dilute combination with lipolytic products from the stomach (lecithin, monoglyceride, fatty 
acids) and biliary lipids. By lowering the bulk pH at which fatty acids are 50% ionised from 
>7.0 to 6.5 the bile adds allow the formation of add soaps.73 Bile salts intercalate with these 
and other hydrolytic products and amphiphiles in the surface monolayer thus increasing 
ionisation at the interface and maximising emulsion stability.
Pancreatic secretions have a pH of 7.5 - 8.0, and contain Na+, K+, HCO‘3 ( CT and other 
salts, in addition to many digestive enzymes. The major enzymes in lipid digestion are 
cholesterol esterase, phospholipase A2 and pancreatic lipase.
• Cholesteryl ester hydrolase has a broad spedfidty catalysing the hydrolysis of water soluble 
carboxyl esters and insoluble esters (cholesterol and vitamins A,D,and E) in bile salt micelles. 
The monomeric form is dimerised to the active form in the presence of 3a and 7a 
hydroxylated primary bile salts. The end products are fatty acids and free cholesterol.77 
•Pancreatic phospholipase A2  is activated by tryptic hydrolysis of a pro-enzyme in the small 
intestine. It catalyses the hydrolysis of fatty acids at the sn-2 position of phosphoglycerides 
(but not sphingolipids). There is an absolute requirement for Ca++ ions and for aggregation of 
the substrate, an arrangement which appears to facilitate the non-equivalent interaction of sn- 
2 fatty acid ester with the catalytic site of the enzyme. The product is a lysophospholipid. No 
further hydrolysis of lysoledthin appears to take place in the intestinal lumen.
• Pancreatic triglyceride lipase can bind to a triglyceride/water interface where it is highly 
active. Bile salts, phospholipids, cholesterol and other physiological emulsifiers however 
appear to inhibit binding.66 The polar surface layer is penetrated by a co-lipase, a factor 
secreted by the pancreas which attaches to ester bonds and provides an anchor for the lipase 
which is then in suitable conformation for hydrolysis of the substrate.71
A number of factors promote the binding of co-lipase to emulsion particles. Small amounts 
of partially ionised fatty adds formed during lingual lipase hydrolysis increase binding.73 Bile 
salts may also help by forming aggregates with co-lipase and enhance the binding of 
phospholipase A2. Calcium ions required for the activity of phospholipase A2 may fadlitate 
the desorption of lipolytic products from the catalytic interface. Pancreatic lipase is virtually 
specific for sn-1 and sn-3  fatty acids, and probably hydrolyses sn-2 acids only after 
isomerisation. Since isomerisation generally occurs very slowly the main products of
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pancreatic lipase activity are sn-2 monoglycerides and fatty acids, with less than a quarter of 
ingested triglyceride completely broken down to glycerol and fatty acid.
The final products of this digestive phase are glycerol, sn-2 monoglycerides, fatty acids, 
cholesterol, and phospholipids (mainly lysolecithin) in dilute suspension at pH6.5. Due to 
their limited solubility in aqueous solution, these materials are not readily available for 
absorption.
As their concentration approaches between 5 -15 nmol/ml however, (the critical 
micellar concentration), bile salts spontaneously form micelles in which the polar hydroxyl 
and amino groups face the surrounding aqueous phase, and the non-polar steroid nuclear 
portions form a hydrophobic core.67 Interaction of these negatively charged micellar 
particles with lipolytic products leads to the formation of m ixed  micelles. At the pH of the 
upper intestine fatty acids are partially ionised. The non-polar chains of fatty acids, 
monoglycerides and phospholipids, along with cholesterol, enter the micelles and are thus 
solubilized. Successful micelle formation permits diffusion of lipid products to the surface of 
the intestinal epithelium, there to make contact with the microvillus membrane.
1.4.3 The absorption o f fat
The luminal surface area of the small intestine is greatly expanded by the presence of millions 
of finger-shaped villi approximately 1 mm long and occurring at a density of some hundreds 
per mm2.™  Each of these villi have access to the lymphatic and blood systems via the central 
lamina propria which is supplied with blood capillary and lymphatic channels. The epithelial 
cells of the villus (enterocytes) are specialised both for the uptake of digestive products and 
for their re-packaging for transport to the bloodstream. At their luminal (apical) surface the 
membrane is thrown up into multiple projections (microvilli) to form the so-called 'brush- 
border1, further expanding the area available for absorption. Lipid digestion products are 
thought to enter these cells by passive diffusion down a concentration gradient.67
Adjacent to the brush border is a layer of water which is not in equilibrium with the bulk 
intestinal fluid. This unstirred water layer (UWL) as it is known, represents an effective barrier 
to the passage of hydrophobic materials, and diffusion through this area is thought to govern 
their overall rate of absorption.67 Micellar solubilization of lipids enhances their passage 
through this region.
Micelles cannot permeate the cell membrane as intact structures however, since it is 
lipid in nature and therefore does not readily admit polar materials. The products of lipid 
digestion are in dynamic equilibrium with the mixed micelle phase, thus maintaining a 
saturated aqueous solution of lipids within the UWL. Lipid moieties also partition into the lipid 
environment of the membrane, and diffuse from there into the cell. Rapid removal from the 
membrane and esterification within the cell ensures a favourable concentration gradient from 
the intestinal lumen into the cells.
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A low molecular weight cytosolic protein has been found to bind fatty acids avidly,79 and 
it has been suggested that this protein, named fatty acid binding protein (FABP), facilitates 
removal of fatty acid from the membrane and aids its transport through the cytosol to sites of 
complex lipid synthesis. Fatty acids of chain length less than 10-12 carbon atoms pass without 
re-esterification directly from mucosal cells into the portal circulation, and free glycerol may 
also leave by this route. Longer chain fatty acids are re-esterifled to form triglyceride.
Cholesteryl ester must be hydrolysed prior to absorption, the free cholesterol then 
entering micellar solution. Even in the presence of bile salt micelles the solubility of 
cholesterol is still poor and depends on the local concentration of monoglyceride and fatty 
acid since these expand the hydrophobic core in which the cholesterol is dissolved.80 Free 
cholesterol passes through the cell membrane as a monomer and must ultimately dissociate 
from the micelle, possible aided by the micro-environment created by similarly dissociated 
fatty acids.
Lysolecithin is the main form of absorbed phospholipid, and partitions into the micellar 
phase. Sphingolipids are thought to be absorbed intact.
1.4.4 The form ation o f chylom icrons
Topologically the lumen of the gastrointestinal tract is still outside the body. Having crossed 
the barrier of the intestinal microvillus membrane the lipid digestive products can be 
considered as inside. The intestine however does not merely passively admit absorbed 
dietary materials to the circulation, but plays an active part in plasma lipoprotein formation 
and metabolism. Once inside, absorbed lipid materials are quickly re-esterified to form 
triglycerides, phospholipids and cholesteryl esters. In addition to the enzymes required for 
lipid resynthesis the enterocyte is a major source of newly synthesized apoproteins, and 
possesses the complex and highly organised machinery for the assembly and export of 
several classes of lipoprotein, the most important of which are the chylomicrons
Lipid components
• Triglyceride is synthesized from fatty acid, sn-2 monoglyceride and/or glycerol. The 
necessary enzymes are present on the inner membrane of the endoplasmic reticulum (ER) 
and are increasingly abundant in enterocytes near the villus tip. There are two enzymatic 
pathways by which triglyceride may be synthesised, both of which have a common first step 
- the activation of fatty acid to its coenzyme-A (CoA) derivative. This is accomplished by the 
enzyme fatty acid:CoA ligase, also called acyl CoA synthetase, which specifically utilises long
chain fatty acid as substrate.
In the monoglyceride pathw ay fatty acyl CoA is transferred to sn-2 monoglyceride to 
form a diglyceride which is then further acylated to form triglyceride. The three enzymes
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necessary for this reaction - acyl CoA synthetase, monoglyceride transacylase and diglyceride 
transacylase are present as a complex called triglyceride synthetase.
In the pbospbatidic acid pathway glycerol is first phosphorylated by glycerol kinase and 
then converted to phosphatidic acid by glycerolphosphate and acyl transferase. Fatty acyl 
CoA is then transferred to phosphatidic acid to form diglyceride (phosphatidate 
phosphohydrolase) and then triglyceride (diglyceride transacylase).
These two pathways function independently the enzyme system for the
monoglyceride pathway is present on the membranes of the smooth endoplasmic reticulum 
(SER) and those of the phosphatidic acid pathway on the rough endoplasmic reticulum 
(RER) . 81 In the enterocyte the monoglyceride pathway is quantitatively more important, 
although it depends to some extent on the lipid mixture available. During absorption, when 
monoglyceride is in abundance the monoglyceride pathway will be favoured. During fasting 
however, the intestine still produces triglyceride, contributing some 20-40% of plasma 
VLDL,82 at which time the phosphatidic add pathway may predominate. Since the glycerol 
for this pathway can be derived from glucose metabolism it provides a link between 
carbohydrate and lipid metabolism.
• Phospholipids, mainly ledthin, are formed by the acylation of absorbed lysophospholipids 
due to the enzyme lysophosphatidyl-acyltransferase present in the ER. Alternatively they can 
be synthesized de novo from diglyceride formed by the phosphatidic acid pathway, and 
cytidine diphosphocholine (synthesised from absorbed choline). Between 20-30% of 
phospholipids may be formed in this way.83 Lysoledthin may can be hydrolysed within the 
enterocyte by lysoledthinase to form glycerolphosphorylcholine and fatty add. The fatty acyl 
composition of phospholipids synthesized in the enterocyte does not reflect the 
composition of dietary fatty acids as accurately as does that of newly synthesized 
triglyceride.84
The pathway of phospholipid synthesis may be determined by the availability of the 
respective substrates, or it may be suited to the needs of the cell. Phospholipids are required 
for the surface coating of chylomicrons and depletion of phospholipid leads to the formation 
of larger lipoproteins,85 whereas excess ledthin leads to the formation of smaller intestinal 
VLDL.86 In addition phospholipids are required for the maintenance of enterocyte 
membrane function.87 During protein biosynthesis and intracellular chylomicron transport 
the membranes of the ER and Golgi are turning over rapidly88 and their continued synthetic 
activity requires constant replenishment with phospholipid.
Sphingomyelin is absorbed intact but is broken down in the mucosal cell to ceramide 
and phosphotidylcholine69
• Cholesterol within the enterocyte may be derived from a variety of sources: from absorbed 
material, both from the diet and from biliary and cellular breakdown, from de novo 
synthesis, or from infiltration of plasma LDL and HDL.66 Esterification of cholesterol
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probably takes place just prior to incorporation into chylomicrons since most cellular 
cholesterol remains free, whereas 80-85% of that exported is in the form of esters. Oleic acid 
is the principal fatty acid found in cholesteryl esters of intestinal origin.89
It seems that the rate of cholesterol absorption may be determined to some extent by 
its rate of esterification.90 Cholesteryl ester hydrolase of pancreatic origin hydrolyses 
cholesteryl esters in the duodenum where pH is neutral to basic. At pH 5-6 however the 
enzyme catalyses the reverse reaction.91 This enzyme has been found in the enterocyte and 
has been suggested to play a role in cholesterol esterification there.92 Acyl CoA: cholesterol 
acyl transferase (ACAT) is another enzyme capable of esterifying cholesterol, and is also 
present in microsomal fractions of mucosal cells, mostly in the villus tips of jejunum and 
proximal ileum.93 It shows a preference for oleoyl CoA, thus agreeing with the main species 
of cholesterol ester exported from the intestine. It has been shown however that in the 
presence of antibodies against ACAT cholesterol absorption and esterification can 
continue.94
Apoprotein com ponents
Approximately 10-20% of the surface of a chylomicron is occupied by proteins similar to 
those found in the plasma lipoproteins. They are crucial in directing the pattern of export, 
catabolism and clearance of chylomicrons. Comprising only 1-2% of total chylomicron mass, 
the large daily flux of lipid through the enterocyte nonetheless ensures a significant 
contribution to the plasma apoprotein pool. Some of these apoproteins are actively 
synthesized by the enterocyte and incorporated during chylomicron assembly, others are 
acquired by transfer from other lipoproteins during transport through lymph and plasma.
•A poA Iis synthesized in the enterocyte95 and is present there in appreciable amounts even 
in the post absorptive state.96 A high rate of synthesis and export is suggested by the fact that 
daily output may be 20-50 times the total mucosal content of AI97 It has been calculated that 
the intestine may contribute up to 56% of AI in rat plasma.98
Much of the AI in enterocytes and in lamina propria is present in free form, only 10% 
being associated with lipoprotein. In mesenteric lymph almost all is associated with lipid.99 
Increasing amounts of enterocyte AI becomes associated with lipid during absorption, and 
secretion into the lymph may increase several fold.97 Rates of synthesis however seem to be 
little altered by triglyceride flux,100 therefore the level at which AI synthesis is regulated and 
the point of action of fat feeding is unknown.
•A poA ll is also synthesized in small amounts by enterocytes.101
• ApoB found in chylomicrons shows immunological similarities with that found in hepatic 
VLDL and LDL but has a molecular weight which is only 48% that of the LDL form. This variety 
of apoB has therefore been called B48 and is apparently specific to intestinal lipoproteins.102
Exogenous fa t transport 22
Synthesis seems to occur in the RER from whence apoB is transferred to the SER and 
incorporated into the nascent chylomicron at or near the junction of the two.103 These then 
move to the Golgi cistemae where the apoB is glycosylated and chylomicrons prepared for 
export.104
Lipid absorption in rats was associated with an increase in apoB concentration within 10- 
15 minutes of exposure to fat,97 though in humans there was a decrease in apoB following fat 
feeding.105 This finding was taken to indicate depletion of a preformed pool of apoB at a rate 
exceeding that of de novo synthesis. More recently it has been suggested that B48 synthesis is 
bile salt dependent and not subject to regulation by acute trans-epithelial triglyceride flux.106
The importance of apoB in lipid absorption is clearly exemplified by the inherited 
condition of abetalipoproteinaemia in which a total lack of apoB synthesis is associated with a 
complete absence of chylomicrons, VLDL, and LDL from the circulation.107 Although lipid 
droplets accumulate in the SER of these people they seem unable to enter the Golgi 
apparatus and chylomicrons are not exported.
•ApoAJV, at a concentration of 12ng/mg protein in the fasting state rising to 46jj.g/mg after 
lipid feeding, is present in human intestinal mucosa in substantially greater amounts than 
other apoproteins.96 Its role in chylomicron formation and transport remains unknown.
• ApoC  constitutes 25-50% of post prandial chylomicron proteins.108 Most of these are 
acquired by transfer from other lipoproteins however, since less than 10% of plasma apoC 
are thought to be synthesised in the intestine.109
• ApoE is probably not produced by the intestine109 but acquired by transfer from other 
lipoproteins during transport through lymph and plasma.108 ApoE plays a crucial role in the 
catabolism of chylomicrons.
•Apola] was found in a fraction of postprandial lipoproteins which were also enriched in 
apoE and apoB48-110 The origin or significance of the apolal component in terms of 
chylomicron formation or catabolism is unknown.
The assembly o f chylomicrons
Chylomicrons are not synthesized in the form in which they eventually appear in the plasma, 
but are continuously modified as they pass through the enterocyte, the lymphatics, and the 
blood. Triglyceride re-synthesis is localised in the SER and lipid droplets subsequently 
accumulate in the Golgi apparatus of the supra nuclear portion of the cell. Apo B is localised 
initially in the RER and on triglyceride droplets in the profiles of the SER, suggesting an 
addition early in chylomicron formation. Glycosylation of lipid and protein components 
takes place in the endoplasmic reticulum and in the Golgi.
There are two proposals, not mutually exclusive, regarding the involvement of the Golgi 
apparatus.81 Firstly vesicles containing maturing pre-chylomicrons may bud off from the 
tubules of the SER and merge with the Golgi apparatus. Secondly the SER are connected by a
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group of tubules called the 'Boulevard Peripherique' which may transport lipid droplets 
between the two organelles. Vesicles containing nascent chylomicrons pinch off from the 
Golgi and migrate towards the baso lateral plasma membrane with which they fuse and 
release their contents into the inter-cellular space.111
Redgrave12 found lymph chylomicrons to differ in their composition from the intra­
cellular lipid droplets found during absorption, and called these droplets 'pre-chylomicrons'. 
They contained more free fatty acids, free cholesterol, more protein and differed in their 
phospholipid composition, indicating a possible change in the surface coat during transit 
through the Golgi apparatus to the plasma membrane.
Intestinal VLDL It is apparent that triglyceride rich lipoproteins of S/  20-400 and diameter 
30-80nm are formed and exported from the intestine during fasting82 and fat absorption.115 
They have also been observed in human enterocytes114 and resemble chylomicrons in their 
lipid and apoprotein content. Although qualifying as VLDL the triglyceride composition of 
these particles clearly differs from that of plasma VLDL.
Incubation of these intestinal VLDL with the p<1.006 plasma fraction leads to an increase 
in apoE at the expense of apoAI and AIV, so that they then resemble plasma VLDL. They 
become more prominent after duodenal infusion of lecithin86 probably due to an increased 
ratio of surface to core materials. It has been suggested that they represent two separate 
populations of triglyceride rich lipoprotein,81 although it is also possible that they represent 
one end of a spectrum of particles varying in size according to the relative amounts of core 
and surface materials available.
1.4.3 Rate lim iting steps in  chylom icron production
In the complex series of events described above there are several potentially rate limiting 
steps. The rate at which food leaves the stomach is influenced by many factors, in particular 
the volume and composition of the meal.75-115 Upon entering the intestine lipases are 
secreted in excess,71 and so it seems unlikely that their activity would be rate limiting. 
Diffusion through the unstirred water layer has been suggested as limiting where large 
micellar structures are concerned,67 and if competition between excess lipolytic products for 
micellar solubilization occurs this step may indeed affect rates of lipid absorption.
Rates of re-esterification, as has already been mentioned, may influence the overall rate 
of absorption.90 In this respect fatty add  binding proteins (FABP) must be produced at an 
adequate rate to ensure a steady supply of fatty acids to the synthetic machinery of the 
enterocyte. In addition suffident surface materials such as apoproteins or phospholipids are 
required not only for incorporation into lipoproteins, but for all membrane bound activities. 
If their supply is restricted then absorption of triglyceride may be compromised.87
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Lipid absorption and chylomicron formation occur mainly in the jejunum, and less 
efficiently in the ileum.111 In the proximal jejunum the limiting step seems to be uptake into 
the enterocyte, whereas in the ileum it is the removal of lipid which is most important.109,117
Having left the enterocyte chylomicrons must cross approximately 50|xm of interstitium 
before reaching the central lacteal. Rates of passage through this gel like material depends on 
the degree of hydration118 and the flow rate of lymph.119
1.4.6 The digestion and absorption o f retinol (Vitamin A)
The unique features of vitamin A absorption have been exploited in studies of exogenous fat 
metabolism, and are therefore included here in some detail. Dietary retinyl esters, retinol and 
provitamin A carotenoids are dispersed and emulsified during digestion in a manner 
analogous to that of cholesteryl esters. A relatively non-specific carboxylic ester hydrolase, 
thought to be the same enzyme responsible for cholesterol ester hydrolysis, hydrolyses long 
chain retinyl esters. Only free retinol may cross the mucosal cell membrane, and to do so is 
solubilized in mixed micelles.
Within the enterocyte retinol is re-esterified with long chain fatty acids. The fatty acid 
composition of retinyl esters is largely independent of the fatty acid composition of meals 
with which they are consumed, palmitate predominating and saturated retinyl esters 
(palmitate and stearate approx 2:1) comprising three fourths. Small amounts of retinyl oleate 
and linoleate may also be present120 It has been proposed that retinol reacts with a fatty acyl 
CoA in a reaction catalysed by an acyl CoA: retinol acyl transferase CARAT), again in analogous 
fashion to the ACAT reaction forming cholesteryl esters. ARAT shows a preference for 
palmitoyl over oleoyl CoA.121
Retinyl esters are thereafter packaged in the hydrophobic core of chylomicrons and 
transported to the liver where they are taken up by hepatocytes along with chylomicron 
remnants. Once within hepatocytes they are either stored as retinyl ester or are hydrolysed to 
retinol and exported to the general circulation bound to a high density plasma retinol binding 
protein. Retinol is not exported from the liver in the form of long chain fatty acid esters.
1.4.7 C hylom icron catabolism
Within an hour of fat consumption chylomicrons begin to traverse the thoracic duct and 
enter the general circulation through the subclavian vein. In the plasma they are fitted for 
catabolism by an immediate and rapid series of interactions with other lipoproteins. ApoAI 
and AIV, synthesised by the intestine, leave the chylomicron surface and enter the HDL and 
lipoprotein free density ranges.122 A poB ^ the other intesfinally derived apoprotein remains 
an integral part of the chylomicron throughout its career. Apoproteins Cl, CII, and CIII 
transfer in the opposite direction, from HDL to chylomicrons,123 as does apoE.124 These
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transfers occur rapidly and spontaneously upon entry of chylomicrons to the plasma, leaving 
a particle whose apoprotein composition is quite different from its lymphatic precursor.
The catabolic processes which rapidly ensue may be divided into two phases. Firstly a 
large percentage of triglyceride is removed from the core of the particle (lipolysis) reducing 
its size considerably, and liberating redundant surface materials which enter the HDL density 
range. Secondly the remainder of the particle - the chylomicron remnant.- is removed 'en 
masse' by a receptor mediated process into hepatocytes. Both of these processes are 
apparendy closely regulated by the fluctuating affinides of the apoC and E components for 
the surface of the diminishing chylomicron.
Lipolysis
Hydrolysis of the bulk of chylomicron triglyceride is accomplished by the acdons of 
lipoprotein lipase (LpL). This enzyme is found attached to the endothelium of capillaries by 
cell surface glycosaminoglycans such as heparin sulphate,125 and may be released into the 
bloodstream by the administradon of heparin.126 The products of hydrolysis are free fatty 
adds and monoglycerides, which eventually enter cells or are bound to circuladng albumin. 
LpL shows some stereosperific preference for the sn-1 over the sn-3 posidon of triglyceride 
but has a much lower affinity for the sn-2 posidon.125 There is debate over its fatty add  
spedfiddes (see later). The enzyme also has phospholipase activity.125
Lipoprotein lipase activity has an absolute requirement for apoCH,127 as is evident from 
an inherited condition in which its complete absence leads to massive chylomicronacmia.128 
Activity of the enzyme requires the formation of a complex comprising apoCII, dimeric 
lipoprotein lipase, and a triglyceride rich lipoprotein substrate.129 It seems likely that 
lipoprotein lipase, an enzyme which catalyses a reaction ultimately requiring water, 
encounters its triglyceride substrate at the surface of the chylomicron.
Triglyceride in the core equilibrates rapidly with the small amount of triglyceride 
solubilized in the surface monolayer,130 thus factors affecting the partitioning of triglyceride 
between core and surface (eg cholesteryl ester content, or increasing saturation of fatty add  
chains) may influence the rate of hydrolysis. The affinity of lipoprotein lipase and apoCII for 
the lipid surface of the lipoprotein may also be important. A build up of lysoledthin, a 
product of phospholipid hydrolysis, decreases fatty add release by approximately 10 fold,131 
and fatty adds not efficiently removed from the active site may lead to product inhibition.132 
An accumulation of free cholesterol in surface layers has also been associated with a decrease 
in lipase activity.21
As triglyceride is removed from the partide the core volume decreases leaving an excess 
of surface material. It is thought that this material, mainly phospholipid, apoAI and All, with 
some free cholesterol, forms bilammellar outfoldings which eventually dissodate to form
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discoidal leaflets.133 These then enter the HDL density range where they interact with the 
enzyme lecithin : cholesterol acyl transferase (LCAT) to give rise to HDL.
It is not clear from the literature whether the triglyceride content of the chylomicron is 
hydrolysed 'at one sitting' or whether a dynamic equilibrium exists between bound and 
circulating chylomicrons at various stages of catabolism, an equilibrium which gradually 
moves from bound to unbound. In any case, at a stage when approximately 75% of 
triglyceride has been removed, the chylomicron becomes a relatively poor substrate for LpL 
and continues to circulate as a chylomicron remnant until it is removed by hepatocytes.
There is some evidence that the enzyme hepatic triglyceride lipase may be involved in 
chylomicron catabolism in its later stages134 although the role of this enzyme remains unclear.
The signal marking the end of LpL hydrolysis (remnant production) and the beginning of 
the remnant clearance phase of lipaemia remains to be established. Presumably factors which 
influence the affinity of the particle for either LpL or its apoCII activator are important in 
reducing its susceptibility to further hydrolysis.
The composition of the chylomicron remnant differs from its precursor in a number of 
important respects. The loss of triglyceride from the core of the chylomicron represents in 
effect a loss of solvent for core located free cholesterol, resulting in a net movement of 
unesterified cholesterol into surface regions.21 In addition there is a movement of unesterified 
cholesterol down a concentration gradient from red and white blood cells and other 
lipoproteins. Enrichment of surface areas with free cholesterol can reduce the solubility of 
triglyceride (from 3-4% to 0.15% at 33% surface cholesterol) 21 in the surface phase and also 
reduce protein binding.130 An increase in the lysophosphatidyl choline content of the surface 
has also been associated with a reduced affinity for C apoproteins.135
These changes in surface composition may be attenuated in part by the loss of most of 
this material to HDL (along with apoAI and All, and apoAIV which enters the lipoprotein 
free fraction) 136 as the chylomicron core dwindles, leading to redundancy of the surface coat. 
This process may in itself be important since the greatly reduced surface area may provoke 
competition for space between apoB4g, apoE and the apoC peptides, with the attendant 
effects on LpL and receptor interactions.
ApoB48 and apoE remain with the particle until it is eventually removed by hepatocytes. 
ApoC's however are gradually lost and re-enter the HDL pool. It has been suggested that 
differing affinities of the shrinking chylomicron for apoCII, CIII, and E regulate not only the 
cessation of lipolysis but the uptake of the remnant by the hepatic apoE receptor.137 In this 
scenario the presence of apoC, particularly apoCIII, on chylomicrons prevents their uptake 
by the apoE receptor. The affinity of the C peptides declines however, as lipolysis nears 
completion and they depart the particles surface. ApoCII is postulated to leave slightly 
before apoCIII, being more influenced by the accumulation of lysophospholipids in the 
surface, at which stage lipolysis is halted. The departure of apoCIII frees apoE to interact with
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its receptor.138 Modulation of lipase action in this way may ensure a slower, stepwise and 
more complete delivery of lipolytic products to the tissues.
Remnant clearance
Chylomicron remnants are removed from the circulation by liver parenchymal cells in a high 
affinity receptor mediated process. ApoE seems to be the ligand responsible for receptor 
interaction139 and apoCIII seems to inhibit uptake.138
Although its identity has not been clearly resolved, the chylomicron remnant receptor 
appears to be distinct from the LDL receptor59 which recognises both apoB and apoE. 
Chylomicron clearance occurs normally in homozygous familial hypercholesterolaemic 
humans and in Watanabe Heritable Hyper-lipidaemic (WHHL) rabbits,140 both of which have 
little or no production of LDL receptors. In addition the chylomicron remnant receptor is 
not affected by factors which regulate LDL receptor activity141'143 and so may lack the ability 
to control cholesterol homeostasis.
Beyond a lack of functional identity with the LDL receptor however, the state of 
knowledge concerning the character of the chylomicron remnant receptor is at present 
unsettled. The validity of liver membrane binding studies which led to the proposal that a 
specific apoE receptor was the chylomicron remnant receptor144 have recently been cast 
into doubt by the discovery that protein components binding apoE now seem unrelated to 
lipoprotein transport.145
Van lenten et a l63 demonstrated that chylomicron remnants can enter human monocyte 
macrophages by the 6-VLDL receptor pathway. Recent work has shown however that the 
receptor responsible for 6-VLDL uptake in these cells is in fact the 'classic' LDL receptor,64 
and that chylomicron remnants can be internalised by human monocyte derived 
macrophages through the LDL receptor. The relevance of 8-VLDL and chylomicron remnant 
uptake by macrophages in the development of atherosclerosis was discussed earlier.
In the absence of apoE on chylomicrons remnant clearance was reduced to about one 
third that of native particles.146 Since apoB48 is not thought to play a significant part in 
receptor binding147-148 some other mechanism must operate. It is possible that some non 
specific uptake may occur, in which respect macrophages may again be important. 
Phenotypic expression of different apoE isomorphs may also affect clearance by remnant 
receptors.149*150 The rate of clearance of remnants from the plasma seems to be independent 
of the rate of triglyceride hydrolysis since the stimulation of lipolysis by heparin injection did 
not affect remnant decay.151
Once within hepatocytes chylomicron remnants are subject to lysosomal degradation 
which releases their components for degradation, storage or resynthesis, thus completing the 
corporeal assimilation of dietary materials.
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1.4.8 Post-pran dial lipaemia and lipoprotein m etabolism
Although often discussed as discrete physiological entities it is now apparent that plasma 
lipoproteins exist throughout their intravascular metabolic transformations in a state of 
dynamic equilibrium with each other and with tissues.55 The entry of a large number of 
chylomicrons into the system introduces a transient dys-equilibrium which has repercussions 
for lipid transport in all lipoprotein classes. The effects of post-prandial lipaemia on 
lipoproteins involve both surface and core materials.
Interactions o f surface areas
The intestine is a major source of apoproteins AI, All, and C. During intravascular lipolysis 
these apoproteins, in association with phospholipid and free cholesterol, are shed from the 
chylomicron surface as bilammellar leaflets. This material is thought to associate with existing 
HDL2 and HDL3 in the plasma,152 and by so doing decrease its density and increase the 
amount of material in the HDL2 density range.153 Alternatively, or additionally, these 
bilammellar leaflets may form vesicles or discoidal structures which are precursors of mature 
spherical HDL.154
Formation of genuine HDL2 from these discs requires the activity of LCAT which 
esterifies free cholesterol with fatty acid moieties derived from the sn-2 position of 
phospholipid. The cholesteryl esters so formed partition into the more hydrophobic 
regions of these structures, eventually forming an oily core and leaving the surface relatively 
depleted of cholesterol. A concentration gradient is thus formed down which free 
cholesterol may travel. HDL3 are rich in phospholipids and are avid acceptors of free 
cholesterol from the plasma membrane. The movement of free cholesterol to HDL under 
the impetus of LCAT activity forms the basis of the so called 'reverse cholesterol transport' 
pathway.155
Movement into HDL may not be the only route by which lipaemia affects cellular 
cholesterol content. Nascent chylomicrons contain little cholesterol (<1% of their total 
weight), whereas red blood cells contain a reservoir roughly equivalent to the circulating pool 
of free cholesterol. Miller21 has suggested that free cholesterol may enter the chylomicron 
pool from this source during lipaemia. In this respect it is of interest to note that LCAT may 
also act on lipoproteins other than HDL,156 and perhaps may be able to act on chylomicron 
surface material prior to or during its transformation to HDL precursor.
Interactions o f core materials
Incubation of fasting human plasma results in a net transfer of triglyceride from VLDL to LDL 
and HDL, and a reciprocal transfer of cholesteryl esters from LDL and HDL to VLDL down 
their concentration gradients.157 Although these transfers may occur spontaneously they are 
facilitated in vivo by the existence of specific transfer proteins.158
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A scheme has been described by Patsch159whereby postprandial lipaemia, through the 
combined actions of lipid transfer proteins and hepatic lipase, affects the distribution of HDL 
subfractions. During lipaemia chylomicron triglyceride enters the core of HDL particles with a 
concomitant loss of cholesteryl esters from HDL to chylomicrons, both catalysed by the 
action of lipid transfer proteins. Enrichment of HDL2 with triglyceride at the expense of 
cholesterol esters makes it a substrate for hepatic lipase, which hydrolyses the triglyceride, 
depleting the core, and converting it to HDL3. He suggests that if lipaemia is regularly elevated 
this sequence of reactions may lead to lowered levels of HDL2 in the steady state .
Studies of hypertriglyceridaemic subjects carried out by Eisenberg and colleagues160 
indicate the consequences in LDL and HDL classes of increased circulating triglyceride-rich 
lipoproteins. The prolonged lifetime of VLDL in the plasma of these subjects led to an 
excessive modification of all lipoprotein classes due to the activity of lipid transfer proteins. 
Hypertriglyceridaemic VLDL contained less protein and triglyceride than normal VLDL and 
was abnormally enriched in free and esterified cholesterol. The converse was true of LDL and 
HDL. These abnormalities were related to the degree of hyper-triglyceridaemia and reverted 
to normal when drug therapy alleviated the problem.
It should be noted that these studies refer specifically to hepatic VLDL elevation in which 
condition the synthesis of LDL may be also be affected,161 thus com-pounding the influence 
of transfer activity. No similar studies of post-prandial triglyceridaemia have been 
documented.
Chapter 2
Materials and Methods
2.1 Outline o f the study
S
Post prandial lipaemia was examined following the administration of an oral fat tolerance test, 
conducted under standardised conditions, to several groups of volunteers. The test used was 
based on that of Patsch,162 and consisted of a liquid format, cream based meal consumed in 
the morning following a 12 hour fast.1®
The absorption and plasma transport of orally ingested vitamin A parallels to some 
extent that of cholesterol, but differs in that once incorporated into hepatocytes retinol does 
not re-enter the bloodstream in esterified form. Thus plasma retinyl esters represent newly 
absorbed material in transit with chylomicrons from the gut to the liver. This feature of 
vitamin A absorption has been utilized for the in vivo marking of chylomicrons and their 
remnants as they pass through the plasma.164 Since the differentiation of exogenously 
(intestinal) and endogenously (hepatic) derived lipoproteins has been a notorious technical 
problem in this type of research, the fat tolerance test employed in this study was modified 
to include retinyl esters.
After consumption of the fat load serum lipoproteins were prepared from samples 
obtained at regular intervals during the post prandial phase. The fluctuations in lipid and 
apoprotein components were quantified and related to an individuals fasting lipoprotein 
profile.
The influence of gender, the effects of lipid lowering drugs, and of varying the 
composition of the fat load, were examined in sub-groups drawn from a pool of healthy 
volunteers. The relationship of lipaemia to coronary artery disease (CAD) was studied in a 
group of men whose coronary arteries were assessed angiographically for evidence of 
atherosclerotic stenoses.
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arabic, trisodium citrate dihydrate, sodium heparin (reagent grade)
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Statistical software
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23 Fat tolerance tests 
S
2 3 .1  Fat load test
The following protocol applied to all participants. Those who fulfilled the selection criteria, 
and who agreed to take part were asked to refrain from alcohol for 24 hours prior to the fat 
tolerance test, and to fast for 16 hours.
B lood  sam pling: On the morning of the test a forearm intravenous catheter was
inserted and a fasting blood sample collected prior to consumption of the fat load All blood 
samples were collected into plain tubes. Serum was separated immediately by low speed 
centrifugation and stored at 4*C until lipoprotein preparations were commenced. Samples 
(20ml) were withdrawn at two hourly intervals till eight hours in normal subjects, and twelve 
hours in CAD patients, and then again on the following morning (24 hours).
F at load: The fat load was a liquid format, cream based meal and was made up in the
following manner. 280ml double cream, 19g sucrose, 12.5g dried skimmed milk and 40ml of 
flavoured syrup were made up to 500ml with water and mixed thoroughly but not blended. 
The total energy content was 1371 kilocalories, derived from 11.4g protein, 137g fat, and 50.3g 
carbohydrate, and contained 400mg of cholesterol. 30,000 units (l65mg) of retinyl palmitate 
(Roche Products Ltd) was added as an oil before homogenisation. Subjects drank the mixture 
within 15 minutes, and timing of blood sampling commenced at the beginning of that period.
A light, low fat meal, free of vitamin A or provitamin A carotenoids, was permitted at 8 
hours in normals and 10 hours in CAD subjects, who were then fasted till the next morning. 
Otherwise only calorie free drinks were permitted, and participants were asked to avoid any 
unnecessary exertion throughout the study period.
2.3.2 D efinitions and Calculations
No consistent definitions or terminology exist to describe quantitatively the events of post 
prandial lipaemia following an oral fat load. It is appropriate at this stage therefore, to define 
certain parameters and to make clear some of the terms used in this study.
VLDL: In this study VLDL refers specifically to fasting  lipoproteins of density less than 1.006 
g/ml, whether derived from intestine or liver, and is used to distinguish fasting from post 
prandial lipoproteins in this density range.
p <1.006 lip o p ro te in s: This term embraces all lipoproteins isolated at a density of less
than 1.006g/ml. Because of the frequent use made of this term the units 'g/ml' are omitted 
when used in the sense of a class of lipoproteins rather than as a specific reference to density.
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Therefore p <1.006 lipoproteins will be equivalent to VLDL while fasting (in 
normolipidaemics), and during lipaemia would include fasting and post prandial lipoproteins 
(VLDL & chylomicrons).
L ip tem ia : This term refers to the period of sampling subsequent to a fat load, and to the
condition of the serum during this period.
Lipcem ic response: This term refers to the difference from fasting levels of any 
parameter either in terms of its magnitude at a particular time, or its magnitude sustained over 
the post prandial sampling period. Lipaemic responses were quantified in two ways. These are 
described here for p<1.006 triglyceride, although they could be applied to any variable altered 
during lipaemia (Figure 2.1).
a). The area under the curve described by p<1.006 triglyceride was calculated after 
normalisation to fasting values using the formula:-
Area -  [2(n2 + n* + n ^ )  + nx] - (2x-l)no
where n -  the measured value at a particular time in hours, and x -  the last time point on the 
curve. This variable is referred to as the 'p<1.006 triglyceride area' .162
b). The difference between fasting value and the amount of p<1.006 triglyceride at any 
given time is referred to as 'A p<1.006 triglyceride' at that particular time.
Fasting
A-ve
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Figure 2.1 The chylomicrograph. Post prandial lipaemia was quantified as a response rather than in 
absolute terms. Responses were expressed as A values representing change from fasting level at a 
particular time, or as an area giving a cumulative figure for change experienced over the entire period of 
measurement.
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2.4 Biochemical analyses 
S
2.4.1 Lipoprotein preparations
Lipoprotein classes while fasting and during lipaemia were prepared by ultra-centrifugation 
followed by analysis of lipid and protein composition. Two different ultracentrifugal 
techniques were employed at various stages in the study. Solutions of precise density are 
required for these procedures, and were made up as detailed below. Densities were checked 
by refractometry prior to use.165
D en sity  so lu tio n s (g /m l):
p 1.006.............. 11.4 g of NaCl and 0.1 g of EDTA Na2 were dissolved in 500 ml of distilled
water and 1.0 ml of 1.0 M NaOH added. This was made up to 1 litre in a 
volumetric flask and 13.0 ml of distilled water added.
pi. 182...............  24.98 g of NaBr was added gradually to 100.0 ml of pl.006 solution
pl.019................ 270.0 ml of pl.006 and 30.0 ml of pi. 182 were mixed.
pl.063............... 75.0 ml of pl.006 and 36.9 ml of p i.182 were mixed.
p l.2 0 .................  11.06 g NaCl + 284.6 g NaBr + lOOmg Na2EDTA were made up to 1.00 litre
with distilled water.
p l.3 1 ..................11.82 g NaCl + 473.2 g NaBr + lOOmg Na2EDTA were made up to 1.00 litre
with distilled water.
f i  q u a n tifica tio n : Lipoprotein classes were prepared by a combination of
ultracentrifugation and selective precipitation, using standard methodologies.166 VLDL (and 
chylomicrons if present) were separated as a floating fraction. The infranatant was then 
treated with heparin/Mn++ (at a final concentration of 1.3mg/ml heparin and 0.092M Mn++) to 
precipitate LDL and leave HDL in solution.167 The cholesterol content of whole serum, of the 
top (VLDL), and bottom (LDL & HDL) fractions, and of the heparin/Mn++ supernatant (HDL) 
were measured as described below.
• Ultracentrifugation: 5ml of serum was placed in a Beckman Ultra-clear centrifuge tube 
(13x64 mm) and overlayered with 2ml of p l .006g/ml solution. Tubes were capped and 
centrifuged overnight at llO.OOOg*, 4°C in a Beckman 40.3 rotor, then sliced 20mm from the 
top and the supernatant collected volumetrically into a 3ml flask. The contents of the bottom 
fraction were transferred to a 5.0ml volumetric flask, the tube washed with saline, the wash 
added to the flask, and the volume adjusted to 5.0ml with saline.
# g is the standard acceleration of gravity (9807m/s2)
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•Precipitation o f LDL 1.0ml of the bottom fraction was placed in a Beckman centrifuge tube 
and 50pl of precipitating reagent (10.39g MnCl2 4 H2O + 1.05g (approximately 5xl05 units) 
heparin sodium salt (Sigma London Chemical Co.) in 25ml saline were added and mixed. The 
mixture was kept at 4°C for 30 minutes then centrifuged at 10,000 rpm for 30 minutes, and 
the supernatant separated immediately for cholesterol analysis.
S eq u en tia l flo ta tio n :  The lipoprotein classes VLDL, IDL, LDL were isolated at limit
densities of 1.006, 1.019, and 1.063g/ml respectively by repeated ultracentrifugations after 
progressively raising the solvent density. HDL were collected from the infranatant after 
removal of the lighter density classes.22*168 All centrifugations took place in Beckman 
Ultraclear tubes (13x64 mm) for 22 hours at 110,000g and 4°C, in a Beckman 40.3 rotor.
•p< 1.006 lipoproteins: 4ml of serum were overlayered with 2 ml of pl.006g/ml solution. 
After centrifugation tubes were uncapped and p<1.006 lipoproteins removed volumetrically 
in 2.0ml by careful aspiration at the surface of the supernatant.
• IDL: The density of the infranatant was increased to 1.019g/ml by mixing 0.32ml of 
pl.l82g/m l solution with the remaining 4 ml infranatant This was overlayered with 1.68ml of 
pl.019g/ml solution, the tubes capped and centrifugation recommenced. IDL was carefully 
aspirated from the surface into a 1.0ml volumetric flask and a further 1.0ml removed and 
discarded.
• LDL The infranatant was then adjusted to pl.063g/ml by the addition of 1.47ml of 
pl.l82g/m l solution, and the mixture overlayered with 0.53ml pl.063g/ml solution. After 
further centrifugation LDL were removed volumetrically from the surface in 1.0ml.
•H D L  At this stage 1.0ml of the infranatant was discarded and the remainder (4.0ml ) used 
for the analysis of HDL lipids.
2.4.2 Analytical ultracentrifugation
HDL subfraction masses were estimated by analytical ultracentrifugation in a Beckman Model 
L8 ultracentrifuge equipped with an ultraviolet scanning attachment, (Beckman Instruments) 
using an AnF rotor with double sector centrepiece cells.169
Sample preparation: A total lipoprotein fraction was prepared from 2.0ml of serum after 
adjusting the density to 1.2l6g/ml by the addition of 4.0ml of pl.31g/ml solution. This was 
mixed and centrifuged in a Beckman 40.3 rotor for 30 hours at 110,000g and 18°C. After 
centrifugation the tube was uncapped and the top 1.0ml removed quantitatively by gentle
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aspiration from the surface. This preparation was then diluted 1:8 with pl.20g/ml solution to 
adjust its optical density at 280nm to between 0 .8  and 0 .9 , a range found to be optimal for 
operation of the ultra violet scanner.
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Figure 2.2 HDL subfractions by analytical centrifugation. A typical recorder trace. Knowing the 
distance between inner and outer reference images and the distance from the inner image to the axis of 
rotation allows radial distances to be measured on the trace. The distances x,y at the S / boundaries 0, 
3.5, and 9.0 are measured in mm and the differences multiplied by a factor (43.74 for HDL  ^and 36.58 for 
HDL2), which incorporates specific molar absorptivities and the conversion of millimeters to units of 
absorbence, giving HDL subtraction concentrations in mg/dl.
Materials and Methods 38
U U racentrifugation: An aliquot of the above material was placed in the sample side of a 
double sector cell of an AnF rotor, and a similar aliquot of pl.20g/ml solution placed in the 
other side as a blank. Centrifugation was conducted at 42,000rpm at 26°C for 2 hours and 11 
minutes. Under these conditions HDL is buoyant and so floats through the cell under the 
influence of the gravitational field at a rate which is a function of its density. As it does so 
absorbence at 280nm may be monitored periodically by the UV scanning attachment, 
revealing a decrease in absorbence at the periphery of the cell.
After a defined ultracentrifugal energy has been applied (to^t -  1.52X1011)* the cell is 
scanned and the change in absorbence within the flotation (F1.2)* intervals 3 5 - 9.0  and 0 - 3.5 
are recorded. A typical recorder trace is shown in Figure 2.2. A template, marked with 
perpendiculars at previously determined boundaries for F12 of 0, 3 5 and 9.0 is placed over 
the trace and the height at which they cross the absorption curve measured in millimeters. 
The differences between 3.5 and 9.0, and 0 and 3.5 are calculated and this data converted, 
using specific molar absorptivities, to give concentrations of HDL2 and HDL3 respectively.
2.4.3 C om positional analyses
Cholesterol, triglyceride, and phospholipid in serum and lipoprotein fractions were assayed 
by enzymatic procedures on a Centrifichem Encore centrifugal analyzer. (Baker Instruments)
C holesterol was assayed using Boehringer kit (N°. 692905, Boehringer Mannheim)
The enzymatic reactions are summarised below:-
cholesterol
Cholesterol ester + H2O —» cholesterol + RCOOH
esterase
cholesterol
Cholesterol + 0 2 —> A4 - cholestenone + H20 2
oxidase
POD
2H2Q 2 + 4 - aminophenazone + phenol —»
4 - (p - benzoquinone - monoimino) - phenazone + 4 H2O
The resultant colour is measured at 500nm. The centrifugal analyser was programmed for 
kinetic (fixed time) measurement.
* 0  is the angular velocity in radians per second (271 rpm/60) and t is the time in seconds.
'Fj 2 is the negative sedimentation co-efficient (in Svedbergs) of the lipoprotein at solvent density 
1.2g/ml and 26°C.
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Free (u n e ste rffled ) cholestero l was estimated with a Boehringer kit (N° 310328) in which 
the cholesterol esterase above is omitted from the enzyme reagents. Esterified cholesterol 
was calculated from the formula
Esterified cholesterol ~ (total - free cholesterol)xl.68
where 1.68 is equal to the molecular weight of cholesteryl linoleate divided by the molecular 
weight of cholesterol, linoleic acid being the most common fatty acid found in the cholesteryl 
esters of lipoproteins. Because of the small amounts of cholesterol found in VLDL and IDL it 
was not possible to estimate free and esterified forms separately in these fractions by these 
methods.
T r ig ly c e r id e  was assayed using Merckotest kit (N° 1431, E. Merck). By this method 
triglyceride is hydrolysed enzymatically to glycerol and free fatty acids by a combination of 
lipases. Glycerol reacts further to give formazone which is monitored at 520nm.
P h o s p h o lip id  was assayed with Boehringer kit N° 691844. This method employs an 
enzymatic, colorometric assay dependent on the liberation of choline by phospholipase D, 
therefore only phospholipids containing this moiety are measured. Contrary to the 
manufacturers claims it was found that ethylenediamine tetra acetic acid (EDTA), commonly 
used as an anti-coagulant in the collection of plasma for lipoprotein analyses, inhibited this 
reaction, probably by inhibition of phospholipase D.170 For this reason serum was used for all 
blood collections.
T ota l p ro te in  in lipoproteins was estimated by the method of Lowry171 modified to reduce 
interference from turbidity in p<1.006  preparations by the addition of sodium dodecyl 
sulphate (SDS) to the Biuret reagent.172
A p o p ro te in s  A I a n d  B  were measured by immuno turbidimetric m ethods173 in the 
centrifugal analyser using kits N° D10051 and N° D10019 (Orion Diagnostica) respectively. 
Polyclonal antibodies specific to these apoproteins are mixed with sample in the optical cells 
of the centrifugal analyser. The antibody-antigen complex so formed absorbs light at 340nm. 
Standard materials were supplied with these kits, and reference material 1883 from the 
Centre for Disease Control Atlanta, Georgia, USA was used for quality control.
A p o p ro te in s A ll, CIII, a n d  E  were estimated by enzyme linked immunosorbent assay 
(ELISA) by Dr Pascal Puchois of the Pasteur Institute in Lille, France. The principles of this 
technique are as follows.174
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A polystyrene microtitre plate is coated with a purified polyclonal antiserum raised 
against the apoprotein of interest. Standards and unknowns are added to the wells in this 
plate and incubated at room temperature for a number of hours, during which time the 
antigen becomes bound to the antibody. After washing the plate a second antibody 
preparation, to which the enzyme alkaline phosphatase has been conjugated, is added to the 
wells and the plate incubated further. Following another wash a solution of p-nitrophenyl 
phosphate is added to the wells for a short time before stopping enzyme activity and reading 
the optical density at 410nm with a purpose built plate reader.
2.4.4 Calculation o f particle diam eters
Using compositional data obtained by the above procedures, and the partial specific volumes 
listed below, it is possible to estimate the particle diameters of VLDL, IDL, and LDL.175 To 
perform this calculation it is assumed that lipoprotein particles are spherical, that the non­
polar lipids cholesteryl ester and triglyceride are in the core of the particle, and that the polar 
lipids free cholesterol & phospholipid, and protein are distributed at the lipoprotein surface. 
From a knowledge of the total amounts and the space occupied by these materials it is 
possible to calculate the ratio of available surface to core material, and from that to calculate 
particle diameter.
Partial specific
volume (ml/g)
Triglyceride.................................................1.093
Cholesteryl ester........................................1.044
Free cholesterol......................................... 0.968
Phospholipid............................................. 0.970
Protein (apo B)...........................................0.777
The total volume of lipoprotein present (Vi) is calculated as follows Oipid weights are g/ml):-
Vj -  (cholesteryl ester x 1.044) + (triglyceride x 1.093) + (free cholesterol x 0 .968)
+ (phospholipid x 0.970) + (protein x 0.777)
The apolar constituents, triglyceride and cholesteryl ester, lie within the core of these 
lipoproteins. The volume of the core materials (V2) was calculated:-
V2 -  (cholesteryl ester x 1.044) + (triglyceride x 1.093)
The units of Vi and V2 are ml of lipid per ml of solvent.
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In the case of p<1.006 fractions, where free and esterified cholesterol were not separately 
assessed, an estimate was made based on published values of the percentage of these lipids 
found in a fasting preparation of human p e l .006 lipoproteins.21
The radius (fi) of the lipoprotein and the radius of the core lipid/surface boundary (r^  were 
then calculated assuming a spherical particle.
I f C t h e nri 3
The more polar components, phospholipid, protein, and free cholesterol, occupy a surface
layer whose thickness seems to be fairly constant for all VLDL particles at about 2.15nm 176__
the approximate length of extended phospholipid fatty acyl side chains. It follows therefore:-
rx - r2 -  2.15
^  r2 since C ■ T-
ri ■ Gi x O “ 2.15
2.15
Calculation of the radius by this method has been found to correlate well with direct 
measurement in the electron microscope.175 An estimate of particle numbers can be 
obtained by dividing the total volume of material present CVi) by the volume of one particle 
of radius r.
2.4.5 R etinyl esters
Retinyl esters in the p<1.006 fraction were estimated by reversed phase High Pressure Liquid 
Chromatography (HPLC) using retinyl acetate as an internal standard.
Standards: Stock standards of retinyl acetate and retinyl palmitate were made by dissolving 
commercially available materials (Sigma products R3000 and R3375 respectively), in 
isopropanol at a concentration of 1 mg/ml. A working standard was prepared as a 1:100 
dilution of the stock in isopropanol. Standards contained 0.009% butylated hydroxyanisole,
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and 0.009% butylated hydroxytoluene (w/w ester) to retard oxidation. Standards and samples 
were stored in the dark at 4°C.
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Figure 2.3 Retinyl esters by HPLC. 0.02pg of retinyl acetate injected in lOOpl of isopropanol onto a 
reverse phase HPLC column (250x4.6mm) containing a lipophilic silica gel of 10pm spheres, 300A pore 
size. A linear gradient of 50-100% acetonitrile was pumped for 15 minutes at 2.0ml/min. Effluent was 
monitored by absorption at 326nm.
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E xtraction: 0.05m£ (50|il) of retinyl acetate internal standard, 500til of saline, and 50|xl of 10% 
acetic acid were added to 500pl of sample (p<1.006 lipoproteins). The sample was then 
extracted 3 times with 1.0ml aliquots of diethyl ether and the combined extracts dried under 
nitrogen. The residue was re-dissolved in 250|il of isopropanol and injected onto the HPLC 
column immediately.
A nalysis: lOOpl of the extract in isopropanol was injected onto a Brownlee Aquapore RP300 
reversed phase column (Brownlee Laboratories), mounted on a Gilson HPLC system (Gilson 
Medical Electronics) fitted with dual pumps.
Q uantita tion: Retention times and response factors for retinyl acetate and retinyl palmitate 
were determined after multiple injections of known amounts of standard materials, and 
integration of the absorption peaks on a Shimadzu Chromatopac C-R1B (Shimadzu 
Corporation). Subsequent injections of unknowns provided absolute concentrations of 
retinyl palmitate in samples. A typical trace is shown in Figure 2.3.
P erform ance: Linearity of extraction and analytical procedures was checked by analysing 
serial dilutions of a particularly lipaemic sample from a patient who had consumed retinyl 
palmitate along with a fat load. The assay was linear up to 5.00pmol/l (Figure 2.4).
Coefficients of variation were measured by repeated assay of stored (-50°C) aliquots of 
lipaemic p<1.006 preparations. Within batch variation for this material was 10.1% (n -6 , mean 
-  0 .88±0 .01pmol/l), and between batch was 8 .6% (n*15, mean ■ 0 .93±0 .01 |imol/l).
5.0 Retinyl
palmitate
(pmol/1)
4.0
3.0
2 0
y  -  0.145  + l  .Olx, R -  1.00
1.0
4.0 5.03.02.01.00
Calculated
Figure 2.4 Linearity of the retinyl palmitate assay.
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2.4.6 Fatty acid com positions
Total lipids in fat loads and in lipoprotein fractions were extracted into organic solvent and 
separated by thin layer chromatography (TLC) into the different lipid classes. The fatty acid 
components of these lipids were converted to their methyl esters and analysed by gas liquid 
chromatography (GLC).
Extractions:177 1.0ml of sample was shaken for 5 minutes with 3.0ml of methanol in a 15ml 
glass tube with a ground glass top. Two consecutive aliquots of chloroform (3.0ml) were then 
added, each time shaking for 5 minutes. 2.5ml of aqueous KC1 (0.88% w/v) is then added and 
the mixture shaken for another 5 minutes.
Tubes were allowed to stand at room temperature for two hours, then spun at 750g, 23*C 
for 5minutes. The upper aqueous phase was removed and discarded, and the remaining 
organic phase evaporated to dryness under vacuum on a rotary evaporator and the residue re­
dissolved in lOOpl of chloroform.
Tbin Layer Chromatography: The total lipid extract was spotted as a band 2cm from
the bottom of a 0.25mm thick silica gel TLC plate (Merck plate 5721), and the plate placed in a 
covered glass tank containing 100ml of hexane: diethyl ether: formic acid, 80:20:2 (v:v:v). The 
solvent was allowed to rise across the plate for 60  minutes, during which time the lipid classes 
move at a rate determined by their differing solubilities in the tank solvent. The plate was 
dryed and sprayed with POPOP/PPO and the lipid bands identified under ultra violet light 
These were then scraped with the silica gel into separate glass tubes.
Transmethylation: The fatty acid moieties of these lipids were prepared for gas
chromatography by base catalysed esterification with methyl groups.178 1.0 ml of toluene and 
2.0ml of sodium methoxide (0.5M in dry methanol, Aldrich Chemical Co) were added to each 
tube and heated to 50’C for ten minutes. To extract the methyl esters 100 |il of glacial acetic 
acid, 5 .0ml of distilled water, and 5.0ml of hexane were added to the tubes which were then 
shaken for 5 minutes and centrifuged at 750g, 23’C, for a further 5 minutes
5 .0 ml of the top layer was removed and evaporated to dryness in a separate tube and the 
extraction repeated with a second 5.0ml of hexane. The combined residues were re-dissolved 
in 25pl of chloroform and applied to the gas chromatograph.
Gas Liquid Chromatography: 5pl of the above sample was injected into a glass
column (4mm x 1.5m) packed with Chromasorb WAW (Supelco) coated with a 10% SP2330 
liquid phase (Supelco). This was mounted in a Pye Unicam 204 gas chromatograph (Phillips 
Analytical). Carrier gas was nitrogen (50ml/min). Injection temperature was 220'C, and the 
temperature of the analytical oven was programmed to 180'C for 3minutes, rising at 3*/min to
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a top temperature of 250*C, at which it remained for 5minutes. The flame ionisation detector 
was set at 300 C, and peaks were integrated on a Trilab II (Trivector Systems International). 
Data were presented as percentages of total peak areas.
2.4.7 Lipase activity
Lipoprotein and hepatic lipase activities were estimated in fasting and post heparin plasma 
after selective inhibition of each by specific antibodies.179 Samples were collected in Glasgow 
as described below, and activities were assayed by Dr Thomas Olivecrona of the University of 
Umei, Sweden.
Sam ple p rep a ra tio n : After withdrawal of a 10ml fasting blood sample sodium heparin, 
lOOunits/kg body weight, (Leo Laboratories Ltd) was administered intravenously. A further 
10ml sample was collected 15minutes after injection. Blood was collected in EDTA K2 and 
plasma separated immediately and placed in a -50°C freezer, at which temperature it was 
stored until transported to Sweden in dry ice.
A ssay: The principles of the method are briefly as follows. A synthetic emulsion of triolein 
(containing trace amounts of in the fatty acid moiety) stabilised by gum arabic is 
prepared by sonication of an oil/aqueous buffer mixture. An aliquot of post heparin plasma is 
added to this mixture and incubated at 25*C for a short time. Lipolytic activity of plasma is 
proportional to the amount of radio-labelled free fatty acid liberated. This is obtained by 
extraction of the free fatty acid into an organic solvent followed by liquid scintillation 
counting.
2.5/if vitro  Hpotysis
S
p<1.006 lipoproteins were isolated 5 hours after consumption of an oral fat load. Radioactively 
labelled triglyceride was incorporated into these lipoproteins, and after standardising their 
triglyceride content they were subjected to lipolysis in vitro by a purified bovine milk 
lipoprotein lipase. The extent of lipolysis was estimated as the amount of radioactive free fatty 
acid liberated during the incubation, and this was compared with the fatty acid compositions 
of fatty meals and lipid substrates.
2.5.1 Preparation o f substrate
5 hours after an oral fat tolerance test 100ml of blood was collected and p<1.006 lipoproteins 
isolated by ultracentrifugation. 20ml of plasma was placed in Beckman tubes (25 x 89mm), 
and overlayered with 6.0ml of pl.006g/ml solution. Tubes were capped and placed in a 
Beckman Ti50.2 rotor and centrifugation conducted at I40,000g, 4'C for 18 hours in a
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Beckman L8-80 ultracentrifuge. The supernatant was aspirated gently from the surface of each 
tube with a fine tipped glass Pasteur pipette, and collected into 3ml volumetric flasks. 
Individual preparations were then dialysed against a Tris buffer (0.01M Tris HC1, 0.15M NaCl, 
0.001M EDTA, pH 7.4). The concentration of triglyceride in the dialysate was measured by 
enzymatic procedures and adjusted with Tris buffer to 30mmol/l.
2.5.2 Preparation o f total lipoprotein and p<1.006 lipoprotein  deficient plasm as
Plasma deficient in p<1.006 lipoproteins was required for incubations of substrate with 
lipoprotein lipase. A proportion of the infranatant from individual preparations described 
above was pooled and dialysed against Tris buffer for future use in this respect.
Infranatants from the above p<1.006 lipoprotein preparation were used as a source of 
lipoprotein deficient plasma which was required for the labelling procedure. The density of 
the infranatant was adjusted to 1.225g/ml by the addition of KBr (0.3517g/ml). 15.0ml of this 
solution was placed in Beckman tubes (25 x 89mm) and overlayered with 11.0ml of 1.225g/ml 
solution prior to 22 hours centrifugation at 140,000g, and 4*C in a Ti50.2 rotor. 11.0ml of the 
supernatant was carefully removed and discarded and the infranatants pooled and dialysed 
against an excess of Tris buffer.
2.5.3 R adiolabelling o f p<1.006 lipoproteins
Triolein labelled with ^H in the fatty acid moiety (Amersham) was incorporated into p< 1.006 
lipoproteins. Sufficient triolein for the entire experiment was washed to remove any 
contaminating free fatty acids. 3H triolein, supplied in toluene, was placed in a glass tube and 
dried under nitrogen, then re-dissolved in 3ml of heptane. 7ml of 0.05M NaOH in ethanol: 
water ( 1:1, v:v) were added, the tube capped and shaken for 3 minutes, and the mixture 
allowed to separate. The heptane phase was removed and placed in aliquots of 135pCi in glass 
tubes and dried under nitrogen.
A 1.0ml portion of the isolated p<1.006 lipoprotein fractions (containing 30mmol/l 
triglyceride), and 0 .5ml of the lipoprotein deficient plasma were added to these tubes, which 
were then incubated at room temperature for 4 hours, mixing occasionally. This mixture was 
then placed in ultracentrifuge tubes (Ultradear 13x64mm) and overlayered with p<1.006g/ml 
solution, followed by ultracentrifugation at 110,000g, and 4'C overnight in a 40.3 rotor. 
Radiolabelled lipoproteins were collected from the surface of this preparation into a 1.0ml 
volumetric flask. Incorporation of label by this method is approximately 50%.180
2.5.4 R econstitution o f plasm a w ith p<1.006 lipoproteins
In vitro lipolysis was conducted in an environment in which physiological cofactors and other 
materials normally present during lipolysis were provided in a controlled fashion. 
Radiolabelled lipoproteins were re-suspended in a pooled plasma fraction of p>1.006g/ml,
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providing both lipoprotein and albumin to act as acceptor for liberated free fatty acid, and 
other lipoproteins to participate in the lipid and apoprotein exchanges which normally 
accompany lipolysis The pooled material had an LDL cholesterol of 34mmol/l, an HDL 
cholesterol of 1.15mmol/l, and a triglyceride concentration of 0.30mmol/l.
The triglyceride content and radioactivity of the labelled p<1.006 lipoproteins were 
measured and the specific activities calculated A fixed activity of 500,000 disintegrations per 
minute (dpm) were added to a vial containing unlabelled p<1.006 lipoproteins derived from 
the same preparation as the labelled material, to give a final concentration of 1.0 mmol/l 
p<1.006 triglyceride in 2.0ml of reconstituted plasma. Volumes were adjusted to 2.0ml with 
Tris buffer.
2.5.5 Preparation o f lipoprotein lipase.
This enzyme was prepared by affinity chromatography from bovine milk. Enzyme from this 
source shows much similarity to that obtained from human post heparin plasma, and has 
been widely used as a model for the human enzyme. The procedure adopted was based on 
that of Iverius.179 Purification of the enzyme was not the objective of this preparation 
however, and the procedure was only pursued as far as optimum recovery of lipase activity 
would allow.
Unpasteurised bovine milk was collected directly from the milking machine (Cockbum 
Farm Dairy) into prepared one litre bottles containing 300ml of glycerol in a phosphate 
buffer, to give a final concentration of 30% glycerol (v:v), 0.01M phosphate, pH7.4. The milk 
was kept cool and transported immediately to the laboratory where cream was separated by 
low speed centrifugation.
The infranatant was adjusted to 0.1M with solid trisodium citrate dihydrate and 500ml of 
this preparation stirred gently with 50ml of a heparin agarose gel (Sigma product H 5380) for 
30 minutes at 4*C. The gel (to which LpL was adsorbed) is then separated on a sintered glass 
funnel and washed with 3x200ml volumes of ice cold 0.5M NaCl, 30% (v:v) glycerol, 0.01M 
phosphate(pH 7.4). It was then re-suspended in 100ml of 1.5M NaCl in 30% glycerol, 
phosphate buffer and stirred gently for 15 minutes, releasing the enzyme into solution.
This solution was collected after separation on a sintered glass funnel, and the gel washed 
with a further 100ml of 1.5M NaCl, 30%glycerol, phosphate buffer, and the wash added to the 
first collection. The pooled enzyme preparation was dialysed against 3.6M ammonium 
sulphate in 0.01M phosphate buffer and the enzyme precipitated by centrifugation at lOOOg, 
4'C, for 15 minutes. The supernatant was discarded and the precipitate dissolved in 1.0ml of 
30% glycerol, 0.01M phosphate buffer, pH 7.4.
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2.5.6 in  v itro  assay o f lipolysis
Aliquots of radiolabelled substrate were incubated with purified lipase and enzyme activity 
assayed as free fatty acid liberated per minute per ml of enzyme.
Incuba tions: 1.0ml of the reconstituted plasmas containing 3Hp< 1.006 lipoproteins
were placed in glass tubes and 0.15ml of purified milk LpL added. Blank tubes were set up 
containing 0.15ml of Tris buffer in place of enzyme. Total fatty acid activities were 
obtained by a direct count of the incubation mix prior to extraction, but in the presence of 
extraction solvents. Tubes were incubated in a shaking water bath at 37*C and 80 cycles per 
minute, and aliquots withdrawn at intervals of 5 , 15, 30, 6 0 , and 90 minutes for determination 
of 3H free fatty acids.
F atty a c id  ex tra c tio n s: 181 A 0.05ml aliquot was withdrawn from the incubation 
mixture and lipolysis terminated by addition to 3.25ml of methanol: chloroform: heptane 
(1.41: 1.25: 1, v:v:v). 1.05ml of 0.1M potassium carbonate-borate buffer, pH10.5, was added to 
these tubes and shaken vigorously for 5 minutes and then centrifuged (lOOOg) at room 
temperature for 15 minutes. A 1.0ml aliquot of the methanol: water upper phase was then 
added to 10ml of scintillation fluid (Cocktail T, BDH) and activity counted in an LKB Rackbeta.
2.5.7 Com putations
After correction for blank values and dilution factors the activity of the enzyme was 
expressed as a percentage of total counts extracted with free fatty acids at each time point.
2.6 Data reduction and statistical analyses 
S
The full data set was mounted on a National Advanced Systems VL60, which forms part of 
Edinburgh University's Multi Access System (EMAS). Statistical analyses were performed by 
the Statistical Package for the Social Sciences (release 2.2 SPSS Inc.) except for multiple 
regression analyses for which the procedures of Minitab release 5 were used (Minitab Inc.).
Several of the parameters were positively skewed (p<1.006 components, HDL2, retinyl 
esters, lipases) and so, unless otherwise indicated, non parametric procedures which make 
minimal assumptions about underlying distributions, were used for comparisons and 
correlations. Tabular data are presented as means ± standard deviations.
2.6.1 Statistical tests
For comparisons of paired data the Wilcoxon matched pairs signed rank test was employed. 
This test computes the differences between paired observations, ranks them, and sums the
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positive and negative ranks, taking into account the magnitude of the differences. A test 
statistic Z is then assigned and a two-tailed P value calculated.
Unpaired data was compared by the Mann-Whitney U test, which tests whether two 
groups of unpaired data are drawn from the same population. It ranks all data in order of 
increasing size and computes a test statistic U, the number of times a score from group one 
precedes a score from group two. A two tailed P value is then calculated.
Spearman rank correlation (one tailed) was used to test for relationships between 
variables. This test ranks both sets of paired data and assigns a value to each rank. It then 
calculates the Spearman rank correlation co-efficient r, and calculates a one tailed P.
P values of more than 0.1 are not quoted in results, but are marked Not Significant (NS). 
The decision to adopt the 10% rather than the arbitrary, but more conventional 5% level for 
significance of P values was taken since several important aspects of the results would 
otherwise have been dismissed as insignificant
Chapter 3
Alimentary lipcemia
in
normal subjects
3.1 Introduction and methods 
5
To assess quantitatively the effects of exogenous fat on lipoprotein metabolism in vivo the fat 
must be introduced into the bloodstream in some standardised fashion. Fat tolerance tests 
presently take several forms in terms of composition, quantity, and mode of application, and 
as yet their is no consensus regarding their design or implementation for purposes of 
quantitative comparison. For this reason investigators generally have to establish the limits of 
a particular fat tolerance test under their own standardised conditions, and within their 
chosen population.
The objectives of this part of the study were to characterise lipaemia in terms of 
alterations in the p< 1.006  lipoprotein fraction and any co-ordinate changes in other 
lipoprotein classes. It was hoped to quantify these changes and to relate them to fasting 
lipoprotein profiles, thus providing a comprehensive description of lipaemia as it relates to 
lipoprotein metabolism in general.
Alimentary lipaemia was examined in a group of twenty-eight healthy volunteers (20 
males and 8  females), recruited from the staff of Glasgow Royal Infirmary. None were 
prescribed any medication known to affect lipoprotein metabolism. None of the females 
used oral contraception. Two of the males and two of the females smoked approximately 
twenty cigarettes per day, and one of the males smoked a pipe (1/2 oz per week). The 
protocol described in Chapter 2 was followed throughout, with blood samples taken two 
hourly till eight hours, and again at twenty four hours. Samples for lipase estimations were 
obtained on a separate occasion. Lipoproteins were prepared by sequential flotation (section 
2.4.1).
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3.2 Results 
5
3.2.1 Fasting lipoproteins
Details of age, body mass index, and the fasting lipids & apoproteins in the serum of male and 
female groups are presented in Table 3.1. Males were on average 6 years older than females, 
and had lower levels of apoAI. Otherwise the differences were not significant.
Table 3.1 Fasting serum lipids and apoproteins in normal subjects
Age Quetelet 
Index 
(years) (kg/m2)
Cholesterol Trig. 
Free Ester.
................... (mmol/1).........
Phos.
AI
Apoproteins 
All B CIII 
........... (mg/dl)................
E
Male 31.9 24.3 1.76 3.01 1.28 2.68 144.1 36.7 94.6 5.0 7.8
(n -20) ±6.9 ±2.8 ±0.56 ±0.54 ±0.60 ±0.43 ±29.2 ±10.4 ±24.9 ±2.1 ±4.1
Female 26 .0* 24.2 1.63 2.95 0.91 2.81 168.5* 35.6 85.0 4.9 7.3
(n=8) ±5.7 ±2.1 ±0.37 ±0.57 ±0.21 ±0.30 ±15.2 ±9.7 ±24.0 ±1.4 ±4.2
Difference between males and females *P£0.05
When fasting lipoprotein profiles were compared (Table 3.2) males were found to have more 
VLDL and less HDL2 than females, but had similar amounts of IDL, LDL and HDL3 . The data in 
Table 3-2 regarding total lipoprotein mass was also representative of their individual lipid and 
protein constituents.
Lipoprotein and hepatic lipase activities in plasma were measured before and after the 
intra-venous administration of sodium heparin. This procedure is known to release these 
enzymes from their binding sites on the vascular wall into the bloodstream, thus increasing 
their activity and allowing direct assay in a blood sample. HL activities so obtained were 
greater in males, but LpL did not differ significantly (Table 3 3). Pre-heparin activities, 
although much lower than post-heparin, provided the same information in these 
comparisons. Pre and post heparin HL activities however, were not correlated, and the 
correlation between pre and post heparin LpL was only 0.54 (P^O.Ol).
Table 3.2 Fasting lipoproteins in normal subjects
VLDL IDL LDL HDL2 HDL3
Males 90.1 15.4 233.0 57.9 221.1
(n -20) ±55.8 ±10.0 ±68.0 ±26.7 ±56.9
Females 45.7* 9.9 207.9 108.6** 220.1
(n-8) ±230 ±3.8 ±52.8 ±38.3 ±35.8
Total lipoprotein masses were calculated from the sum of their lipid and protein components 
expressed as mg/dl. HDL subffactions were derived from the analytical ultracentrifuge. Differences 
between males and females.*P£0.05, **P£0.01
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Tabic 3.3 Lipase activities in normal subjects
Lipoprotein lipase 
Pre-heparin Post-heparin
Hepatic lipase 
Pre-heparin Post-heparin
Males 
Cn -  20)
Females
<n^8)
0.52
±0.24
0.45
±0.10
196.7
±55.7
168.4
±61.2
0.20
±0.15
0 .06*
±0.07
171.6
±61.6
74.9“
±51.5
Units for lipase activity are mU/ml where ImU -  lnmol fatty acid released per minute at 25*C. 
Difference between males and females*P£0.005, “P£0.001
An examination of the inter-relationships between lipoprotein classes (Table 3.4), revealed a 
positive association between VLDL, IDL, and LDL levels, and a weak inverse relationship 
between VLDL and HDL2 . Quetelet index, a measure of obesity, was positively related to 
VLDL and negatively to HDL2 .
Total circulating VLDL mass (Table 3.2) was calculated by summation of the weights of its 
lipid and protein constituents as assayed in the ultracentrifugally isolated p<1.006 fraction. It 
should be remembered however that VLDL are heterogeneous in terms of size, and that 
differences in total mass may reflect variation in either the number of VLDL particles, the size 
of individual particles, or a combination of both. The more detailed specification of the VLDL 
fraction in Table 3-5 shows the similar (but not identical) particle compositions and average 
diameters in males and females, and indicates that the greater amount of VLDL in males was 
due primarily to a greater number of particles in the circulation. Pre heparin LpL activity was 
negatively related to fasting VLDL size (r=-0.40, P£0.05), but not to number.
3.2.2 Post prandial lipids and lipoproteins
Serum : Subsequent to consuming the fat load all subjects exhibited a rise in serum 
triglyceride of variable magnitude and duration. The other lipid constituents of the serum did 
not respond in such a predictable fashion, mean values tending to obscure an inter-individual 
variability which included cases of increase, decrease and stasis during lipaemia.
Table 3.4 Correlations between fasting lipoproteins
Age Quetelet VLDL IDL LDL h d l 2 HDL3
Age •
Quetelet 0.30 •
VLDL 0.08 0.52“ •
IDL -0.02 0.24 0.53“ •
LDL 0.37* 0.45“ 0.44" 0.50" •
h d l 2 -0.11 -0.45" -0.35* -0.05 -0.24 •
HDL3 -0.01 0.16 0.12 -0.14 -0.22 0.21 •
Correlations are between total lipoprotein masses in male subjects (n-20), *P £ 0.10, “P £ 0.05
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Choi.
Percentage composition
Trig. Phos. Protein
Particle
Diameter Number 
A xlO1*
Males 13.4 58.7 20.5 7.4 39.9 2.83(n=20) ±2.8 ±7.5 ±4.2 ±3.1 ±8.2 ±1.29
Females 14.3 54.1 21.0 10.6 35.4 2 .02*
(n-8) ±2.9 ±9.0 ±2.2 i6.4 ±7.7 ±0.70
Average particle diameters in individual preparations were estimated from a knowledge of their 
chemical composition as described in section 2.4.4. Figures quoted are the mean of these average 
diameters for male and female groups. Particle number was estimated as the total volume of lipo­
protein present divided by the volume of a sphere of the calculated diameter. Differences between 
males and females, P£0.1.
Alterations in the lipids and apoproteins of un-fractionated serum are given in Table 3.6, and 
are further illustrated in Figures 3.1 & 3.2. The rise in serum triglyceride was less in females 
than in males, but showed the same single peak at 4 hours. The form of the phospholipid 
profile differed from that of triglyceride in that it persisted considerably longer. 
Phospholipid flux tended to be greater in females.
The overall trend was towards a rise in serum total cholesterol. In males this rise was 
positively correlated with the esterified cholesterol response at all stages of lipaemia (eg. areas 
r-0.74, P^O.OOl). Free cholesterol response (A) was only correlated with total cholesterol flux 
at 6 , 8 , and 24 hours (r-0.51, 0.41, and 0.55 respectively, P£0.05). Therefore total serum
TaHI* X (\ Mosiyi nnct trra.nA.inl restm nses in  seru m  cholesterol in male Subjects
seemed to be a function of 
cholesteryl ester flux during 
the early stages of lipaemia, and 
a combination of free and 
esterified at later times.
In female subjects the rise 
in serum  cholesterol was 
significantly less than in males, 
and could be attributed more 
to an increase in free rather 
than esterified cholesterol, the 
latter tending in fact to decline 
during lipaemia. Post prandial 
cholesterolaem ia in these 
females differed therefore not 
only in magnitude from that of 
male subjects, but also in its 
molecular nature.
% change from  fasting
Hours Males Females 
post prandial (n -20) (n-8)
Total cholesterol 2-8 T r -
Free cholesterol 2-8 - Tg’
Esterified cholesterol 2-8 Tsr -
Triglyceride 2-8 1 193" T 140"
Phospholipid 2-8 Til T 12
Apo AI 2-8 - -
Apo All 2-8 T 8 -
Apo B 2-8 T 12* T6*
ApoCIII 2-4 T 16 -
6 - -
8 i l6 121
Apo E 4-6 T 28 -
8 - 116
The percentage figures given refer to the maximum mean 
deviation from fasting levels during the times indicated. ApoCIlI 
and E showed a biphasic response to the f^at load. Significance 
of difference from fasting levels, P £ 0.05, P ^ 0.01.
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phospholipid 
mmol/1
A triglyceride 
mmol/1 4.0
Males
(n-20)
II
Hours 2 4 6 8
H  Triglyceride
[771 Phospholipid
.02 .02 .01 .05
Figure 3.1 Serum tri-glyceride 
and phospholipid  during 
lipaemia. P values refer to the 
significance of differences 
between male and female 
responses. See Table 3.6 for 
significance of differences from 
fasting levels.
Mmllteg
(n-20)
A mmol/1
IFcnmuolkcs
(n-8)
♦ -  Total - t— :— .05 [ ■ I™ ■ -
Cholesterol .02 | .05 10 !
•
i -
Esterified
! .005 .001 !
•
Cholesterol .02 ■ 1
Figure 3>2 Serum cholesterol during 
lipaemia. Total cholesterol is 
depicted  here to facilitate 
comparison with other studies, and 
represents the total amount of 
cholesterol present in both free and 
esterified form, not corrected for 
the fatty acid content of the ester 
(section 2.4.3).P values refer to the 
significance of differences between 
male and female responses. See 
Table 3-6 for significance of 
differences from fasting levels.
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L ip o p ro te in s o f  p<1.006g/mk The influx of chylomicrons into this density range was 
the main feature of the changing lipoprotein profile during lipaemia, and is represented 
diagrammatically in Figure 3.3. All constituents of this lipoprotein fraction were significantly 
increased between 2 and 8  hours in both male and female subjects. The following description 
refers specifically to the males.
The increase in p<1.006 triglyceride was disproportionately greater (between 3 and 4 
fold) than that of other components, and was reflected in an increased particle diameter. 
Thus in contrast to the variations found in fasting VLDL, post prandial triglyceridaemia was 
due mainly to fluctuation in particle size rather than in number.
Protein
•70% T ^ T riglyceride T 375%
Cholesterol
t o r  105%
Fasting 2 4 6 8  24
Figure 3*3 All components of the p<1.006 class of lipoproteins were raised during lipaemia. The 
percentage increases at the peak (4 hours), are shown above. The disproportionately greater increase in 
triglyceride led to an increase in particle diameter. Results are the average for twenty males.
Post prandial fluctuations were quantified as described earlier (Figure 2.1). Both types of 
measurement (area and A) are normalised to fasting levels, and are therefore designed to 
gauge response rather than to provide an absolute measure of lipaemia. The inter­
relationships of these two measures (Table 3.7b), shows that p<1.006 triglyceride area was 
correlated with all A triglyceride between 2 and 8  hours. The decline in the strength of the 
association at 8  hours suggests that the major influence on the overall magnitude of 
triglyceridaemia was due to circumstances during early and peak periods. The A24 hour value 
appeared unrelated to the magnitude of lipaemia and will be discussed more fully later.
Individual responses to the fat load were highly variable, with p<1.006 triglyceride areas 
ranging from 1.50 to 38.4 mmol/1 • 8  hours in the male group. Reproducibility of response 
was examined in a group of 9 males who consumed the test meal twice (Figure 3.4). Although 
mean values for this group were remarkably similar on both occasions, there were three 
subjects (DB, DW and JMcK) in whom p<1.006 triglyceridaemic response was not so precisely 
reproduced. These deviations could not be ascribed to any specific factors although it was 
noted that they occurred among those with a greater response.
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Table 3.7 Correlation between measures o f response in male subjects 
a). A
D<1.006 2 4 6 8 24 Areas
Retinyl Palmitate 
and Triglyceride
0.73*** 0.77*** 0.20 0.23 0.21 0 .60-
b). Tridvtwide
Triglyceride Area 0.79“ 0.98“  0.78“ 0.41* -0.04 •
o . Refinvi Palmtafp
Retinyl Palmitate 0.82“ 0.88“  0.97“ 0.73*** 0 .61** •
Significance of correlations between the various measures of response, 'P50.05, **P£0.005, ***P£0.001, 
n-20males.
Cholesterol and triglyceride responses in p<1.006 lipoproteins were highly correlated (eg. 
areas r=0.93, P^O.OOl). The rise in p<1.006 cholesterol was also positively related to serum 
total and esterified cholesterol response A2-A8 (eg areas p<1.006 total cholesterol with serum 
total cholesterol r-0.52, P£0.01, and with serum esterified cholesterol r=0.47, P^0.02). 
Cholesterol flux in p<1.006 lipoproteins was unrelated to free cholesterol flux in whole serum. 
In terms of magnitude the rise in cholesterol in pel.006 lipoproteins during the early stages of 
lipaemia could account for much of the rise in serum cholesteryl esters.
(mmol/1)
5.0 HL
4.0
3.0
2.0
1.0
0
BD RB CP
5.0
4.0
3.0
2.0 
1.0
IW DB
5 °  D W  
4.0
JMcK
2.0
1.0
E D
Hours
Areas
(mmol/l • 8hours)
HL 1.02 0.27
BD 3.11 2.52
RB 5.03 3.03
CP 6.96 5.98
IW 6.90 6.75
DB 3.69 8.24
DD 14.69 14.81
DW 11.84 18.34
JMcK 18.24 11.65
Mean 7.91 7.95
±SD ±5.45 ±6.65
F ig u re  3 .4  Reproducibility of the fat tolerance test. Results are p<1.006 triglyceride.
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p <1.006  
lipoprotein mass 
(mg/dl)
400 t
p <1.006  Triglyceride 
Responses (mmol/1) 
Males Females
300 ■■
200 ■ ■
100
Hours
2 1.66*1.45 0.77*0.57 *♦
4 2.69*1.87 1.29*0.97 *♦
6 1.97*2.13 0.53*0.45 ***
8 0.85*1.59 0.07*0.46 •
24 0.20*0.37 0 .11* 0.36
Area 13.50±10.64 5.27±3.47 ***
n - 2 0  males
O n - 8  females
Fasting
F ig u re  3 .5  Post prandial lipaemia in males and females. Male subjects had a greater lipoprotein mass
in the p<1.006 fraction initially, and showed a greater increment (A) in response to the fat load. 
Significance of differences between male and female responses *P<0.10, **P£0.05, P£0.01.
The differing profiles of lipaemia in male and female subjects are shown in Figure 3 5. Area 
and A values reveal that the greater lipaemia in males was due not only to higher initial VLDL 
mass, but also to an increased response to the fat load evident throughout all stages of 
lipaemia.
R etin y l e s te rs  in  p<1.006 lip o p ro te in s: Triglyceride and RP flux is illustrated in
Figure 3.6, and responses in male subjects compared in Table 3 7a. RP rose more slowly than 
triglyceride and continued to rise after triglyceride had begun to decline. RP and triglyceride 
responses showed a degree of independence, particularly as lipaemia progressed. Although 
areas were correlated the relationship appeared to derive from A2-A4 rather than the entire 
range of A values.
Plasma RP concentrations were significantly less in females than in males at all time 
points, with the difference becoming more marked latterly (Table 3 8). The ratio of RP to
_________________ T abl e 3 .8  Retinyl palmitate flu x  in males and females_________________
Fasting 2 4 6 8 2A Area
. (jimol/1)... . (*8hour)
0.02 0.48 0.85 1.44 1.87 0.29 7.24
±0.03 ±0.40 ±0.68 ±1.26 ±1.50 ±0.35 ±5.47
0.01 0.24* 0.45* 0.53" 0.47“ 0.07** 2 .88“
±0.02 ±0.19 ±0.25 ±0.50 ±0.61 ±0.06 ±2.08
Males 
(n-20)
Females 
(n-8)
Significance of difference between male and female groups, P£0.05, P^0 02, P^O.01. See Figure 3.6
for profiles.
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0 2 4 6 8
Males
(n-20)
I
L mjt
Females
(n-8)
□  Triglyceride (mmol/1) H  Retinyl palmitate (junoi/D) RP/tg ratio
Hours
F ig u re  3 -6  p<1.006 triglyceride and RP responses in males and females.
triglyceride, both residents of the lipoprotein core, provides an index of the relative 
enrichment of the p<1.006 fraction with retinyl ester as lipaemia progresses. This ratio was at 
its highest measured level in the last post prandial sample drawn (8  hours), and even at 24 
hours was still as high as at the peak of lipaemia.
Despite significant gender differences in absolute levels of both RP and triglyceride, the 
RP/triglyceride ratios were quite similar (Figure 3.6). The implication is that the greater mass 
of RP in male subjects is distributed throughout a larger number of particles rather than 
present in greater concentration within the particle core.
L ip o p ro te in s q f  p>1.006g/mL Lipid flux during lipaemia was not limited to the 
triglyceride rich fraction, but was observed throughout the lipoprotein spectrum. 
Representation of the average changes is given in Figures 3 7-3 9 The following summary of 
these responses applies to the male group alone, although the pattern observed in females 
was qualitatively similar.
•IDL In the density fraction 1.006g/ml to 1.019g/ml phospholipid content rose (24-39%) 
and the cholesterol content fell (26-37%) during the first six hours of lipaemia. Triglycerides 
were not significantly altered.
•LDL The phospholipid content of this fraction rose continually throughout lipaemia and 
was at its highest level (Tl2%) in the last post prandial simple drawn (8  hours). Triglyceride 
was also increased during lipaemia but peaked (t9%) earlier, at 4 hours, and then declined. 
Mean levels of free and esterified cholesterol in LDL tended to fall initially and then rise later, 
although individual variations in the pattern of cholesterol flux meant that these values did not 
differ significantly from fasting.
•HDL The post prandial changes in HDL phospholipid, triglyceride, and free (but not 
esterified) cholesterol paralleled those of LDL. Phospholipid rose to its highest level (T11%)
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Triglycerides
p < 1.006
IDL
LDL
J l  ■  ■ _ _ _ _ _ _ _
i l l . HDLr
4 6 8 24
Hours
in lipoprotein triglyceride during lipaemia. Zero marks fasting levels and vertical 
rhange from fasting. Significance of difference from fasting, *PS0.05, ••PSO.Ol,
l/iouirl y
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F ig u re  3 .8  Changes in lipoprotein phospholipid during lipaemia. Zero marks fasting levels and 
vertical bars represent mean change from fasting. Significance of difference from fasting, •Pi0.05, 
-PS0.01, •~P£0.001. n-20 males.
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F ig u re  3 .9  Changes in lipoprotein cholesterol during lipaemia. Zero marks fasting levels and vertical
bars represent mean change from fasting. Cholesterol bars in p<1.006 fractions refer to total 
cholesterol. Significance of difference from fasting, *P<0.10, **P<0.05, ***P 0^.01. n-20 males.
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by 8  hours, while HDL triglyceride peaked (T63%) at 4 hours. Free cholesterol fell marginally 
at first but then rose gradually to be increased by 12% 8  hours after the fat load. HDL 
esterified cholesterol however, in contrast to the changes in LDL cholesteryl esters, fell 
consistently by between 5 and 8% throughout lipaemia.
The magnitude of post prandial triglyceridaemia was positively related to A LDL esterified 
cholesterol & triglyceride, and A HDL triglyceride, and negatively to A LDL free cholesterol 
and A HDL esterified & free cholesterol at various stages of lipaemia (correlations not quoted 
here). The pattern of changes in these lipids and post prandial lipaemia could be best 
understood by considering them as components of either core or surface domains.
so
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F igu re  3 .1 0  Core lipids in LDL and HDL. Difference of CE/TG ratio from fasting, *PS0.05, **P^0.01, 
n-20 males. See figures 3 7 & 3 9 for significance of A values.
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Core: In both LDL and HDL the ratio of the core constituents cholesteryl ester and
triglyceride (CE/TG) fell during lipaemia (Figure 3-10). In LDL, even when both lipids showed a 
net increase, the reduction in CE/TG ratio indicates that triglyceride influx exceeded that of 
cholesteryl ester. The same ratio in HDL fell by a much greater amount, from 8.8  to 5.5 (38%) 
at four hours, P^O.Ol, and showed a strong negative correlation with p<1.006 triglyceridaemia 
(r--0.71, P^O.OOl). During lipaemia therefore the cores of both LDL and HDL became 
enriched in triglyceride, although only in HDL was this at the expense of cholesteryl ester.
By 8  hours the CE/TG ratio had risen again, and by 24 hours, despite little change in the 
absolute amount of cholesteryl ester, there was an increase in HDL of approximately 8%, 
P^O.Ol.
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S u rfa ce: The time scale of flux in free cholesterol and phospholipid, both associated
with lipoprotein surfaces, differed from that of p<1.006 triglycerides, being at their highest 
levels in the latest samples drawn (8  hours).
The ratio of free cholesterol to phospholipid (FC/PL) was calculated as a measure of free 
cholesterol concentration at the lipoprotein surface (Figure 3.11). This ratio was 
approximately 5 times greater in LDL than in HDL. In HDL the ratio remained constant during 
lipaemia, but was increased by 20% at 24 hours (0.09 to 0.11, P^O.001). Figures 3.8 & 3-9 show 
that this late rise was due to the higher free cholesterol content of HDL since phospholipid 
levels were little changed at this time. Neither the rise in HDL free cholesterol, or FC/PL ratio 
at 24 hours were statistically related to the magnitude of the preceding post prandial 
triglyceridaemia.
The greater increase in phospholipid over free cholesterol in LDL led to a significant fall 
in the FC/PL ratio during lipaemia (8% at 6  hours, P^0.005). The free cholesterol content of 
LDL was apparently linked to the triglyceride content of p<1.006 lipoproteins. LDL free 
cholesterol levels were positively related to both fasting (r=0.36, P^O.l), and post prandial 
(r-0.51, P£0.01) p<1.006 triglycerides. However, post prandial changes in LDL free 
cholesterol, and in the FC/PL ratio were negatively related to both fasting and post prandial 
p<1.006 triglyceride (Table 3.9).
Table 3.9 Correlations o f post prandial triglyceride and  free cholesterol flu x
p<1.006
Triglyceride 2
A LDL Free cholesterol 
4 6 8 24
Fasting -0.12 -0.31 -0.46* -0.40* -0.56"
Area -0.10 -0.51* -0.48* -0.52" -0.67"
LDL FC/PL ratio
Fasting -0.64" -0.42* -0.58" -0.58" -0.63"
Area -0.63" -0.41* -0.52" -0 .61" -0.63"
Significance of the correlations between fasting and post prandial triglyceride response and the changes 
in LDL free cholesterol after the fat load, *P£0.05, PS0.01.
The actual free cholesterol content of LDL and its flux during lipaemia were therefore both 
related to the magnitude of lipaemia, but with opposing sign. In fact there was a negative 
relationship between fasting levels and the response in LDL free cholesterol at 8  (r=-0.49, 
P^0.02), and 24 hours (r*-0.55, P£0.01), at which times LDL free cholesterol showed a mean 
rise (Figure 3.9). Those in whom lipaemia was greatest therefore tended to have higher fasting 
LDL free cholesterol, but were less likely to show a rise in free cholesterol during lipaemia.
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3.2.3 L ipoproteins 24 hours alter Cat ingestion
Fasting blood samples obtained on the morning following the fat tolerance test differed in 
several respects from those obtained 24 hours earlier. Serum triglyceride in male subjects was 
lowered by an average 15%, P^0.005, (Figure 3.1), mirroring a fall of similar magnitude in cir­
culating VLDL mass (Table 3.10). The reduction in VLDL seemed primarily due to fewer 
particles, although composition was also altered in that relatively less cholesterol and more 
triglyceride was present compared with the previous days sample. It should also be recalled 
that a significant amount of RP continued to circulate in this density fraction at 24 hours 
(Figure 3.6).
The triglyceride content of HDL was 35% less (P^O.OOl) than it was prior to the fat 
tolerance test, whereas HDL free cholesterol was increased by 17% (P10.02). Free cholesterol 
in the LDL fraction was also increased (4%, P^O.l) (Figures 3.7-3.10). Significant and 
qualitatively similar changes were also observed in females.
Table 3.10 The composition o f fasting VLDL initially and  a t 24 hours
Total mass 
(mg/dl) chol.
Percentage composition
trig. phos. protein
Particle 
diameter N°
A xlO1^
Initial 90.1 13.4 58.7 20.5 7.4 39.8 2.83
±558 ±2.8 ±7.5 ±4.2 ±3.1 ±8.2 ±1.29
24 hours 73.1 11.4 61.8 18.7 8.1 42.3 1.97
±50.0 ±2.8 ±5.4 ±2.4 ±4.2 ±6.8 ±1.11
il9%~ ll5%~* t5%* i9%* • • i30%~
Significance of the changes at 24 hours, *P!S0.10, **P£0.05, ***P£0.01
3.2.4 Lipaemic response and Casting profile
To investigate the position of alimentary lipaemia as a component of an individuals 
lipoprotein constitution the principal markers of lipaemia (triglyceride and retinyl palmitate 
in p<1.006 lipoproteins) were correlated with fasting lipid profiles.
p< 1.006 tr ig ly ce rid tem ic  resp o n se: p < 1 . 0 0 6  triglyceridaemic response correlated 
positively with all serum lipids, and with apoproteins B & CIII, and inversely with apo AI 
(Table 3.11). It also correlated positively with fasting VLDL, IDL, and LDL masses, the 
relationship to VLDL seemingly dependent on the size rather than the number of fasting 
particles. Fasting HDL2 mass was inversely related to the magnitude of lipaemia, but HDL3 
mass was not. Two aspects of these correlations deserve further mention.
Firstly, regardless of sign, they were more pronounced during the first four hours, 
declined by six hours, and had disappeared by eight hours. Bearing in mind the inter­
relationships of A and area measurements in Table 3 7, suggesting a more significant influence 
of earlier A values on the overall magnitude of lipaemia, it would seem that the determinants
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Table 3.11 Correlations o f fasting, parameters with triglyceride response
A p<1.006 Triglyceride
Fasting 2 4 6 8  24 Area
Free cholesterol 0.59*** 0.50" 0.47" 0.12 0.16 0.53"*
Ester, cholesterol 0.41** 0.35* 0.36" 0.03 -0.07 0.39"
Triglyceride 0.84~ 0.88T 0.56- 0.15 -0.19 0.86-
Phospholipid 0.61*** 0.59- 0.30* 0.04 0.16 0.58-
Apo AI -0.31’ -0.39" •0.35* -0.25 0.00 -0.34*
Apo All 0.11 0.25 0.25 0.34* 0.12 0.32*
Apo B 0.62~ 0.51- 0.54- 0.18 0.08 0.53-
Apo cm 0.41" 0.54- 0.34* 0.29 0.08 0.58~
Apo E 0.26 0.07 -0.23 -0.20 0.27 0.03
VLDL O.83— 0.86~ 0.58- 0.19 -0.32* 0.83~
.........Diameter 0.71- 0.77- 0.48" 0.11 -0.15 0.76-
.........Particle N“ 0.16 0.10 0.07 0.14 -0.16 0.09
IDL 0.49" 0.42" 0.17 -0.13 0.16 0.42"
LDL 0.54- 0.50- 0.49" 0.09 0.20 0.53-
hdl2 -0.40" -0.44" -0.35* 0.22 0.45" -0.39"
HDL3 0.13 0.15 -0.06 0.02 0.10 0.10
LpL pre heparin -0.33* -0.31* -0.09 -0.05 -0.13 -0.30*
LpL post heparin 0.17 -0.01 -0.08 -0.26 -0.07 -0.05
HL pre heparin -0.38" -0.57~ -0.58- -0.33 0.08 -0 .62-
HL post heparin 0.23 0.29 0.09 -0.26 -0.24 0.25
Significance of the correlation between various fasting parameters and triglyceridacmic response, 
*P£0.1, "PS0.05, ~*P£0.01-
of the earlier stages of triglyceridaemia in these subjects have more relevance to their fasting 
lipoprotein profile.
Secondly, in the case of fasting VLDL and HDL2 , the sign of the correlation with 
response is reversed at 24 hours. Therefore in those people initially possessed of high fasting 
VLDL and low HDL2 there was a greater tendency for VLDL triglyceride to be reduced below 
original baseline levels following a fat load.
Post heparin lipase activities were unrelated to triglyceridaemic responses. There was 
however a weak negative correlation between pre heparin LpL activity and A2-A6 triglyceride, 
and a negative correlation between pre heparin HL and all phases of triglyceridaemia.
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(X 1 .006  re tin y l p a lm ita te  response: The relationship of RP flux to fasting profile
resembled generally that of p<1.006 triglycerides, but differed from it in several important 
respects (Table 3.12). Whereas triglyceride responses beyond their peak declined in their 
associations with fasting profile, it was notable that even the later RP responses were related 
to fasting levels of serum triglyceride, phospholipid, VLDL and IDL.
Closer examination of the relationship of fasting VLDL to RP indicate that the initial rise 
in RP was related to fasting VLDL diameter, but not to particle number, whereas the opposite 
was true for later values of RP response. Therefore the factors governing fasting VLDL 
diameter appear more closely related to those involved in the initial rise in RP, and those 
involved in the determination of VLDL numbers more closely related to RP clearance.
Table 3.12 Correlations o f fasting parameters with retinyl palm itate
Fasting 2
A p<1.006 Retinyl palmitate 
4 6 8 24 Area
Free cholesterol 0.40" 0 .3 / 0.24 0.29 0.34* 0.33*
Ester, cholesterol 0.45" 0.44“ 0.29 0.3 / 0.09 0.39"
Triglyceride 0 .62"* 0.83“ 0 .68T 0.62*“ 0.72*" 0.72*"
Phospholipid 0.41" 0.44" 0.35* 0.57“ 0.48" 0.49"
Apo AI -0.31’ -0.54"* -0.38" -0.16 -0.20 -0.37"
Apo All 0.16 0.24 0.38" 0.08 0.40 0.33*
Apo B 0.31* 0.41" 0.21 0.27 0.26 0.28
Apo CIII 0.29 0.40" 0.38“ 0.53“ 0 .60“ 0.46“
Apo E 0.11 0.05 0.14 0.21 0 .36* 0.19
VLDL 0.59“ 0.79“ 0.64*" 0.71“ 0.64*" 0.72*"
.........Diameter 0.74“ 0.69“ 0.48" 0.30 0.42" 0 .61“
.........Particle N° -0.15 0.19 0.36* 0.59“ 0.35* 0.28
IDL 0.31 0.27 0.39* 0 .38* 0.49" 0.44"
LDL 0.44" 0.41" 0.23 0.12 0.26 0.32*
h d l 2 -0.40" -0.38* -0.28 0.07 -0.08 -0.29
HDL3 -0.06 0.11 0.16 0.18 0.33* 0.14
LpL pre heparin -0.01 -0.19 -0.04 0.13 -0.30* -0.02
LpL post heparin 0.13 0.16 0.20 0.15 -0.01 0.20
HL pre heparin -0.17 -0.25 -0.28 -0.45" -0.3/ -0.34*
HI post heparin 0.15 0.09 0.23 0.09 0.28 0.21
Significance of the correlation between various fasting parameters and response, ’PS0.1, "PS0.05, 
“ P<0.01
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Ap< 1.006 RP at 24 hours was also related to initial fasting triglyceride, phospholipid, 
VLDL, and IDL concentrations. RP was more likely to be raised in those subjects with greater 
initial fasting levels of the VLDL and IDL classes.
Post heparin lipase activities were again unrelated to response, although a negative 
correlation did exist between pre heparin HL and A8  RP, and between both pre heparin 
enzyme activities and A24 hour RP.
3.3 Discussion 
S
The nature o f post prandial triglyceridaemia
The magnitude of post prandial triglyceridaemia has been described as the most variable of all 
parameters of lipid transport.182 Within this normal population it was found to range in male 
subjects from 1.50 to 38.4 mmol/1 *8hours, a 26 fold difference between individuals in p<1.006 
triglyceride area. Although of lesser magnitude, fasting VLDL triglyceride also exhibits a high 
degree of variability, the corresponding figures to those above being 0.06  to 1.8 mmol/1; a 30 
fold range. The results of this study illustrate however, a fundamental difference in the nature 
of fasting and post prandial triglyceridaemias.
The present findings confirm those of Redgrave and Carlson175 which show that post 
prandial triglyceridaemia is accounted for primarily by an increase in the average size of 
p<1.006 lipoproteins, rather than an increase in their total number. The formation of larger 
particles by the intestine probably represents an adaptation for the conservation of surface 
materials (phospholipid and proteins) in the face of increased triglyceride flux after a fatty 
meal.86
Fasting triglyceridaemia on the other hand is a result of variability in the num ber of 
particles in the p<1.006  lipoprotein classes in both normo- and hyper-triglyceridaemic 
subjects,175 manifest here in the difference in the number of VLDL particles in males and 
females. Size differences (as suggested by the slightly greater percentage of triglyceride in 
males) may make a minor contribution to fasting triglyceride variability. It has been calculated 
that 71% of the variation in fasting triglyceride is due to differences in particle number and 
29% due to size.183
The present data suggest a degree of independence in the expression of size and 
number, affecting triglyceride rich lipoproteins of both hepatic and intestinal origin. Firstly, 
males and females differed not only in fasting triglyceride but also in their response to the fat 
load. Therefore in addition to a difference in the number of particles in the fasting condition, 
the magnitude of the post prandial increment (mainly due to size) also differentiated male and 
female groups.
Secondly, the increment in size was found to be a characteristic feature of an individual's 
metabolic profile, a finding supported by previous reports of the reproducibility of the fat 
tolerance test.51-182-184 Lastly, post prandial triglyceridaemia was correlated with fasting VLDL
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diameter, but not with particle number, suggesting a link in the physiological regulation of 
triglyceride rich lipoprotein size applying to hepatic as well as intestinal lipoproteins.
These findings agree with the concept of a competition between fasting and post 
prandial triglyceride rich lipoproteins for a common and saturable removal mechanism .185'186 
Since lipoprotein size in this density range is largely a function of triglyceride content, the 
importance of this variable suggests that it is the triglyceride burden of individual particles 
rather than simply total circulating triglyceride, which underlies the competition for 
triglyceride removal.
Grundy and Mok,187 in discussing the discrepancy between chylomicron and VLDL 
catabolic rates, concluded that the type of particle in which fat was presented, rather than the 
total fat load was the important factor determining rates of hydrolysis. In addition Quarfordt 
and Goodman188 have found that larger chylomicrons are catabolised faster than smaller ones. 
Although the determination of lipoprotein size will depend to some extent on the availability 
of apoprotein and other surface materials relative to the prevailing flux of triglyceride, it will 
also depend on individual capacity for triglyceride removal.
The enzyme responsible for triglyceride hydrolysis is LpL, and by virtue of a preference 
for larger and more triglyceride enriched particles its activity will tend to reduce average 
lipoprotein size. Individual variability in the capacity to hydrolyse triglyceride may therefore 
provide the link between fasting and post prandial lipoprotein size, since greater activity 
would alleviate competition for lipolytic sites, and thus maintain smaller sized VLDL and 
chylomicron populations. Such a relationship may be of more than academic interest in view 
of the divergent catabolism of large and small VLDL species.189
The clearing o f lipaemia
The dual character of chylomicron catabolism was clearly illustrated by the differing profiles 
of retinyl palmitate and triglyceride. RP was added to the fat load as a tracer for chylomicron 
remnants. Its delayed rise, and its continued rise after the peak of triglyceridaemia, are 
evidence that its absorption is slower than that of triglyceride. The extended plasma lifetime 
of RP and the difference in RP & triglyceride clearance rates are in keeping with the concept 
of a biphasic catabolism of chylomicrons comprising an initial period of triglyceride lipolysis 
followed by uptake of the whole remnant. During the first catabolic phase triglyceride and RP 
responses were related, but during the second phase this relationship disappeared.
The first stage: The initial incorporation of RP into newly formed chylomicrons
presumably contributes to the positive associations between RP and triglyceride during the 
early stages of lipaemia. In a study similar to the present one Weintraub et attempted to 
assay chylomicron and non-chylomicron (remnant) populations by measuring RP in post 
prandial lipoproteins isolated at S/>1000 and S/<1000 respectively. They found that RP and
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triglyceride in chylomicrons were correlated but that there was no relationship in 
lipoproteins of S/<1000.
In the present study, in which RP was assayed in lipoproteins of S/>20 (p<1.006g/ml), the 
initial correlation between RP and triglyceride followed by a period in which they are not 
related may mark the passage from a stage of lipaemia in which chylomicrons predominate 
(ie. when absorption is still active), to a period when they are superseded in the circulation by 
remnant species.
Weintraub et found that RP in chylomicrons (S/>1000) was negatively related to LpL 
activity, the implication being that departure of RP into more dense fractions was contingent 
on rates of triglyceride hydrolysis. RP in the more heterogeneous mix of lipoproteins isolated 
in the present study did not show such a relation to LpL.
The second stage: The persistence of RP at densities of less than 1.006g/ml beyond
triglyceridaemia, and until at least 24 hours alter the original fat load, supports the concept of a 
second stage in chylomicron catabolism unrelated to triglyceride removal rates. Present 
evidence suggests that this second stage involves removal of the chylomicron remnant by a 
receptor mediated process taking place at the surface of hepatocytes.139 The simplest 
explanation for the prolonged circulation of RP in the p<1.006 fraction would therefore be 
that chylomicron remnants can persist for long periods after a fatty meal.
Further illustration of the passage of RP from chylomicrons to remnants took the form
of an early correlation of A RP with fasting VLDL size but not number, giving way to a later 
correlation with number but not size. As discussed above, variation in fasting VLDL pertains 
mostly to particle number, and so is presumably a function of both particle synthesis and 
removal rates. The correlation between RP and fasting VLDL number may reflect the similar 
mode of clearance of these particles, and suggests a possible competition between hepatic 
and intestinal remnants for the removal process.
The relationship to IDL which was confined to later A RP would follow from the above 
argument. The distinction between IDL and remnants on the basis of ultracentrifugation is an 
operational one, and since remnants will occupy a spectrum of flotation rates traversing the 
arbitrary boundary separating VLDL and IDL, higher levels of IDL may reflect to some extent 
the presence of remnant material. The correlation of RP with fasting triglyceride may be a 
further reflection of the importance of VLDL particle number (and remnant clearance) in the 
determination of triglyceride levels in the steady state.
It is implicit in the preceding argument that remnants are not the major source of 
triglyceridaemia in its later stages. Despite a positive A triglyceride, RP and triglyceride were 
not correlated latterly in either the mixture of lipoproteins of p<1.006g/ml in the present 
study, or in the non-chylomicron fraction of S/<1000.184
Continued, although lessened, triglyceride absorption and chylomicron formation at a 
time when the more slowly removed remnants are more plentiful, may lead to triglyceride
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levels no longer directly related to amounts of intestinally derived particles, as described by 
RP levels. Alternatively triglyceridaemia may become contaminated with material of non- 
intestinal origins, perhaps through an augmented output of hepatic VLDL in response to the 
increased availability of fatty acid. Recycling of chylomicron triglyceride has been 
demonstrated in rats,190 and hepatic VLDL secretion can be stimulated by both standard and 
triglyceride rich remnants.191 A post prandial increase in apoBioo during alimentary lipaemia 
in humans has also been noted .192-193 Recycling of exogenous material may underlie the 
biphasic triglyceride response reported by several groups.193"195
Effects at 24 hours
A lowering of plasma and VLDL triglyceride subsequent to a fat load has been noted 
frequently, but has remained an unexplained observation.184-187-196 This effect may represent 
the lag phase of an adaptive response to the large influx of fat the day before, although 
whether this is due to stimulated lipolysis (LpL activity can be stimulated by an orally 
administered fat load197), or whether there is a temporary inhibition of endogenous 
triglyceride secretion is unclear.
In male subjects 24 hours after the fat load fewer particles circulated in the p<1.006g/ml 
density range, and in the average particle the amount of triglyceride was more, and the 
amount of cholesterol less than on the previous day. The evidence that a proportion of these 
particles were RP enriched remnants means that the 'average particle' represents a hybrid of 
hepatic VLDL and intestinally derived remnants, making compositional changes difficult to 
interpret. Nevertheless the restriction of the effect to particle number suggests a fall in VLDL 
production. The greater reduction in those with higher fasting VLDL and lower HDL2 may 
perhaps reflect a more labile regulation of triglyceride metabolism in such subjects, of which 
a post prandial increase in hepatic VLDL production, as discussed above, may be another 
manifestation.
Lipases and lipolysis
Conventional methods for the assessment of LpL and HL activity involve the release of 
enzyme into the blood stream by the administration of heparin, permitting assay in plasma. 
Lipase activity in this study was also measured in fasting plasma obtained prior to the 
administration of heparin. Pre and post heparin lipase activities were much lower than, and 
were poorly correlated with post heparin measurements. Nevertheless, pre heparin activities 
showed similar gender differences and a greater relationship to other physiological variables 
than those obtained post heparin. It would seem therefore that free lipase, although not 
present in physiologically significant amounts, may still provide a marker of the potential 
pool of available lipase. 198-199
A negative correlation between LpL activity and alimentary lipaemia has been 
reported ,184-200 although in the present normal subjects the relationship was of only marginal
Lpcemia in normal subjects 72
significance. However, although it is now evident that LpL has a major role to play in the 
clearance of lipaemia, plasma lipase activity may offer only a crude guide to lipolytic capacity.
The measurement of post heparin lipase activity is known to be sensitive to the 
methodology used, and in particular to the amount of intravenous heparin administered.201 
Although correction was made here for body weight it is possible that the poor (or absent ) 
correlation between pre and post heparin values is at least partly due to a semi- or non- 
quantitative release of enzyme from tissues. In addition LpL in plasma reflects enzyme activity 
released from several tissues, mainly adipose and skeletal muscle, but including heart and 
lung, each of which are independently regulated and may respond differently to such stimuli 
as fat feeding.202
Furthermore, as it progresses triglyceridaemia will become increasingly associated with 
remnants whose disposal from the circulation is seemingly less related to lipolysis. Redgrave 
& Carlson175 concluded from their studies that a major proportion of post prandial 
triglyceridaemia was due to remnant particles rather than to chylomicrons.
The role of HL in lipoprotein metabolism is at present less well defined than that of LpL. 
A recent study has suggested that the triglyceride lipase activity of HL may be important 
when the capacity of LpL for triglyceride hydrolysis is exceeded, as for example occurs 
during fat absorption.134 There is also evidence that HL has a role to play in the catabolism of 
smaller triglyceride rich lipoproteins. Conversion of small VLDL to IDL, and IDL to LDL is 
reduced in HL deficiency.203
The negative correlation between HL and lipaemia in the present study could be 
explained by either or both of these roles. Saturation of the lipolytic system is evident from 
the rise in triglyceride during lipaemia, and clearance of the excess may conceivably be related 
to HL activity. In addition, chylomicron catabolism is associated with the production of 
remnant particles whose smaller dimensions may place them in a population for which HL 
has greater affinity.
The negative relationship between HL activity and RP does not agree with the report of 
Berr151 who stimulated lipolysis in humans by injecting heparin, but found no change in 
remnant clearance. Weintraub184 however, did find a negative relationship between HL and 
non-chylomicron RP clearance. This negative correlation suggests a possible involvement of 
HL prior to, or coincident with, remnant uptake, and may hinge on the phospholipase 
activity of HL which could expose receptor re-cognition sites on apoE.
The concentration of apoCIII in fasting plasma showed an interesting relation to post 
prandial triglyceride and RP levels. This apoprotein has been suggested to modulate the 
activity of LpL,135 and also to regulate the affinity of remnants for their hepatic receptor.138 
The association of apoCIII with A2-A6 triglyceride suggests that higher levels may indeed be 
associated with reduced lipolysis rates. The relationship to RP levels is confined to later 
responses, and is at its strongest with A24 RP. Again this is in agreement with the proposal 
that apoCIII is inhibitory in its effects on remnant uptake.
Lpcemia in normal subjects 73
Lipaemia as a com ponent o f the lipoprotein  profile
The apo B containing lipoproteins VLDL, IDL, and LDL form a metabolic cascade in which 
synthesis and catabolism of VLDL are important determinants of LDL levels. This relationship 
probably underlies the positive association of these lipoproteins and apoB in the fasting 
state. The positive association between post prandial triglyceridaemia and apo B containing 
lipoproteins may simply reflect the importance of lipolytic processes in determining the 
levels of both hepatic and intestinal lipoproteins, although the possibility that lipoprotein 
production in liver and intestine are under some form of co-regulation cannot be dismissed.
A reciprocal association between VLDL and HDL has been documented regularly in both 
population and clinical studies,45 and has also been ascribed to differences in lipolytic activity. 
More efficient lipolysis, acting to maintain lower levels of VLDL will increase the transfer of 
surface materials (mainly phospholipid) into the HDL density range where they may either 
increase existing HDL mass, or act as a precursor in HDL formation. The negative relationship 
between post prandial triglycerides and HDL observed in this and in other studies200 
supports the operation of the above mechanism on chylomicrons as well as VLDL.
Lipid flux during lipaemia
A prolonged post prandial rise in plasma phospholipids, outlasting that of triglycerides, was 
noted initially by Havel196 They concluded that there was a transfer of phospholipid into 
higher density lipoprotein classes which were removed from the circulation more slowly 
than the triglyceride rich fractions. The phenom enon of phospholipid transfer from 
triglyceride rich lipoproteins to HDL during lipolysis is thought to underlie the frequently 
observed reciprocal relationship between VLDL and HDL discussed above. The mechanism 
of transfer to higher densities involves either a specific phospholipid transfer protein, or a 
form of bulk transfer in which redundant surface materials forming subsequent to lipolytic 
reduction of the triglyceride core, fold outwards and eventually 'pinch' off, passing into the 
HDL density range.133 A similar, but less widely documented transfer of phospholipid into 
LDL was observed in the present study.
In such a scenario more efficient lipolysis should therefore increase phospholipid flux 
through more rapid reduction of core volume, and indeed in females, in whom LpL activity 
was greater and triglyceride response less, the magnitude of phospholipid flux exceeded that 
of the male group.
It might be expected that free cholesterol, also a resident of surface regions, would 
accompany phospholipid into the higher density fractions during such bulk transfer, and in 
fact a rise in free cholesterol in LDL and HDL did occur. However this is not the only 
mechanism by which lipaemia might increase the free cholesterol content of the p> 1.006 
fractions.
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The development of a reduced FC/PL ratio in LDL, presumably due to a greater influx of 
phospholipid compared with free cholesterol to the surface, may be instrumental in raising 
plasma levels of free cholesterol. Since free cholesterol can transfer spontaneously between 
cell membranes and lipoproteins, a decline in the FC/PL ratio would create a concentration 
gradient encouraging a net movement into plasma. Such a mechanism is thought to underlie 
the so-called 'reverse cholesterol transport* system by which cholesterol is returned from 
peripheral tissues to the liver. In the present study post prandial triglyceridaemia was 
negatively related to the magnitude of free cholesterol flux into LDL. An increase in 
triglyceridaemia, associated with reduced lipolytic rates and transfer of phospholipid into 
higher density lipoproteins, may therefore attenuate any decline in the FC/PL ratio, and so 
reduce the subsequent flux of free cholesterol into the LDL fraction.
This could explain why female subjects who demonstrated a lesser degree of 
triglyceridaemia also tended to have a greater amount of phospholipid entering plasma, 
accompanied by a greater increase in plasma free cholesterol during the later stages of 
lipaemia.
Interestingly, the concentration of free cholesterol in fasting LDL was positively related 
to lipaemia, and negatively to the flux of free cholesterol into LDL. However if it is indeed the 
ratio of free cholesterol to phospholipid which influences flux from cells, then an increased 
concentration of free cholesterol will tend to elevate that ratio in the face of similar 
phospholipid assimilation, and will therefore shorten the gradient driving cellular free 
cholesterol efflux.
Free cholesterol and phospholipid in HDL also increased, and in absolute terms the flux 
into HDL was greater than that into LDL. However the ratio of these lipids in HDL remained 
more or less constant The stability of the FC/PL ratio may be a result of LCAT activity which, 
in plasma, is mostly associated with the HDL fractions. This enzyme, using both free 
cholesterol and phospholipid as substrate, and activated by apoAI, catalyses the formation of 
cholesteryl esters. Due to their hydrophobic nature these esters then move inwards to the 
core of the HDL particle. The combination of a decline in FC/PL ratio and LCAT activity 
would thus propagate a continuous movement of free cholesterol from cells into cholesteryl 
esters in HDL.
Despite this activity cholesteryl ester does not accumulate in HDL. In fact there is a highly 
significant fall leading, in combination with a reciprocal rise in triglyceride, to a marked 
change in the composition of post prandial HDL core lipids. This change is presumably a 
result of lipid transfer protein mediated hetero exchange of these lipids between 
lipoproteins,204 in which cholesteryl esters transfer into particles with the lowest CE/TG ratio, 
and triglyceride moves in the reverse direction. The large influx of dietary triglyceride into the 
p<1.006 fraction will considerably steepen this gradient and encourage a fall in HDL 
cholesteryl ester.
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The acquisition of triglyceride at the expense of cholesteryl ester is thought to render 
HDL susceptible to HL action, leading to the formation of a small HDL species, depleted of 
both cholesteryl ester and triglyceride. By this means post prandial lipaemia may cause a 
redistribution of HDL towards the smaller HDL3 subfraction, and thereby contribute to the 
low levels of HDL2 associated with exaggerated alimentary lipaemia.200
The position of LDL in core lipid transfer is less well defined. The positive association 
between A cholesteryl ester and triglyceride cannot be explained by simple, gradient driven 
hetero exchange of these lipids, particularly since the CE/TG ratio in HDL fell well below that 
of LDL.
It has been suggested205 that LDL are in fact the major acceptors of LCAT derived 
cholesteryl esters, at least during fasting, and argues that the FC/PL ratio may make an 
important contribution to enhancing transfer rates. These authors suggest further that by 
providing an acceptor for transferred cholesteryl ester the post prandial decline in LDL 
FC/PL ratio will release inhibition on LCAT activity giving rise to the previously documented 
stimulation of this enzyme during lipaemia206
The free cholesterol content of lipoproteins can influence protein binding,21 and since 
transfer activity seems to depend on the binding of transfer protein to lipoprotein 
substrates,207 it would seem feasible that this mechanism would enhance transfer activity. The 
influx of phospholipid to lipoproteins has also been reported to enhance lipid transfer.208 
These findings are perhaps two aspects of the same phenomenon, the ratio of the lipids 
being the important factor.
Enhanced transfer activity however, need not necessarily affect the direction of lipid flux. 
The ultimate changes in LDL core lipids may be a composite effect of several transfer 
processes. Triglyceride from the p<1.006 fraction and LCAT derived cholesteryl esters from 
HDL may both enter LDL. LDL however may also lose cholesteryl ester by transfer to the 
p<1.006 lipoproteins, and also to IDL, with a proportion of this lipid subsequently returning 
to the LDL density range as a result of VLDL and IDL catabolism.
Although LDL may provide an acceptor for transferred cholesteryl ester in the post 
absorptive state, it would be reasonable to expect that the large influx of cholesteryl ester- 
poor chylomicrons during lipaemia would provide an additional route for transfer. 
Furthermore the efficient removal of remnants by the liver subsequent to accepting 
transferred cholesteryl ester might provide an explanation for the lowering of plasma 
cholesterol observed in some subjects (females) during lipaemia.
Lipaemia In m ales and fem ales
Several features of lipoprotein metabolism distinguished male and female groups in this 
study. The lower fasting VLDL and greater HDL further polarised the reciprocal relationship 
governing the concentrations of these lipoprotein classes the in plasma. The magnitude of 
triglyceridaemia was less in females than in males, and the activity of LpL was greater. There
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was an increased flux of free cholesterol into plasma, and a post prandial reduction in plasma 
esterified cholesterol. In addition retinyl palmitate levels were less in females at all time 
points, but particularly at 24 hours. All of these features are compatible with an enhanced rate 
of catabolism of triglyceride rich lipoproteins in females.
Chapter 4
Alimentary lipcemia
in
coronary artery disease
4.1 Introduction and Methods 
S
Plasma lipid abnormalities derive much of their interest from their association with coronary 
and peripheral atherosclerosis, although many of those developing CHD do not have clinical 
hyperlipidaemia. To explain the deposition of lipoprotein cholesterol in the arteries of 
normolipidaemic individuals alimentary lipaemia was proposed by earlier workers as a kind of 
'latent1 form of hyperlipidaemia, not apparent from normal fasting assessments. Based on 
then available techniques, these studies14 concentrated on the particulate nature of 
chylomicrons in the aetiology of the disease. In this part of the study the relationship of 
alimentary lipaemia to atherosclerotic disease was re-examined using the retinyl palmitate fat 
tolerance test and modem analytical techniques.
The severity of atherosclerosis in a group of middle aged men was determined by 
coronary angiography, a common technique in the assessment of coronary artery stenosis. 
These arteries are particularly susceptible to atherosclerotic occlusion leading to the 
condition known as coronary artery disease (CAD), in which lipolysis of vital areas of the 
myocardium induces tissue necrosis (infarction) and cardiac dysfunction.
The extent of arterial stenosis is quantified by passing a radio-opaque material through 
the coronary arteries and taking an X-ray photograph. The lumen of the artery and the 
presence of any narrowing are thus revealed. The X-ray is then assessed and scored in 
standardised fashion by trained personnel. Angiogram scores thus obtained were compared 
with the incidence of established lipid and non-lipid risk factors in these men, and also with 
the lipid profiles of alimentary lipaemia.
4.1.1 Subjects
Males aged between 40 and 60, referred for assessment of CAD and admitted to the 
Department of Medical Cardiology at Glasgow Royal Infirmary for routine coronary
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angiography, were asked to participate in the study. Upon consenting to undertake a fat 
tolerance test details of age, height, weight, resting blood pressure, smoking habits, and any 
family history of heart disease were obtained, in addition to a routine biochemical and 
haematological screen.
The use of drugs which block 6  adrenoceptors has been found to interfere with lipid 
and lipoprotein metabolism .209 Since these drugs are commonly prescribed to hypertensives 
and angina sufferers a large proportion of referrals for angiography are already on long term 
8  blocking therapy. In view of this and the dangers involved in stopping such treatment at a 
time of stress for patients, particularly when participating voluntarily in a research project, it 
was decided that use of these drugs should not exclude subjects from taking part
4.1.2 Protocol
CAD subjects were admitted to the ward in the evening two days before, and administered 
the fat tolerance test one day before angiography. The test was conducted as described in 
section 2.3 and lipoproteins prepared by 6  quantification. In a subgroup of 8  men 
lipoproteins were additionally prepared by sequential flotation ultracentrifugation. Subjects 
re-attended on a separate occasion for the estimation of lipase activities.
Smoking habits and any family history of heart disease were scored by a procedure 
adopted from Angaard et a /210 Of able 4.1). Angiography was performed by staff of the 
Department of Medical Cardiology and scoring of angiograms carried out by Dr JH Maclean of 
that Department using the method of Brandt eta l.2n (Figure 4.1).
Table 4.1 Risk scoring* fo r  smoking habits and  fam ily  
______________ history o f heart disease_____________
Sm oking habits___________________________ Score
Non smoker > 1 year................................................... 0
0-10  cigarettes/day,
pipe, cigar, non smoker>6 months........................... 1
Heavy smoker stopped <6 months........................... 2
11-20 cigarettes/day........................................................3
21-40 cigarettes/day...................................................... 5
40+ cigarettes/day.......................................................... 7
Fam ily history __ _________________________
No IHD# in relatives..................................................... 0
For each family member
with diagnosed IHD.....................................................  1
For each family member
with MI*! or dying from IHD....................................... 2
’Adapted from reference 210, #Ischaemic heart disease, 
^Myocardial Infarction
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A V  Groove
R V
Septum
L V W all
Myocardial Score
Percentage
Obstruction 1 2 3
Myocardial value
4 5 6 7 8 9 10
100 1 2 3 4 5 6 7 8 9 10
90-99 0.8 1.6 2.4 3.2 4.0 4.8 5.6 6.4 7.2 ao
75-89 0.6 1.2 1.8 2.4 3.0 3.6 4.2 4.8 54 6.0
50-74 0.4 0.8 1.2 1.6 2.0 2.4 2.8 32 3.6 4.0
<50 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 20
1. Left main coronary
2. Anterior descending
3. Septal branches
4. Diagonal branches 
5- Left circumflex
6. Left atrial
7. Marginal branches
A. Right coronary
B. Right atrial
C. Right ventricular
D. Posterior descending
E. Left ventricular inferior branches
Figure 4.1 Angiogram scoring. Stenoses are assigned a myocardial value on the basis of their position, 
the importance of the area of the myocardium served, and the presence of any collateral pathways. The 
degree of stenosis is then graded according to cross sectional area loss and a myocardial score derived 
from the table.
4.2 Results 
S
4.2.1 Angiogram  score and conventional risk markers
Angiogram scores ranged from 0 to 17 from a possible total of 36. The relationship of this 
score to some common risk factors is given in Tables 4.2 & 4.3. Of the non lipid factors only 
body mass index approached significance. Angiogram score was positively correlated with 
fasting serum and LDL cholesterol, and negatively with HDL cholesterol (Table 4.3). HDL3_ as 
measured in the analytical ultracentrifuge also showed a negative relationship. Fasting levels of 
triglyceride, whether in serum or in VLDL, were not significantly related to angiogram score.
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Table 4.2 Non lipid risk factors in CAD subjects 
Mean Correlation with
±SD angiogram score
Age
(years)
50.1
±7.3
0.06
Quetelet index 
(kg/m2)
2.63
±0.30
0.35'
Blood pressure 
(mmHg)
Systolic 126.9
±13-7
0.23
Diastolic 80.2
±12.7
0.23
Smoking score • 0.08
Family history score • -0.06
n-27 , ’Mean scores not quoted, *P£0.10
Table 4.3 Fasting lipids in CAD subjects#
mmol/1
Mean
±SD
Correlation with 
angiogram score
Serum cholesterol 6.73
±1.35
0.45**
Serum triglyceride 2.29
±0.87
0.18
VLDL triglyceride 1.27
±0.57
0.17
LDL cholesterol 4.65
±1.30
0.58**
HDL cholesterol 1.05
±0.25
-0.37*
HDL2 (mg/dl) 32.3
±152
-0.22
HDL3 • 236.0
±46.9
-0.39*
Lipoprotein lipase 
(mU/ml)
154.2
±57.2
0.20
Hepatic lipase 
(mU/ml)
"122.5
±49.4
0.30
n-27, ^One mil -  one nmol fatty acid released per minute at 
25’C, *P£0.05, **P£0.005
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Table 4.4 The relationship o f post prandial p<1.006 triglyceride and  retinyl palmitate 
________________________ response to angiogram score________________________
4
fxino6 Area 2 4 6 8 10 12 24 hours
Triglyceride 18.3 0.80 1.92 2.46 1.89 1.45 1.22 -0.18
(mmol/1) ±134 ±0.67 ±1.10 ±1.81 ±1.93 ±1.44 ±1.18 ±0.33
0.32* -0.12 0.17 0.42** 0.51*** 0.25 0.16 -0.35**
Retinyl 44.9 0.39 1.78 3.88 6.05 7.47 6.32 1.03
palmitate ±29.1 ±0.47 ±1.68 ±3.89 ±4.39 ±5.07 ±4.54 ±1.37
Qxmol/D
0.05 -0.04 -0.08 -0.14 0.22 -0.03 0.11 0.56***
Correlation with angiogram score *P£0.1, **P^0.05, ***P^0.01> n-27
4.2.2 Angiogram  score and post prandial lipaemia
The profiles of triglyceride and RP in the CAD group are depicted in Figure 4.2. Although the 
correlation of p<1.006 triglyceride area with angiogram score was of only marginal significance 
(Table 4.4), A values revealed a greater correlation beyond the peak of triglyceridaemia, on the 
steepest part of the descending limb of the chylomicrograph (A6-A8). Table 4.5 shows that 
the area under the triglyceride curve was also more strongly related to peak and later A values 
than to those during the rise in triglyceridaemia.
RP rose and peaked later than triglyceride, and levels during lipaemia were unrelated to 
angiogram score (Table 4.4). RP was also unrelated to A triglyceride during the first 6 hours of 
lipaemia, but became increasingly related at 8, 10, 12, and 24 hours (Table 4.5).
Triglyceride (mmol/1) 
Retinyl
Palmitate (pmol/1)
Ratio (RP/Tg)
0 2 4 6 8 10
Hours
Figure 4.2 p<1.006 triglyceride and RP profiles in CAD subjects
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Table 4.5 Correlation between measures o f post prandial response in CAD subjects
a).  A  _ _
p<1.006 2 4 6  8  10 12 24 Areas
RP & I 0.14 0.16 0.03 0.35* 0.44** 0.48 0.34 0.45*
Triglyceride |
b).  Triglyceride  —_________
Triglyceride I 0.68*** 0.76*** 0.93*** 0.83 0.89 0.84 -0.10
Area |
cD.__________ ________________________ Retinyl Palmitate A
RP I 0.29 0.59*** 0.54** 0.67 0.49** 0.46^ -0.10
Area I
•P£0.05, ••P^O.Ol, **• PS0.001, n -  27
4.2.3 24 hours after fat Ingestion
VLDL triglyceride fell by 14%, P^0.02 at 24 hours. Serum triglyceride was also lowered (19%, 
P^O.002), as were serum cholesterol (5%, P^O.01), and phospholipid (8%, P<0.025). The 
magnitude of A24 VLDL triglyceride was negatively related to angiogram score, and so a fall in 
VLDL triglyceride was more likely in those with a higher angiogram score.
RP remaining in the p<1.006 fraction 24 hours after the fat load was positively related to 
angiogram score (Table 4.4). Although RP was also detected in the p>1.006g/ml fraction at this 
time (0.47 ± 0.30pmol/l, mean ± SD), no relationship was observed between this amount and 
angiogram score. 24 hours after the fat load therefore, the VLDL fraction was relatively 
depleted in triglyceride, but enriched in RP to a degree that was related to angiogram score.
4.2.4 Predictors o f angiogram  score
Linear regression analysis was performed to determine the best predictors of angiogram 
score among the various parameters measured. Before this procedure was undertaken 
skewed data (fasting & post prandial triglycerides, RP, and HDL2) were transformed to their 
natural logarithms. Assayed individually the best predictors of score were RP at 24 hours and 
LDL cholesterol (Table 4.6), although serum cholesterol and A8  hour triglyceride were also 
positive, and HDL3 a negative predictor of angiogram score.
None of the non-lipid risk markers demonstrated significant ability to predict score, nor 
did HDL2, HDL cholesterol, fasting triglyceride or any other of the postprandial responses.
Risk factors with significant R2 values were then assayed in combination by multiple 
linear regression. In multiple regression models only LDL and RP at 24 hours retained 
significance, although when these two variables were included in the same model the 
significance of RP 24 hours was lost. In these equations the maximum R2 obtained was 31.6% 
for the model containing A8  hour triglyceride plus LDL cholesterol. In models containing 
more than 2 parameters none retained significance.
Several of the parameters showing a relationship to angiogram score were themselves 
inter-related. LDL cholesterol was positively correlated with RP at 24 hours (r*0.59, P^O.001),
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Table 4.6 Predictors o f angiogram score
Predictor R 2  ( o/0) #
_______________ U nivariate______________
RP 24 hours!***................................................................. 19.8
LDL cholesterol***............................................................... 19.3
Serum cholesterol**..............................................................15.7
HDL3 (-ve)**....................................................................  13.8
A8  hour p<1.006 triglyceride*!**.................................................... 13.1
_______________ M ultivariate______________
LDL cholesterol**
+---------------------------- }------------------------------ 31.6
A8 hour p<1.006 triglyceride
LDL cholesterol*
+ }-------------------------------26.9
RP 24 hours
RP 24 hours**
+ }------------------------------ 26.7
A8 hour p<1.006 triglyceride
LDL cholesterol**
+ }-------------------------------25.3
HDL3
RP 24 hours**
+ }-------------------------------------21.0
HDL3
*  Coefficient of determination corrected for degrees of freedom, *! After conversion to natural 
logarithms, *P£0.05, **PS0.025, ***P£0.010
and HDL3 was negatively related to A8 hour triglyceride (r=-0.49, P^O.Ol). The correlations of 
post prandial triglycerides with non-lipid parameters and with fasting lipids are given in 
Tables 4.7 & 4.8. Lipaemia was negatively related to age and positively to systolic blood 
pressure, fasting VLDL triglyceride and LDL cholesterol. HDL cholesterol and HDL2 were 
negatively related to lipaemia. The activity of LpL was not related to fasting lipoprotein levels, 
but HL activity was inversely related to HDL (HDL2 r=-0.70, P^O.Ol, & HDL3 r*-0.44, P<0.05). 
Neither LpL or HL showed significant relation to lipaemia.
Table 4.7 Correlation o f lipaemic response with non-lipid parameters in CAD subjects#
p<1.006
triglvoeride Area
A 24 hour 
RP2 4 6 8 10 12 24
Age 0.34** -0.35** -0.40*** -0.38** -0.09 -0.22 -0.20 0.15 0.22
Quetelet index 0.02 -0.29 0.01 -0.04 0.13 0.18 -0.05 0.07 0.14
B.P.Systolic 0.41 0.27* 0.37 0.44*** 0.22 0.32* 0.30* -0.14 0.06
B.P. Diastolic 0.20 0.06 0.27 0.25 0.16 0.09 -0.04 -0.06 0.14
Smoking score 0.27 0.31* 0.15 0.34** 0.21 0.09 0.22 0.16 0.10
Family history 0.08 -0.15 0.15 0.06 0.17 0.08 0.06 0.19 0.39**
#n  -  27, #P<0.1, ~P£0.05, ***P£0.025
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Table 4,8 Correlation o f lipcemic response with fasting lipids in CAD subjects*
p<1.006 triglyceride A 24 hour
Fasting Area 2 4 6 8 10 12 f t RP
VLDL triglyceride 0.54" 0.36* 0.51" 0.67*" 0.39* 0.40* 0.42" -0.14 0.34
LDL cholesterol 0.36* -0.14 0.39* 0.49" 0.46" 0.28 0.26 0.07 0.59*"
HDL cholesterol -0.48" -0.13 -0.20 -0.45" -0.62*" -0.47" -0.41" 0.00 -0.43"
hdl2 -0.60"* -0.27 -0.49" -0.62*" -0.45" -0.45** -0.46" 0.15 -0.35*
HDLj -0.30 0.10 0.14 -0.22 -0.49" -0.43" -0.28 0.14 -0.32
#n-27, *P£0.05, **P£0.01, *"PS0.001
4*2.5 The effects o f  ft blockade
Patients on ft blocking drug therapy were not excluded from the study. One volunteer was 
prescribed propranolol, three atenolol, five metoprolol and one was prescribed Trasidrex, a 
combination of 8 blocker and thiazide diuretic. These drugs have been found to interfere 
with lipid metabolism and in particular they seem able to raise triglyceride and lower HDL 
cholesterol levels. Kruskall Wallis one way analysis of variance failed to support any significant 
influence of these drugs on angiogram score, total & LDL cholesterol, or fasting & post 
prandial triglycerides (Table 4.9). There was an indication that HDL levels were lower in those 
on ft blockade. In addition, although there was no statistically significant difference in RP 
levels at 24 hours between those taking ft blockers and those on no therapy, subjects taking 
metoprolol appeared to have greater amounts of RP at 24 hours. Elimination of the 6 subjects 
taking metoprolol from the statistical analyses however, did not reduce the correlation of 24 
hour RP with angiogram score.
4.2.6 Sequential flotation  analyses
In a subset of 8 patients lipoproteins were prepared by the sequential flotation technique as 
well as by 6 quantification, providing a more detailed analysis of lipid fluctuations. These are 
summarized in Figures 4.3 to 4.6.
In these men the mean response was a rise in triglyceride and phospholipid in all 
lipoprotein classes. Cholesterol in the p<1.006 fraction was also raised. Cholesterol levels in 
the p>1.006 fraction (IDL, LDL, HDL) fell between 2 and 8 hours. (Free and esterified 
cholesterol were not separately measured in this part of the study).
Closer examination of Figure 4.6 reveals that A cholesterol in LDL and HDL were 
reciprocal rather than parallel during lipaemia, and in fact LDL and HDL cholesterol areas were 
correlated negatively (r * -0.74, P < 0.05), ie a greater fall in HDL cholesterol was associated 
with a lesser fall (or a rise), in LDL cholesterol.
The post prandial rise in HDL triglyceride tended to parallel that in the p<1.006 fraction. 
A LDL triglyceride however, was not related to other triglyceride fluctuations, but was related
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positively to A LDL cholesterol in the later stages of lipaemia (A6 hours r * 0.86, P <, 0.01, and 
A8 hours r -  0.75, P £ 0.05), and at 24 hours (A24 hours r = 0.75, P £ 0.05).
24 hours after the fat load all components of VLDL, and the triglyceride content of HDL 
were lower than on the previous day (Figures 4.3 to 4.6). The fall in HDL triglyceride at 24 
hours was negatively related to the magnitude of the previous day's lipaemia, (AHDL 
triglyceride and p<1.006 triglyceride area r--0.77, P<0.05) and also to the post prandial decline 
in HDL cholesterol (AHDL triglyceride and HDL cholesterol area r-0.72, P£0.05). Increased 
post prandial triglyceridaemia is therefore associated with a greater decline in HDL cholesterol 
during lipaemia, and a greater decline in HDL triglyceride at 24 hours.
4.3 Discussion 
S
Fasting lipids and lipoproteins in this group illustrate the well characterised profile of the 'at 
risk' individual. Greatest risk was associated with serum and LDL cholesterol, with average 
levels in a range at which risk increases steeply.32 In addition the rather low average levels of 
HDL cholesterol212 were a negative risk marker, by now a well established finding.213
Notably however, although mean fasting triglyceride also fell into a range meriting dietary 
advice,38 individual levels did not show any direct relationship to CAD severity. The 
controversy surrounding the role of triglyceride in the pathogenesis of atherosclerosis was 
discussed in section 1.3.3. When presented with the challenge of an oral fat load the resultant 
triglyceridaemia in these subjects was a positive indicator of angiogram score.
In agreement with earlier studies50-51 the greatest predictive power of the chylo- 
micrograph, and the majority of the influence on overall post prandial triglyceridaemia, 
coincides with a time when "the elim ination o f fa t is greater than the addition, and  the 
steepness o f the curve indicates the relative excess o f the reduction." In other words risk is 
associated with a slower clearance of triglyceridaemia.
An obvious explanation for this would be reduced activity of LpL as a feature of CAD. 
Although not confirmed by this study, LpL has been reported by others to have an inverse 
relationship to alimentary lipaemia.200 The intravenous fat tolerance test, using radio labelled 
synthetic emulsions to measure lipolysis rates in vivo, can discriminate between CAD positive 
and negative populations.214
The data do not exclude the possibility that re-cycling of dietary triglyceride into hepatic 
VLDL occurs to a greater extent in CAD. The possibility of this pathway was mentioned in the 
previous chapter. Earlier studies51-184 concluded that exaggerated lipaemia in CAD was the 
result of a high initial fasting VLDL, leading to competition for triglyceride removal. Such a 
mechanism was postulated to explain the positive relationship commonly observed between 
fasting VLDL and post prandial lipaemia. Fasting VLDL triglyceride was not itself related to 
angiogram score. Nevertheless an increase in VLDL production during lipaemia would place
l/purrl
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Figure 4.3 Changes in lipoprotein triglycerides in CAD subjects. Zero marks fasting levels and bars
represent mean change from fasting, 'P^O.l, **P^0.05, ***P^0.01, n-8.
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Figure 4.4 Changes in lipoprotein phospholipid in CAD subjects. Zero marks fasting levels and bars
represent mean change from fasting, *P£0.1, **P^0.05, ***P^0.01, n~8.
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Figure 4.5 Changes in lipoprotein cholesterol (total) in CAD subjects. Zero marks fasting levels and
bars represent mean change from fasting, *P<0.1, **P^0.05, ‘“ P^O.Ol, n-8.
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increased pressure on the lipolytic system,invoking greater competition for lipolytic sites. 
Whether or not this became excessive would depend on the stringency with which VI.DT. 
production rates are controlled during periods of high substrate availability. A more labile 
responsiveness to fatty acid influx may occasion a greater output of recyled triglyceride in 
VLDL.
A poorly regulated responsiveness in VLDL production could also explain the 
phenomenon of a fat load induced over compensation in fasting levels of VLDL at 24 hours. 
This was also found to be related to the severity of CAD in these subjects. The reduction in 
serum cholesterol and triglyceride observed 24 hours after the fat load may also be 
reconciled with this model if a temporary lowering of VLDL synthesis reduces the entry of 
hepatic lipid to the circulation.
An alternative possibility is that triglycerides remaining at this time are associated with an 
increased number of chylomicron remnants which are relatively resistant to further lipolysis. 
Evidence for this comes from the increasing correlation between post prandial triglycerides 
and RP in the later stages of lipaemia.
RP was added to the fat load to trace remnant clearance. During lipaemia individual levels 
of RP were not significantly correlated with angiogram scores. In a study based on paired 
comparisons however, Krauss et aP1* found an increasing divergence between CAD positive 
and negative populations at 10, 12, and 14 hours after a fat load. In the present study the 
amount of RP remaining in the p<1.006 fraction at 24 hours was the single most powerful 
predictor of angiogram score. The simplest explanation for this is that chylomicron remnants 
are cleared more slowly in CAD.
As a risk marker the ability of RP 24 hours to predict score was greater than that of LDL 
cholesterol, although when combined in a multiple regression model only LDL cholesterol 
remained significant.
The clearance of both LDL and chylomicron remnants from the circulation are both 
accomplished by a receptor mediated process, although different receptors are believed to 
be involved in each case. It now seems however that the scope of the apo B/E receptor 
extends beyond stria affinity for LDL alone,64-216 and has been implicated in the clearance of 
VLDL remnants from the S/20-60 density range.216 In view of the present uncertainties 
concerning the identity of the chylomicron remnant receptor, the positive relationship 
between LDL and remnants may feasibly have its basis in either an element of co-regulation of 
LDL and remnant receptors, or a degree of competition for uptake by the same receptor.
The inverse relationship between HDL and A triglyceride is not surprising in view of the 
dynamic processes linking VLDL lipolysis and HDL production.45 The influx of post prandial 
triglyceride penetrated all lipoprotein classes during lipaemia, and was accompanied by a shift 
of cholesterol from lipoproteins of density less than 1.006g/ml to those of density greater 
than 1.006g/ml This pattern of events has been well described for HDL,217 and under the
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direction of the LTP is thought to lead to a redistribution of LCAT derived cholesteryl esters 
from HDL to p <1.006 lipoproteins, a process considered to have atherogenic potential. A 
concomitant enrichment of HDL with triglyceride and renders it susceptible to hydrolysis by 
HL.200 A negative correlation between HDL and HL activity has been reported previously.218 
By virtue of both triglyceride and phospholipase activity HL may play a major part in the 
conversion of HDL2 to HDL3 and in the regulation of HDL levels.
The position of LDL and IDL in this scheme is less clear. The flux of phospholipid into 
LDL was not significant, and the changes in LDL were not so obviously related to lipaemia as 
were those in HDL
It was of interest to note the reciprocal relationship between the flux of cholesterol in 
LDL and HDL, and also the positive association between A triglyceride and cholesterol in LDL. 
Clearly a simple exchange of LDL core lipids does not occur. Musliner et a l have reported the 
formation of VLDIADL complexes during lipolysis,219 and that complex formation can be 
inhibited by HDL.220 Since it seems that binding of lipoproteins in a complex with LTP is an 
integral part of the transfer process it is likely that the relative amounts of these lipoproteins 
will affect its direction and efficiency.
In addition, if exaggerated lipaemia were to lead to a greater loss of cholesteryl ester from 
HDL, and if an increased amount were transferred to VLDL as well as to chylomicron 
remnants, then, since VLDL are catabolised to LDL, more cholesteryl ester would find its way 
into LDL. Such a process could conceivably lead to a reciprocal relation between the change 
in HDL and LDL cholesteryl esters. The suggestion, discussed above, that VLDL production 
may be affected by lipaemia complicates the picture even further, and may amplify the 
reciprocal effect.
In summary, the features of alimentary lipaemia which marked CAD were an exaggerated 
triglyceridaemia, particularly in the later stages, an indication that VLDL production was more 
easily affected by acute dietary intake of fat, and evidence for a persistence of chylomicron 
remnants. In the small number of subjects in whom more detailed information was available, 
no relationship of angiogram score to lipid flux in lipoproteins of density greater than 
1.006g/ml was found.
Chapter 5
Acute dietary effects
in
alimentary lipcemia
5.1 Introduction and Methods 
S
A dietary component attached to both the susceptibility to atherosclerosis, and to the 
regulation of lipoprotein metabolism is well recognised. In individuals identified as 'at risk1 
by virtue of elevated plasma lipids the first line of therapy is always dietary advice, even if 
drugs are eventually also required.
Dietary recommendations concentrate initially on a reduction of total caloric intake and 
the correction of obesity, which may in itself help to alleviate any hyperlipidaemia. These 
recommendations however also pertain to specific dietary constituents, namely the amount 
of cholesterol and the amounts and types of fat consumed.38
Although the role of dietary cholesterol and fat has been a subject of great interest for 
many years, most studies have concentrated on longer term effects on fasting lipoproteins 
and cholesterol homeostasis. Relatively little information is available on the acute effects on 
post prandial lipoproteins of altering the composition of the diet. In this section the effects 
of adjusting the cholesterol content and the fatty acid composition of the fat tolerance test 
were studied.
5.1.1 The effects o f  Increasing the cholesterol content o f the fat load
It has been proposed that the inclusion of cholesterol in a fatty meal may be essential to the 
formation of cholesterol enriched remnants during the post prandial phase.61 In rabbits and 
several other animal species fat feeding alone produces only chylomicronaemia, whereas the 
inclusion of cholesterol leads to high levels of cholesterol rich remnants. On this evidence 
Zilversmit suggested a fat-plus-cholesterol tolerance test for studies of remnant metabolism. 
To pursue this suggestion further the cholesterol content of the standard fat load was raised 
and post prandial lipoprotein responses assessed as before.
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500mg of cholesterol were added to the standard fat load bringing the total cholesterol 
content to 900mg. This was administered to a group of 8 male volunteers, and post prandial 
responses compared to those obtained when the original standard fat load was administered 
to the same subjects. Standard and cholesterol enriched meals were administered in random 
order, with an interval of 2 weeks between.
5.1.2 The effects o f fatty acid saturation on alim entary lipaemia
The physical and chemical characteristics of dietary triglycerides are highly dependent on the 
nature of their component fatty acids. These characteristics are in turn dependent on the 
number of carbon atoms in the fatty acid, and on the presence and positioning of double 
bonds along the carbon chain.
Fatty acids with no double bonds are referred to as saturated. These molecules are readily 
synthesized endogenously from acetate by animals, and dietary saturated fats are mostly 
derived from animal tissue. Increasing amounts of saturated fats in the diet raises plasma 
cholesterol, and is positively associated with CHD.31
The inclusion of double bonds between the carbon atoms of fatty acids eliminates their 
hyper-cholesterolaemic effect and the positive association with heart disease is no longer 
seen. Fatty acids containing double bonds are termed unsaturated. Mono-unsaturates have 
only one double bond. The most common example of these is oleic acid which has 18 
carbon atoms and one double bond (18:1), positioned at the 9th carbon from the methyl 
terminal (co9).
Fatty acids with two or more double bonds are poly-unsaturated (PUS). PUS fatty acids 
with a double bond at the 0)6 position cannot be synthesized by animals, and since they are 
biologically essential they must be obtained from plant materials in the diet. Linoleic acid 
(18:2 0)6) is the most common representative of this type of fat.
Replacement of dietary saturated fats with 0)6 PUS has been found to lower plasma 
cholesterol,221 and low tissue levels of linoleic acid seem to be associated with an increased 
risk for CHD.222
A further series of PUS fatty acids have the first double bond at the 0)3 position. These 
are also essential in the diet since, although they are required for several important biological 
functions, they cannot be synthesized by terrestrial animals and are derived ultimately from 
marine plankton. They enter the human diet through the consumption of fish. 0)3 fatty acids 
have also been found to influence lipoprotein metabolism, particularly by reducing the 
amounts of triglyceride rich lipoproteins,223 and have also been associated with a reduction in 
cardiovascular risk.224
As with manipulations of dietary cholesterol, studies on the influence of fatty acid 
saturation have tended to concentrate on fasting lipoproteins, and few have examined their 
effects on post prandial lipid flux. This part of the study was undertaken to examine the
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effects of replacing a proportion of the saturated fats in the fat tolerance test with unsaturated 
fat.
7 males consumed two fat loads of differing fatty acid composition. The standard fat load, 
described in section 2.3.1 derived its fat from dairy cream, and was designated the 'saturated* 
fat load. An 'unsaturated' meal took the form of a delicious mayonnaise in which the major 
source of fat was safflowerseed oil. This meal was made according to the following recipe.
30g of egg yolk, lOg of caloreen, 20ml of vinegar and a quarter teaspoon of suet were 
placed in a blender. With the blender at full speed 125ml of safflowerseed oil was poured in 
slowly. This mixture was consumed with 200g of potatoes and one small white bread roll. 
80ml of natural yoghurt was eaten separately. A comparison of the composition of the two
meals is given in Table 5.1. The 
 Table 5.1 The composition q fo ra lfiu  leads  com bined  ca ro ten o id  and
vitamin A contents of the meals 
was 2mg for the saturated and 
0.2mg for the unsaturated load,225 
plus l65mg added as described 
earlier. It was noted that most 
subjects had more difficulty in 
consuming the unsaturated meal, 
although all m anaged to 
com plete b o th  and  none 
suffered any serious discomfort 
as a result.
Saturated Unsaturated
Protein
Carbohydrate
Fat
8.8g
31.0g
135.0g
8.8g
30.0g
135.0g
°/o
58 saturated 12 
38 mono- 20 
4 poly- 68 
unsaturated
Cholesterol 
Retinyl esters 
Calories
394.0mg
l67.0mg
1371
384.0mg
l65.2mg
1368
5.1.3 In vitro lipo lysis o f  lipoproteins o f differing fatty acid com position
In an extension to the above experiment the susceptibility to lipolysis of p<1.006 
lipoproteins generated after consumption of the different fat loads was examined. This 
section of the study was done in collaboration with Mr Keith Dyson, a medical student 
conducting a project for honours biochemistry
The enzyme lipoprotein lipase is responsible for the hydrolysis of triglycerides in 
triglyceride rich lipoproteins, and its activity is one of the major determinants of lipaemia. 
This enzyme has not generally been found to have a preference for any particular class of 
fatty acids, although the experiments performed to examine specificity have mostly used 
synthetic substrates, either in vitro, or given as a bolus injection intravenously.
The true biological substrates of this enzyme however are endogenously synthesized 
particles whose fine structure is determined by physiological as well as physical factors, not 
easily reproduced in  vitro. To further investigate the influence of dietary fatty acid saturation
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on the process of lipolysis, the activity of a partially purified bovine milk LpL was assayed in  
vitro  with naturally synthesized post prandial triglyceride rich lipoprotein substrates, 
prepared in vivo.
In outline the protocol for this experiment was as follows. Fat loads of differing fatty acid 
compositions as described above, were administered to a group of 9 healthy male volunteers. 
5 hours after consumption of this meal a blood sample was withdrawn and p< 1.006 
lipoproteins prepared by ultracentrifugation. These lipoproteins were then labelled with 
radioactive triolein and incubated with a bovine milk LpL preparation and the extent of 
hydrolysis compared with the fatty acid composition of the substrate as determined by gas 
chromatography ( section 2.4.7).
5.2 Results 
S
5.2.1 The effects o f  increasing the cholesterol content o f the fat load
Figure 5.1 illustrates p<1.006 cholesterol fluctuations in this group. The inclusion of an 
additional 500mg of cholesterol in the fat load produced no systematic or statistically 
significant changes in the post prandial responses of the 8 male subjects studied.
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.0
Figure 5.1 The effects of additional dietary cholesterol on p<1.006 lipoprotein cholesterol content. The 
control load contained 500mg of cholesterol and the test load contained 900mg. The amount of 
cholesterol passing through the triglyceride rich fraction was not significantly different in either case.
T mmol/1
Hours
Q
Control
F = q With additional
E = cholesterol
24
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p<1.006 Triglyceride 
mmol/1
4
Responses (mmol/1) |
■ 9
Saturated Unsaturated |
A 2 1.32±0.94 1.3010.50
4 2.45±2.20 1.9611.45
6 2.03±2.83 1.2611.05
8 0.9912.02 0.09±0.14
24 -0.0410.32 -0.0510.19*
| Area 12.58±13.0 9.1415.74
0 2 4 6 8 24
Figure 5-2 p<1.006 triglyceride after fat loads of differing fatty acid composition. *P£0.05, n-7males.
5.2.2 The effects o f  altering the fatty acid saturation o f the fat load  
P o st p r a n d ia l resp o n ses: Mean p<1.006 triglyceride profiles for the saturated and 
unsaturated fat loads are given in Figure 5.2. Responses to the two types of fat diverged during 
the later stages of lipaemia, although only achieving statistical significance at 8 hours. p<1.006 
triglyceride areas were not significantly different. Retinyl palmitate responses however 
differed markedly in the two fat load tests (Figure 5.3). Replacement of saturated fat by 
unsaturated resulted in an RP profile which rose earlier, to greater peak levels, and started to 
decline sooner. There were no observable differences in the lipaemic responses in the other 
lipoprotein classes.
p<1.006
Retinyl palmitate 
5 t  p.mol/1
Responses (pmol/1) |
t i a
Saturated Unsaturated
A 2 0.54±0.51 3.1511.62***
4 0.9811.05 4.4712.39**
6 1.5011.82 4.9114.23*
8 1.911198 2.6210.91
24 0.1910.17 0.1810.12
Area 7.9418.31 27.7115.5***
Hours
24
Figure 5-3 The flux of retinyl palmitate was greater when consumed with the unsaturated compared
with the saturated fat load, *P<0.02, •*P<0.002, •**P£0.001, n-7males.
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% Lipolysis
f  Unsaturated Saturated
5 15 30 60 90
Minutes incubated
Figure 5*4 Chylomicrons formed after saturated and unsaturated fat loads were Isolated at 5 hours post 
prandially, labelled with tritiated triolein and incubated with partially purified bovine milk LpL. The 
extent of lipolysis was estimated as liberated free fatty acid bound tritium. 9 subjects consumed both fat 
loads. Error bars are standard deviations. No significant differences were found.
In  v itro  U polysis: Radioactive free fatty acids liberated during lipolysis were extracted,
and lipolytic activity expressed as a percentage of total added radioactivity. The mean percent 
hydrolysis from 9 subjects are plotted in Figure 5.4. Paired comparisons of these values failed 
to reveal any differences in the extent of hydrolysis of either substrate.The fatty acid 
compositions of fat loads and p<1.006 lipoprotein substrates are summarised in Figure 5.5. 
Some general points can be made from this data.
Firstly, within a specified fat load the fatty acid compositions of triglycerides and 
phospholipids were broadly similar. It can be seen however that consumption of a fatty meal 
does not give rise to lipoproteins of identical fatty acid composition to the meal fed. Analysis 
of lipid classes reveals that triglyceride fatty acids do resemble those of the fat load, therefore 
triglyceride fatty acids are noticeably different in each of the two groups of substrate.
Phospholipid compositions however did not change with the fat load to the same 
extent They differed considerably from the composition of the fatty meal and were similar in 
the two substrates. Fat loads therefore acutely affected the fatty acid composition of 
triglycerides in p<1.006 lipoproteins, but did not influence phospholipid fatty acids so 
markedly. These alterations did not significantly alter their susceptibility to lipolysis in vitro 
by a purified bovine milk LpL. There was a negative correlation between the percentage of 
16:0 in substrate phospholipid & % lipolysis (-0.83, P^0.005), and a positive correlation 
between the percentage of 18:2 & %lipolysis (0.76, P<0.02).#
# Results quoted for 5 minute samples also held at other time points.
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1C ream '
Triglyceride
Phospholipid
Triglyceride
Phospholipid
|  Fat load
} p< 1.006 lipoprotein
’M ayonnaise'
Triglyceride
Phospholipid
Triglyceride 
Phospholipid
0 10 2 ) 3 0  40 50 60 70 80 90 100
p< 1.006 
lipoprotein
Percentage composition
c m
Saturated
Mono­
unsaturated
0)6 0)3
Poly-unsaturated
Figure 5.5 Fatty acid compositions of lipids in fat loads and product chylomicrons as analysed by TLC. 
Lipoprotein compositions are the mean of 9 preparations.
Discussion
S
5.3 The cholesterol content o f a Cat load
Supplementation of the diets of certain animals with cholesterol has been found to lead to 
marked hypercholesterolaemia as well as to the formation of abnormal lipoprotein species.54 
Although controlled metabolic ward studies indicate that increased dietary cholesterol can 
raise plasma cholesterol in man, the effect is not as great as that found in experimental 
animals.226 An increase of 500mg of cholesterol in the fat load did not materially alter the 
magnitude or direction of post prandial cholesterol flux in the present experiment.
It was hypothesized that additional dietary cholesterol, by expanding the cholesterol 
content of newly secreted chylomicrons, might enhance the formation of cholesteryl ester 
enriched remnants in plasma. Several factors probably contributed to an attenuation of the 
impact of additional cholesterol on post prandial lipoproteins.
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Firstly, much of the cholesterol absorbed from the gut is derived from endogenous 
sources (bile and gut endothelial cell debris). Thus while 400-500mg is the average daily intake 
of dietary cholesterol, a further 800-1200mg per day enters the intestine in bile.227 Therefore 
increasing the cholesterol load by 125% (from 400mg to 900mg), may effectively increase the 
amount of cholesterol traversing the gut by only 35%.
Secondly, cholesterol absorption from the gut is not quantitative. Estimates vary widely 
between 25 - 75%.226,227 Therefore of the 35% extra passing through the gut only a rather 
poorly defined proportion will be absorbed and enter the bloodstream.
Thirdly, nascent chylomicrons seem to contain considerably less cholesterol than their 
plasma counterparts, most being acquired by transfer from cell membranes and other 
lipoproteins upon entering the plasma compartment.21 The proportion of chylomicron 
cholesterol derived from newly absorbed material may therefore be relatively small, and 
increasing this amount by a small percentage will make minimal impact on the total 
cholesterol content of this plasma fraction.
A clearer determination of the significance of the cholesterol content of a fat load in post 
prandial lipoprotein metabolism will require more sensitive techniques than those applied 
here.
5.3.2 The fatty ad d  saturation o f  the fat load
A reduction in the degree of saturation of the fat load reduced the triglyceridaemic response 
only marginally. Two similar studies,228,229 published recently, also found that alteration of the 
fatty acid composition of a fat load has, by itself, little effect on lipaemia when adm inistered 
against a background diet which is relatively rich in saturated fats. The importance of the 
chronically fed fat was emphasized by both of these studies.
The free living Scottish diet, against which the the present study was conducted, has a P/S 
ratio in the region of 0.3,230 which lies between the experimental 'saturated' diets instituted 
by Harris et a l (0.5), and Weintraub et a l (0.07)*. Therefore the habitual diets of these subjects 
may have minimised any differences in lipaemia induced by changing acutely the composition 
of the fat load.
Nevertheless there was a reduction in triglyceridaemia biased towards later A values. This 
suggests a more efficient clearance of un-saturated fat loads, and led to the hypothesis that 
chylomicrons formed after a saturated fat load may be more susceptible to lipolysis by LpL 
than those formed after an unsaturated load. Studies on the fatty acid specificity of LpL, have 
however yielded contradictory results. It seems in general that when synthetic substrates are 
examined LpL exhibits a preference for short chain, unsaturated fatty acids at the 1 or 3
* The potential role of mono-unsaturated fats should be borne in mind when comparing the results of 
these studies. Whereas the 'saturated' loads had reasonably similar P/S ratios in both studies (0.07), 
Weintraub et a l specifically examined the effects of replacing saturated with poly-unsaturated fat, 
whereas the present study explored the effects of reducing the saturated fat content. Therefore the 
relative contributions of mono and poly unsaturated fats were not considered.
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position of triglycerides,231,232 but when lipoprotein substrates are assayed preferences are 
not so evident.233'235
Although synthetic emulsions can be useful for assaying lipolytic activity (eg in the 
intravenous fat tolerance test), they cannot be expected to reproduce the subtle interaction 
of components which guide the metabolism of lipoproteins in vivo. For this reason we chose 
to manufacture chylomicrons in vivo by administration of different fat loads. By this means 
they were endowed with the full complement of apoproteins and co-factors, in physiological 
combination with naturally derived lipid components endogenous to the individuals studied, 
and so reflecting the sum of the processes of chylomicron formation and transport in their 
response to differing fat loads. These were then labelled with l4C trioleate and incubated with 
LpL.
The purpose of the incubation therefore was not to test the specificity of LpL for 
particular fatty acids, but to assay the susceptibility to lipolytic attack of chylomicrons whose 
bulk composition was determined by oral intake of different fats. No major differences were 
found.
This finding might appear to contradict the in vitro lipolysis data of Weintraub et 
a f2*who performed a similar experiment and found greater overall fatty acid release when fat 
loads were poly-unsaturated. They found this to be an acute effect, not dependent on the 
nature of the long term diet, and suggest that it may be due to a greater susceptibility of poly­
unsaturated triglyceride to LpL activity. The conflicting evidence regarding this possibility has 
been mentioned above, and these authors themselves concede that it is contrary to their 
finding of no difference in the clearance of saturated and poly-unsaturated fat loads while on a 
saturated fat diet.
Differences in the methodologies employed by these studies may provide a clue to these 
apparently contradictory results, and may also help to explain the differing chronic and acute 
dietary effects on alimentary lipaemia. The rate of release of fatty acid during lipolysis, as 
assayed by Weintraub, depends not only on the reaction between LpL and triglyceride, but 
also on the rate of the preceding interaction between the enzyme and the chylomicron 
surface. It is the combined influence of the multiple interactions at this earlier stage, and the 
effects of dietary variations on them, which were assayed in the present study.
Therefore while poly-unsaturated triglycerides may be preferred by LpL, if 
chylomicrons differ only  in their triglyceride composition then the initial interactions 
between enzyme and substrate, which are dependent on surface considerations, may not 
differ, and the overall impact on lipaemia may be reduced. The importance of the fatty acid 
composition of phospholipid was underlined by the correlations observed between %18:2, 
%l6:0, and %lipolysis. Their influence on lipolytic rates has been demonstrated previously.236- 
238 Emulsions carrying saturated phosphatidyl cholines seem to be poor substrates for LpL 
compared with those containing mixed chains (egg yolk)238
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Although phospholipid fatty add composition is readily altered by dietary glycerides, 
yet metabolic controls on phospholipid composition seem to be more stringent than those 
on triglyceride,239 and they are therefore more resistant to acute dietary changes.84 This may 
be due to a quantitatively greater endogenous contribution to chylomicron phospholipids.69
When acute effects alone are investigated in vitro, then any differences will be due 
mostly to triglyceride preferences. If the end point of the assay is the release of the same fatty 
ad d  from both species of chylomicron (ie radio-oleic acid in the present study) then this 
difference will be obscured, whereas a measure of the total release of fatty ad d  (as in 
reference 228) would be expected to allow differences to be more easily detected.
When the effects of chronic feeding are investigated in vitro the influence of surface 
composition will be more evident. Such changes may be more apparent when assaying with a 
single labelled triglyceride, but not so when triglyceride release is the end point.
An alternative explanation for improved dearance after a poly-unsaturated meal would 
be the swifter removal of remnants. Evidence for this should have come from the RP data. 
However the increased response of RP after an unsaturated load is difficult to explain, and 
contrasts with other reports.228 Dietary fatty acid composition has not been found to affect 
RP absorption.228,240 It is possible that the different format of the mayonnaise (semi-solid as 
opposed to liquid) affected digestion and absorption of RP.
Chapter 6
Lipid lowering drugs
in
alimentary lipcemia
6.1 Introduction and Methods 
S
Pharmacologic intervention is used as a second line of treatment when dietary measures fail to 
correct plasma lipid abnormalities. At least two large studies have shown that such 
intervention not only improves the lipid profile, but can lower the risk of suffering from 
CHD .33-35 Although the main use of such drugs is obviously in the correction of lipid 
abnormalities, their biochemical effects are now sufficiently well described to allow their use 
as probes of lipoprotein metabolism. Thus in this part of the study two classes of lipid 
lowering drugs with known hypo-triglyceridaemic potential were administered to normal 
volunteers in order to further elucidate the nature of post prandial lipaemia.
Eight males, mean age 29.4 ±3 .7  years, took 300mg of fenofibrate (isopropyl 2-[p-(p- 
chlorobenzoyl) phenoxy]-2-methyl propionate) (Laboratoire Fournier) per day as three 
lOOmg tablets. A separate group of eight males, mean age 34.3 ± 9.5 years were given 3g of 
nicotinic acid (Napp Laboratories) in the form of two 500mg tablets 3 times per day. In each 
of these studies fasting & post prandial lipoproteins and lipase activities were assayed before, 
and again six weeks after embarking on the course of drug treatment Subjects were asked 
not to alter their dietary or exercising habits for those six weeks.
6.2 Results 
S
6.2.1 Fenofibrate
Six weeks of treatment with fenofibrate reduced serum cholesterol from 5.00±0.63 to 
4.29±0.59 mmol/1 (ll4% , P^0.005), and fasting triglyceride from 1.29±0.68 to 0.88±0.31 
mmol/1 (i32%, P<0.05). The fasting lipoprotein profile in Table 6.1 shows a reduction in the 
mass of apo B containing lipoproteins, and an increase in HDL3 . Post heparin LpL activity was 
increased from 196.4±67.0 to 268.1±77.0 mU (t36%, P<0.05), but HL activity was not changed.
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Table 6.1 Fasting lipoproteins after fenofibrate treatment
VLDL IDL LDL HDL2 HDL3
Control 80.7 18.7
(mg/dl)
252.5 68.8 228.1
±54.6 ±14.4 ±55.3 ±31.3 ±30.0
Fenofibrate 59.0 11.9 195.9 56.6 271.4
±29.7 ±5.7 ±40.9 ±35.6 ±33.0
l27%‘ NS i22.4%“ NS tl9%**
Significance of changes in total lipoprotein mass following 6 weeks treatment with fenofibrate. • P^O.l, 
••PiO.Ol, NS -  not significant, n-8 males.
The fall in fasting VLDL mass was of only marginal significance, and in VLDL triglyceride 
(0.55±0.42 to 0.39±0.21mmol/l), it was not statistically significant. The effects on post prandial 
p<1.006 triglyceride were more pronounced. The overall response to the fat load was reduced 
by 50% (Figure 6.1), affecting particularly A4 to A6. RP levels on the other hand were if 
anything increased by fenofibrate treatment (Figure 6.2).
Among the associated post prandial changes in lipoprotein lipids the magnitude of the 
decline in HDL cholesteryl ester during lipaemia was virtually eliminated for the group as a 
whole (HDL cholesteryl ester areas -33.1±34.0 to 0.4 ±23.1, P<0.05).
Figure 6.1 Triglycerides in the PS1.006 fraction after 6 
w eeks on fenofibrate. Fasting levels were noi 
significantly less but the post prandial response was 
reduced. *P£0.1, ••P£0.05, n-8 males.
p e l .006 
Triglyceride
mmol/1
Post prandial response
2.50 t
2.00 ■■
1.00 ■■
Hours
A
Control Fenofibrate
l = o = |
2 1.66±1.58 1.11±1.09**
4 2.18±1.62 0.81±0.31*
6 1.21±l.l6 0.66±0.67M
8 0.54±0.80 0.11±0.29*
24 0.06±0.14 -0.13±0.14
Area 10.63±9.15 5.26±3.64**
...................
24
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Retinyl palmitate 
pmol/1 
3.0 T
Hours
Area Q±mol/l • 8hours) 1
[ 2 |  Control 6.02±3.89
Fenofibrate 10.51±5.l6*
\
\
\
^  x  \
V»O
— — — -1------- -H
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Figure 6.2 Treatment with fenofibrate was associated with an increase in post prandial RP response. 
•P^O.l, •*P£0.05, n-8 males
6.2.2 N icotin ic acid
Nicotinic acid treatment led to a reduction in fasting serum cholesteryl ester, triglyceride, and 
phospholipid (Table 6.2). Alterations in the distribution of fasting lipoprotein mass in Table
6.3 shows a reduction in VLDL and LDL, and an increase in HDL2. LpL activity fell from 
210.1±54.5 to 178.9±70.6mU ('19.5%, P^0.02), but HL was not significantly altered. Nicotinic 
acid also lessened the post prandial triglyceride response to the fat load (Figure 6.3), although 
RP flux was not significantly affected by drug treatment (Figure 6.4).
Despite the absolute changes in LDL and HDL, the response to the fat load, ie the rise in 
CE/TG and the fall in FC/PL ratios during lipaemia, were not affected by nicotinic acid.
Table 6.2 The effects o f nicotinic acid on fasting serum lipids
Cholesterol 
Free Esterified
Triglyceride Phospholipid
Control 
Nicotinic acid
1.55
±0.70
1.44
±0.50
NS
3.14
±0.68
2.28
±0.48
427%**
mmol/1
1.47
±0.55
0.88
±0.42
440%”
2.68
±0.50
2.22
±0.41
417%**
Significance of changes in serum lipids following 6 weeks treatment with nicotinic acid. P^O.05, 
"P^O.001, NS -  not significant, n-8males.
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Fl0ire63 The effects of nicotinic acid on p< 1.006 
triglycerides. Both fasting levels and the post prandial 
response were reduced; *P£0.1, MP£0.o5, ***P£0.02, 
n-8 males.
p<1.006
Triglyceride
mmol/1
Post prandial response 
Control Nicotinic add
2.0 ■
1.0 ■
Hours
A l= < > = 1
2 1.60±1.08 1.0310.84**
4 2.94±1.82 1.7511.69*
6 2.4312.65 1.1211.07*
8 1.1012.06 0.5910.54
24 -0.2410.26 -0.0510.18***
Area 15.04111.19 8.3916.50**
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6.3 Discussion
The two dasses of drug used in this part of the study were selected for their known ability to 
lower triglyceride, and because both have seen many years of dinical use, during which time 
much has been learned regarding their pharmacology and their hypotriglyceridaemic 
mechanisms.
Nicotinic add  is thought to act by reducing VLDL synthesis.241 It does this by lowering 
the activity of hormone sensitive lipase in adipose tissue, inhibiting triglyceride mobilisation 
and so circulating free fatty add falls sharply. This in turn reduces triglyceride formation and 
incorporation into VLDL in the liver. Fenofibrate on the other hand is considered to act by 
promoting triglyceride clearance at the periphery through a stimulation of LpL. 242 Both 
dasses of drug effectively lowered post prandial triglyceridaemia in line with these proposed 
mechanisms of action.
Fenofibrate raised post heparin LpL. At the same time there was a reduction in fasting 
VLDL and a rise in HDL3. This is in line with an increased flux of p<1.006 lipoprotein surface 
materials into HDL subject to an increase in lipolytic activity. The reduction in VLDL and in 
post prandial triglycerides also means that there is less opportunity for transfer of cholesteryl 
esters from HDL into p<1.006 lipoproteins, and so the post prandial decline in HDL 
cholesterol was eliminated.
Nicotinic add  produced a similar reduction in post prandial triglycerides without a rise in 
LpL activity. This effect may be secondary to the reduction in hepatic VLDL which will ease 
competition for the lipolytic pathway, and so enhance the throughput of post prandial tri-
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Table 6.3 Fasting lipoproteins after nicotinic acid
VLDL IDL LDL HDL2 HDL3
Control 108.3 11.5
(mg/dl)
218.9 44.3 224.1
±58.2 ±4.6 ±81.2 ±18.1 ±82.9
Nicotinic acid 59.1 11.4 175.0 82.3 196.4
±48.5 ±7.1 ±60.7 ±26.3 ±46.3
4-45%* NS 420%** t 86%* NS
Significance of changes in total lipoprotein mass following 6 weeks treatment with nicotinic acid. 
P10.02, ** Pi0.005, NS -  not significant, n-8 males.
glycerides. Without an increase in lipolysis however one would not expect an increase in 
HDL. On the contrary the smaller amount of VLDL substrate should provide less material for 
transfer to HDL. Although there was a fall in HDL3 it was not statistically significant. HDL2
however was virtually doubled.
These changes in HDL _ an increased HDL2/HDL3 ratio due to a fall in HDL2 and a rise in 
HDL3 _ are a frequent consequence of nicotinic acid treatment,243-244 and serve to illustrate the 
point that these drugs may have effects other than on triglyceride turnover.
Both fenofibrate and nicotinic acid lowered LDL. In the case of nicotinic acid this may 
stem from the fall in production of VLDL precursor. Fibrates on the other hand may 
promote LDL clearance.242 Despite the fall in levels of LDL neither drug altered the post
prandial compositional changes
Gemfibrozil, a fibrate related to fenofibrate, was found to reduce RP in Type IV and 
Type Ha hyperlipidaemia,1®4 although the effect was more striking in the chylomicron 
(S/>1000) than in the non-chylomicron (S/<1000) fraction. There is also evidence that 
gemfibrozil may be able to promote uptake of VLDL remnants by apoE receptor mediated 
pathways.245 There was no evidence from this study that either fenofibrate or nicotinic acid 
could reduce the amounts of circulating chylomicron remnants. The cardioprotective
influence of these
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Chapter 7
General discussion
7.1 On the fat tolerance test 
S
It is a principle function of the plasma lipoproteins that they distribute newly ingested dietary 
fats to the tissues; a function in which they are engaged for a major part of daily life. Since 
dietary fat intake therefore represents a significant component of the lipoprotein system, 
and since both dietary fats and lipoprotein metabolism are strongly linked to the 
development of coronary heart disease, it is perhaps surprising that research has focussed 
largely on lipoprotein metabolism in the fasting state. This is particularly so since early studies 
clearly identified alimentary lipaemia as a feature of CHD.13-14'4®-51
The reasons are probably mostly operational, deriving from the difficulties in designing 
and applying a uniform test in a reproducible way, and then in the interpretation of the 
widely varying results. The advent of the ultracentrifuge, the discovery of an endogenous 
lipoprotein system, and the subsequent identification of distinct disorders, easily recognised 
in fasting sera, may have distracted attention from the less well defined 'alimentary lipaemia'. 
More recently however, the increasingly detailed knowledge of the morphology of the 
lipoprotein system, of the enzymes involved in its regulation, and the growing appreciation 
of its essentially dynamic nature, have led to a resurgence of interest in post prandial 
metabolism, and have highlighted the necessity for some sort of function test in addition to 
existing static assessments of fasting, 'steady state' levels.
Although the problems of standardisation attending the implementation of fat tolerance 
tests remain, it is hoped that this study has shown how post prandial metabolism may be 
related to the fasting lipoprotein profile of an individual, and has indicated some features to 
which attention might be directed in the future.
It is worth considering first some general features of the test itself, and how some of its 
problems may be reduced or accounted for. To some extent these will depend on the 
resources available, and the detail with which the subject is to be studied.
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The background to the test: Obviously, as with any physiological system, individual 
genotype in combination with environmental & behavioural circumstances combine in 
determ ining lipoprotein response to a fat load. In addition to any explicit dys- 
lipoproteinaemias or other metabolic conditions, it may be informative to include 
measurement of apoE isoforms when conducting fat load tests. Although not addressed 
specifically in this report it has been shown to affect the pattern of post prandial response.150
It is clear that the habitual diet of individuals, in particular the fatty acid composition, is 
equally, if not more important than the composition of the fat load in determining response. 
Therefore careful dietary assessment, or perhaps the implementation of standard diets prior 
to testing, combined with fatty acid analysis of lipoprotein lipids, may eventually simplify 
interpretation.
It may also be helpful to assess levels of fitness in addition to age, body mass etc, since 
exercise can influence lipaemia,246 lipase activities, and lipoprotein levels.247
The form  o f the test: Tolerance to fat depends on many processes, from digestion to
remnant clearance, and it is possible to modify the test to make it more specific to particular 
aspects. Thus rates of absorption can be tested more directly by intra-duodenal infusion, and 
rates of clearance can be studied by intra-venous administration of emulsions. The oral fat 
tolerance test is the least specific, but the most physiologic of these methods since it tests the 
combined efficiency of all of these processes.
The objective of the present study was to assess lipoprotein changes during lipaemia, 
without particular regard to the factors regulating its magnitude. In this context the oral route 
was the most suitable since by this means the endogenous lipoprotein system was exposed 
to exogenously derived material in the form of chylomicrons manufactured according to the 
natural physiology of the individual.
The composition o f the fa t toad: This can be tailored to the investigations being
undertaken, with due consideration to the background long term diet. It may be 
representative of the normal diet, or it may be experimental in design. It should however 
contain carbohydrate and protein in amounts sufficient to allow physiological digestion to 
take place. Future work may perhaps involve the use of a 'mixed meal' containing 
carbohydrate, fat and protein in proportions representative of realistic diets. Such meals will 
call into play all of the control mechanisms of intermediary metabolism, and may require 
assessments of ‘non lipoprotein’ parameters such as glucose or insulin responses. The results 
may be more difficult to interpret but would however, have the advantage of being more 
relevant to real life.
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Regarding the amount of fat given, it is necessary to provoke a measurable response in 
an individual, and to allow discrimination of those with impaired or poor ability to cope with 
exogenous fat Even with the comparatively large loads given in this study (of the order of a 
days supply of fat calories) some of the subjects demonstrated triglyceridaemia barely 
exceeding fasting levels. Such is the variation even in a normal population however, that 
others experienced massive and prolonged lipaemia after the same fat load. It is important to 
remember nevertheless, that the total quantity of fat passing through the lipoprotein system 
was the same in each case, and that it is the relative rates of appearance and disappearance 
that account for the different levels of triglyceridaemia.
It has been common practice to administer fat according to body mass or surface area, 
so that larger individuals receive more.162-184 There is little evidence however that larger 
people can accommodate greater amounts of fat. On the contrary there seems to be a 
negative correlation between body mass and the magnitude of lipaemia, so that giving less fat 
to smaller individuals may only bias results.
Tbe co n d u c t q f  tb e  test: Standardisation of the fat tolerance test is facilitated by
starting at a set time of day, probably in the morning after an overnight fast. This fits with a 
normal physiological situation, and also circumvents any problems arising from the diurnal 
variations known to affect triglyceride levels.248 To continue the fast after administration of 
the fat load introduces a further problem however, since such a situation is neither 
physiological nor practical. A compromise may be to allow standard low fat meals at 
appropriate times.
Samples should be taken more frequently and for longer than they were in this study. It 
seems that triglyceridaemia in the more extreme cases may still be significant up to 12 hours 
after consuming the fat, and that remnant particles can persist in significant amounts at least 
as late as 24 hours. More frequent (hourly) sampling would reduce the danger of missing the 
narrow or biphasic peaks described by some studies.192>195 This may be even more 
important when considering the rapidly changing responses affecting flux of lipid between 
lipoprotein species.
M easurem en ts: Although triglyceridaemia is the most obvious and well recognised
change in post prandial plasma, it is not the only one. Free cholesterol changes for example, 
were inversely related to triglyceridaemia. Therefore in those who suffered the least lipaemia a 
post prandial rise in free cholesterol was more easily detected. It remains to be established 
whether it is simplistic only to measure triglycerides, or whether some other estimates may 
say more about the efficiency of post prandial lipid transport. The next section, in describing 
some of the features of post prandial lipoprotein metabolism, may suggest some areas to 
which attention could be directed.
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7.2 Post prandial lipoprotein metabolism
S
7.2.1 Post prandial lipoprotein  m etabolism
Oil 2nd water, according to the commonly held maxim, don't mix. Since 'oils' must travel 
through an aqueous environment to satisfy the bodies requirements for lipid material, 
physiological systems have evolved which permit not only the transport of lipid, but the fine 
regulation of its distribution according to the requirements of the tissues. This system 
integrates the movements of polar and non-polar lipids, in conjunction with specific 
specialized proteins, by exploiting the amphiphilic character of the polar lipids in the 
dissolution of the non-polar triglycerides and cholesteryl esters. The polar lipids enclose the 
non-polar in a spherical particle, and the proteins direct their movements.
It is an inevitable consequence of this arrangement however, that the metabolism of 
these lipid groups have become interdependent to a degree, so that flux in one will influence 
that of others. One should remember nevertheless, that the common transport system does 
not necessarily signify a common origin, destination, nor function for these hydrophilic 
molecules. Thus the operation of the triglyceride transport system, designed primarily for 
the distribution of fuel materials, can affect the movements of cholesterol and phospholipid 
whose turnover in the tissues are not strictly related to energy requirements. This effect is 
nowhere better observed than during post prandial lipaemia. The following scheme may 
account for many of the observations made in this and in other studies.
The first and most obvious feature characterising lipaemia is an increase in the average 
size of the triglyceride rich lipoproteins, producing the characteristic turbidity of the serum. 
This increase in size distinguishes alimentary from endogenous triglyceridaemia, which is 
associated with an increased number o f circulating hepatic VLDL.175 The periodic influx to the 
bloodstream  of these large triglyceride enriched particles perturbs transiently the 
'equilibrated' state of fasting lipoprotein transport by altering the composition of both the 
polar and non-polar phases of circulating lipid.
Firstly the non-polar core of the chylomicron is initially relatively poor in cholesteryl 
ester, and has a lower ratio of cholesteryl ester to triglyceride compared with surrounding 
membranes and other lipoprotein species. Secondly, the surface phospholipid film is 
relatively deficient in free cholesterol, and has a lower ratio of free cholesterol to 
phospholipid. The concentration gradients thus developed induce several processes which 
run in parallel during the lifetime of the chylomicron and its remnant These are illustrated in 
Figure 7.1.
L ip o lysis: Upon entering the circulation chylomicron triglycerides are hydrolysed by
LpL, free fatty acids are released, become bound to albumin, and are removed from the lipo-
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lytic site. As the triglyceride core diminishes surface phospholipids become superfluous and 
are also released into the circulation. The pattern of lipid flux observed as this proceeds is a 
rise followed by a decline in the triglyceride and phospholipid content of the p<1 .006  
fraction, with a peak at around 4 hours. In whole plasma however levels of phospholipid do 
not fall away after this peak, but continue to rise, in many individuals till at least as late as 8 
hours after consuming the fat load. The greater the rate of lipolysis the more phospholipid 
will enter the p>1.006 fraction, and since LDL and HDL are turned over more slowly than 
p<1.006 lipoproteins the more prolonged the phospholipid peak will be.
F ree ch o leste ro l flu x :  The result of phospholipid uptake by these lipoproteins is a
reduction in the ratio of free cholesterol to phospholipid in the surface regions, leading to 
the formation of a free cholesterol gradient between cell membranes (mainly red blood cells) 
and circulating LDL and HDL. Since free cholesterol can diffuse between lipoprotein and 
tissues there is a subsequent movement into the circulation where it becomes associated with 
both LDL and HDL. Since this flux depends on the uptake of phospholipid by these 
lipoproteins the rise in free cholesterol comes even later than the rise in plasma 
phospholipid. The greater the transfer of phospholipid the steeper the free cholesterol 
gradient will be. A greater flux of free cholesterol would therefore be expected to 
accompany more efficient lipolysis.
LCAT a c tiv ity : Although their is evidence that LCAT may act on LDL,156 quantitatively the
majority of plasma activity is associated with HDL. The transfer of both phospholipid and 
cholesterol to these lipoproteins will therefore provide substrate for the known increase in 
post prandial LCAT activity,206 the cholesteryl esters so formed enriching the core of HDL. 
The extent to which this occurs in LDL is unknown. Despite the assimilation of free 
cholesterol & phospholipid and the activity of LCAT, there was no absolute rise in cholesteryl 
esters in LDL or HDL. On the contrary their was a highly significant fa ll in HDL cholesteryl 
ester during lipaemia.
C ore lip id  tra n sfe r: Lipolysis takes place against a background of LTP activity which 
strives to bring about equilibrium in the distribution of core lipids between the lipoprotein 
fractions. The introduction of a large triglyceride pool initiates a period of core lipid flux in 
which triglyceride was seen to penetrate all of the lipoprotein classes in parallel with the rise
and fall in the p<1.006 fraction.
Cholesteryl esters on the other hand should move in the opposite direction, leaving HDL 
(and LDL) and entering the triglyceride rich fraction. This phenomenon has been described 
before and is most evident in the HDL.152-153-217 Having become enriched in triglyceride at the 
expense of cholesteryl ester the HDL apparently acquire affinity for hepatic lipase which
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hydrolyses triglyceride (and phospholipid) leaving a small sized HDL3 like particle. This 
scenario is thought to underlie the reciprocal link between lipaemia and HDL levels. The 
position of LDL in the scheme is less clear.
R em nant fo rm a tio n  a n d  clearance: Hydrolysis of chylomicron triglyceride is
extensive but not complete. At an indeterminate stage in its catabolism the chylomicron 
loses affinity for lipase and is broken down no further. At this stage the whole remnant is 
removed from the circulation by a hepatic receptor. The present study suggests that a 
significant proportion of these particles remain in the circulation for up to 24 hours after 
ingestion of fat
VLDL p ro d u c tio n : Evidence that levels of hepatic VLDL rise during lipaemia has
accumulated steadily.190-195-249*250-251 Material for the production of VLDL would presumably 
be derived from FFA which are not effectively cleared at the periphery,252 and which have 
been found to rise during lipaemia, and from breakdown products delivered to hepatocytes 
in the form of chylomicron remnants.191
The preceding diagram and notes represent a simplified and idealised description of the 
processes operating during post prandial lipaemia. The situation in vivo however, is clearly 
one in which they work in an integrated and interdependent fashion, and the observed 
pattern is therefore a compound one.
7.2.2 Factors influencing the pattern o f post prandial lipaemia
The regulation of post prandial lipoprotein metabolism may be viewed on several different 
levels. The environmental/behavioural effects of diet, alcohol consumption, exercise habits, 
etc, are superimposed on genetic influences acting through the medium of apoprotein 
polymorphisms, receptor activities and enzyme production rates (Table 1.1). These are the 
factors most commonly identified by clinical or epidemiological study. It is important to 
remember that lipoprotein metabolism takes place within the context of whole body 
metabolism, and that nervous, hormonal, or metabolic conditions perhaps only indirectly 
related to fat metabolism may also have repercussions during the post prandial phase.
The above factors impinge on one or more of the metabolic processes discussed 
throughout this thesis. At this ‘systems’ level the relative rates of lipolysis (LpL & HL), lipid 
transfers, and LCAT activity, in conjunction with the pool sizes and lipid carrying capacities of 
all the lipoprotein classes combine in determining the pattern of events.
The central process here would seem to be the rate at which chylomicrons traverse the 
lipolytic cascade since this determines not only the size of the circulating triglyceride pool, 
but also the production rate of remnants and the rate of phospholipid flux into p<1.006
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fractions. These in turn influence free cholesterol efflux, compositional changes, and LCAT 
activity. Since chylomicrons are turned over much faster than other lipoprotein classes the 
rate of their removal will largely determine the period available for transfers to take place.
A second key event is the conversion of chylomicron to remnant. This transition 
represents the end of lipolysis and a change from a fast to a slower phase of catabolism. The 
suitability of the remnant as a ligand for its hepatic receptor at this stage will be crucial in 
determining the plasma residence of the remnant and its subsequent fate. If, at the cessation 
of lipolysis, the remnant is only poorly identified by its receptor, then further remodelling in 
the plasma may eventually preclude hepatic uptake leaving clearance to take place by other 
routes.
Physical methods are unable to isolate such remnants, and metabolic methods are only 
approximate. Notwithstanding these difficulties the question of what regulates the transition 
to remnant and permits its uptake by receptors is important and should certainly provide a 
focus for future investigation.
In approaching these problems we may benefit from an examination of the many fine 
variations in affinity between lipids, apoproteins, enzymes, and cofactors etc. In a dynamic 
process involving constant flux and interchange of components even small fluctuations in 
affinity may be fundamental in directing the course of events.
On this more subtle level there are several examples of such regulations, and room for 
speculation on others. The cholesteryl ester content of the chylomicron,256 the nature of the 
fatty acid components of phospholipid at the chylomicron surface,257'258 or the build up of 
lipolytic products (FFA and lyso phospholipid) in the micro environment around the 
lipolytic site may affect the rate of lipolysis.157 In this circumstance the ability of plasma 
factors to clear these materials, or the capacity of the tissues to assimilate them may be 
important.255
Other possibilities may include the change in curvature at the surface, or a change in the 
composition of the core as triglyceride substrate is replaced by cholesteryl ester. At the 
critical stage of catabolism which depends on the ordered departure of apoCII and CIII, and 
the activation of apoE even small changes in affinity between chylomicron, apoproteins and
enzyme may be important.
Similar factors may apply to core lipid transfer rates where the binding of lipoprotein 
and transfer protein appears to be an essential step in the process.207 The raised 
phospholipid and FFA content of HDL,2Ce and the increase in LDL free cholesterol205 have 
both been proposed as enhancing transfer activity, and of having as a consequence a 
stimulating effect on LCAT activity.
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7.2.3 A lim entary lipaem ia and atherosclerosis
There seems little doubt that alimentary lipaemia, certainly as defined by post prandial 
triglyceridaemia, is positively associated with coronary heart disease. From this and other 
studies several aspects emerge whereby a more massive and prolonged lipaemia may be 
causally related to the development of the disease. Although these mechanisms are not 
necessarily directly related to the triglyceridaemia itself, they stem from the influence that a 
delayed clearance of triglyceride rich particles has on the distribution of cholesterol among 
the tissues and other lipoprotein fractions.
1. A prolonged lipaemia will be marked by a reduced flux of phospholipid into p> 1.006 
fractions, and hence a reduced flux of free cholesterol from tissues into the lipoprotein 
system. Such a decrease in the efficiency of free cholesterol clearance from tissues may have 
the further repercussion of inhibiting receptor mediated uptake there and thus raising 
plasma levels of LDL cholesterol.
2. Cholesterol which does enter the bloodstream may be directed into metabolic pathways 
with atherogenic potential.
a). Cholesteryl esters may increasingly accumulate in relatively long lived remnant particles 
whose ultimate disposal is not physiologically controlled by receptor systems.
b). HDL levels may be lowered and subfraction distribution shifted towards the smaller HDL3 
by virtue of triglyceride accumulation and cholesteryl ester depletion followed by hepatic 
lipase activity. 200
3. Chylomicron remnants seem to persist longer in plasma in those with CHD. The risk that 
cholesteryl ester enriched remnants represent has been discussed previously. The factors 
underlying the prolonged lifetime of these remnants are not known. Apo E isoforms may 
contribute a genetic component.150 Cholesteryl ester enrichment or related compositional 
changes may themselves lead to a lengthening of their circulation.
4. It may be that metabolic control over VLDL production is less stringent in those at risk for 
CHD, so allowing a rise in production when supplied with an abundance of substrate. 
Inefficient clearance or utilisation of lipolytic products in peripheral tissue may be an integral 
feature of this phenomenon.
5 Although not addressed in the present study post prandial triglycerides may be related to a 
hyper coagulable condition. Thus as well as contributing to the long term development of the 
disease, a rich fatty meal may provide a focus for the acute event.
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